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A bstract
The relationship between ground-state structure and fluorescence lifetime of
tomaymycin was studied using steady-state and time-resolved fluorescence, absorption,
NMR, and photochemical techniques. Excited-state proton transfer and intersystem
crossing were identified as the major nonradiative processes. Solvent isotope effect was
found in aqueous solution, which did not involved C 80H . Photochemical H-D exchange
on aromatic C6H and C9H were observed with similar rate. At 77 K, the total
luminescence quantum yield was determined as 0.99. The quantum yield ratio of
phosphorescence to fluorescence was 1.2. The limiting anisotropy was -0 .3 4 for
fluorescence and -0.1 for phosphorescence.
The number and type o f tomaymycin-DNA adducts present on natural DNA were
identified using time-resolved fluorescence spectroscopy. At low bonding density, only
two species were observed with lifetimes of 4.3 and 7.1 ns and amplitude ratio of
0.4:0.6, presumably representing R5' and S3' binding modes at preferred bonding site
5'AGA. These species were present over a range of solution conditions. The two
species have the same emission spectra, but slightly shifted absorption spectra. The
fluorescence lifetimes were weakly temperature dependent with Ea = 21 kJ*moH. The
kinetics of adduct formation was also studied. At saturating bonding density, the
fluorescence decay showed a bimodal lifetime distribution whether analyzed by least
squares assuming a Gaussian distribution model or by the maximum entropy method.
The bimodal distributions were centered around 2-3 and 6-6.6 ns, reflecting multiple
species on different bonding sequences.
Flexibility of calf thymus DNA and poly(dAdG)*poly(dCdT) (1000+50 bp) were
measured in <41 ns range using time-resolved fluorescence emission anisotropy. A
global data analysis program was developed from the predicted non-exponential

anisotropy decay model for twisting and bending motions of a semi-flexible rod. The
program provides options o f linking or fixing decay parameters and associating lifetimes
with anisotropies. Initial anisotropy o f -0.36 and orientation of the emission transition
dipole o f the drug toward the DNA helix axis of -35° were obtained for both DNA
samples. The torsional rigidities were 2.4 and 2.2 x 10-19 erg«cm~1, and the persistence
lengths were 470 and 140 A, respectively.

x

Chapter 1. Introduction

1.1 Biological Activity and Structure of Pyrrolo[ 1,4]benzodiazepines
Anthramycin, tomaymycin, and sibiromycin (Figure 1.1) are the best-known
members o f the structurally related pyrrolo[l,4]benzodiazepine antitumor antibiotics
produced by various Actinomycetes. The drugs were isolated from Streptomyces
refuineus var. thermotolerans , Streptomyces achromogenes var. tomaymyceticus, and
Streptosporangium sibiricum, respectively (Arima et al., 1972; Brazhnikova et al.,
1972). Other known members are neothramycins A and B, and dextrochrysin.
Extensive reviews on biological activities, structure elucidation, chemical synthesis,
biosynthesis, interaction with DNA, and DNA adduct structure have appeared over the
years (Kohn, 1975; Hurley, 1977; Hurley, 1980; Thurston & Hurley 1983; Hurley &
Thurston, 1984; Hurley & Needham-VanDevanter, 1986; Remers, 1988; M ountzouris
& Hurley, 1992; Remers et al., 1992). This introduction will give a brief summary with
emphasis on tomaymycin and its interaction with DNA.
Pyrrolo[l,4]benzodiazepines have shown highly potent cytotoxic activities as
antitum or agents in animal model studies (Horwitz & Grollman, 1968) and in the trial
o f human cancer treatment (Hurley, 1977; Korman & Tendler, 1965), which was
attributed to their ability to alkylate DNA to inhibit DNA synthesis in cells (Hurley &
Needham-VanDevanter, 1986). The cytotoxic potency in vivo showed an excellent
correlation with the ability to form covalent adduct, i.e., sibiromycin > anthramycin >
tomaymycin > neothramycins (Thurston & Hurley, 1983; Hurley & NeedhamVanDevanter, 1986; Hurley et al., 1988). These drugs have little effect on the synthesis
of protein and RNA (Nishioka et al., 1972). They are nonmutagenic, but highly
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Figure 1.1. Structures o f (lli?,llaS )-an th ram y cin (I), (ll/?,llaS )-to m ay m y cin (II),
and sibiromycin (III).
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recombinogenic in bacteria (Hannan et al., 1978). Unfortunately, their clinical
application has been limited by various dose-limiting toxicities. For example,
anthramycin and sibiromycin can cause cardiotoxicity and tissue necrosis at the site of
injection, while tomaymycin and neothramycins do not. The cardiotoxicity is
presumably due to 9-phenolic and N10-H groups, which the latter two drugs lack and
which can be oxidized into quinone imine (Petrusek et al., 1981). Aided by molecular
modeling studies, nevertheless, it is very promising to use these naturally occurring
drugs as templates for the design of new antitumor agents that have reduced side effects
while maintaining the potent antitumor activity o f the parent compounds. Combining
multidimensional NMR, fluorescence, and molecular modeling techniques,
investigations of the drug-DNA interaction and the structures o f adducts has developed
a firm basis for subsequent design and synthesis aiming at this purpose. A recent
example is DSB-120, a DNA-DNA cross-linker, designed based on tomaymycin (Bose
et al., 1992; Wang, et al., 1992).
These drugs share the same tricyclic nucleus but differ in the ring substituents
and the saturation degree of the pyrrolo ring. The chemical structure o f tomaymycin
was originally proposed by Kariyone et al. (1971) using chemical degradation methods.
The hydroxy group at C l 1 will be replaced by methoxy group in methanol, from which
the crystal was prepared. The X-ray structure was solved by Arora in 1981. The seven
membered ring appears to adopt a boat conformation with prow at C l 1. C l 1 has R
configuration, while C l la has S configuration. The chiral C l la atom causes a 9° righthanded twist conformation along the length of the nucleus, compared to 45° in
anthramycin crystal (Mostad et al., 1978). Although the exclusive R configuration at
C l 1 was found in the crystal, a mixture of C l \-R and C l 1-5 diastereomers were
observed in methanol solution from a combined *H and l3C NMR, fluorescence, and
absorption study (Barkley et al., 1986). This facile epimerization reaches equilibrium in
two hours, presumably by a nucleophilic substitution mechanism through an N 10-C 11

4

imino intermediate (Figure 1.2). The , H NMR conformational analysis and absorption
spectra also indicate that the C5 carbonyl lies closer to the aromatic ring plane in the
(1 IR,1 laS)-diastereomer. The *H and 13C NM R results from another study showed
that the natural tomaymycin in solution had exclusive trans structure at the tail as found
in the crystal, although the cis isomer possessed the similar antitum or antibiotic activity
(Tozuka & Takaya, 1983). In non protic solvent such as chloroform , tomaymycin is
rapidly converted to 10,11-anhydrotomaymycin, a nonfluorescent species.
The total syntheses of tomaymycin (Tozuka et al., 1983) as well as anthramycin
(Leimgruber et al., 1968) and neothramycins (Aoki et al., 1969) have been reported.
The biosynthetic studies using radioisotope ( 14C and 3H) labeling and ,3 C enriched
methods indicate that tryptophan, tyrosine, methionine, and dihydroxyphenylalanine all
serve as precursors for anthramycin, tomaymycin, and sibiromycin (Hurley, 1977).

1.2 Interaction with DNA
Pyrrolo[l,4]benzodiazepine drugs specifically react with B DNA in the minor
groove through a covalent bond between the C l 1 o f the drugs and guanine N2 o f DNA.
Although the covalent linkage site was proposed as early as 1970 (Kohn & Spears,
1970), direct evidence was not provided until 1984 in anthram ycin-d(ATGCAT ) 2
adduct (Graves et al., 1984) and 1990 in tom aymycin-d(CICGAATTCICG ) 2 adduct
(Boyd et al., 1990b) from two-dimensional 'H and ,3C NM R experiments. Shown in
Figure 1.2 is the proposed reaction mechanism, which has the same intermediate as in
the epimerization of tomaymycin. The reaction is quite slow com pared to other DNAbinding drugs such as mitomycins, adriamycin, or actinomycin. The DNA adducts are
stable over a range of pH 5-10. The adducts saturated with drug have P/D ratio of 18.2
for tomaymycin, 12.9 for anthramycin, and 8.8 for sibiromycin as determined from

Figure 1.2. Proposed mechanism for the reaction of pyrrolo[l,4]benzodiazepines with DNA.
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radioisotope labeling method (Hurley et al., 1977). The binding kinetics as well as
stability o f adducts exactly mirrors the order o f the P/D ratio at saturation (Hurley,
1977; Hurley & Needham-VanDevanter, 1986).
Pyrrolo[l,4]benzodiazepines are buried inside the minor groove o f B DNA helix
as indicated by NMR, fluorescence quenching, and molecular modeling studies
(Petrusek et al., 1981; Barkley et al., 1991; Remers et al., 1992). Unlike many other
m inor groove DNA-binding drugs, pyrrolo[l,4]benzodiazepines are basically nondistortive to the DNA helix. For example, viscosity and sedimentation data indicate
that anthramycin causes only stiffening without lengthening of the DNA helix
(Glaubiger et al., 1974). Some other experimental results including the digestion of
drug-bound DNA by SI nuclease (Hurley & Petrusek, 1979) and the tomaymycin-DNA
adduct structures resolved from NMR spectra (Boyd et al., 1990b; W ang et al., 1992)
do not show helix distortion or unwinding either. The DNA helix is stabilized by drug
binding as indicated by about 15 °C increase o f the melting point o f E. coli DNA in the
presence o f excess o f drug (Nishioka et al., 1972). Footprinting data shows that each
drug molecule covers about 3-4 base pairs (Hertzberg et al., 1986; Hurley et al., 1988).
Several m olecular modeling studies suggest that this class o f drugs fits very well into
the minor groove of B DNA because o f the right-handed twist conformation o f these
drugs caused by 1 la chiral carbon (Petrusek et al., 1981; Remers, 1986; Barkley et al.,
1991; Hurley et al., 1988; W ang et al., 1992). In tomaymycin-d(ATGCAT ) 2 adduct, for
example, it is suggested that there are three to five water molecules displaced from the
minor groove with little distortion of B DNA helix, depending on binding mode
(Barkley et al., 1991). The modeling studies also explain why these drugs do not
directly bind to Z DNA (Hurley et al., 1988), although the bound tomaymycin may not
be dissociated when B DNA is converted to Z DNA (our unpublished data). Another
m olecular modeling study on d(GCGCGCGCGC ) 2 and
d(GCGCGTGCGC)*d(GCGCACGCGC) adducts predicted that anthramycin could bind

to Z DNA, but with a few key structural differences from B DNA adduct. The 5'
orientation is preferred and the drug has a left-handed twist. The Z DNA in the adducts
was "bent due to a wedge created in the vicinity o f the guanine covalently bound to the
drug" although the overall DNA distortion energies were less than those in the B DNA
(Rao, 1990).
According to the reaction mechanism (Figure 1.2), the original stereochemistry
o f C l 1 of the drug in solution is not necessarily maintained after binding. In addition,
the aromatic ring of the drug may point toward either 3' or 5' end o f the modified DNA
strand. Therefore, there are four possible binding modes: 53', 55', R3', and R5'. In spite
of the specific binding site at N2 of guanine, experimental data indicate that the
occupancy of a site as well as the binding mode varies with drug structure and flanking
base sequence (Remers et al., 1992). There are 16 flanking base sequences with G in
the middle. 5'PuGPu groups were reported to be preferred binding sequences
(Hertzberg et al., 1986; Hurley et al., 1988). Recent results indicate that 5'AGA is most
preferred (Pierce et al., 1993).
Both NMR and molecular modeling techniques can give detailed structural
inform ation but are limited to oligonucleotide adducts. The definite elucidation of
fluorescence results from oligonucleotide can be helped by NMR results and then
extended to high molecular weight DNA. Therefore, a combined multidimensional
NM R (*H, 13C, and 3lp), fluorescence, and molecular modeling approach is very
powerful in investigating the structure of drug-DNA complex containing multiple
binding sites (Remers, 1992). NMR data have shown that anthramycin-d(ATGCAT ) 2
adduct contains only a single adduct 53' (Graves et al., 1985; Boyd et al., 1990). In
contrast, a combined fluorescence, NMR, and molecular modeling study showed there
are two diastereomeric species (11R and 115) on tomaymycin-d(ATGCAT ) 2 adduct.
The relative populations of the two species are roughly equal. The identity of the two

species were inferred as S3’ and R5' (Cheatham et al., 1988). On the other hand,
NM R o f tom aymycin-d(TTCGAA ) 2 and -d(AAGCTT ) 2 adducts showed predominantly
one species (Cheatham and Boyd, unpublished results, from Boyd et al., 1990b). Only
one species was found in the bis(tomaymycin)-d(CICGAATTCICG ) 2 adduct from *H
and ,3C NM R experiments, while fluorescence studies revealed the presence o f two
species with more than 90% o f the major one. 2D COSY spectra unequivocally showed
that C l 1 o f tomaymycin covalently bonds through N2 o f guanine with an 1 IS"
stereochemistry in the sequence 5’CGA. 2D NOESY spectra indicated 3' orientation.
These results suggested that only one or a predominating species was present in 5'AGC
or 5'CGA, while two species in 5’TGC. In general, these observations agree with the
predictions made by the molecular modeling studies in the error margin o f about 7
kcal/mol (Remers et al., 1986; Wang et al., 1992).

1.3 Fluorescence Spectroscopy
M any processes occur in the time scale of 10"8- l O 10 s, including protonation or
deprotonation, solvent-cage relaxation, translational and rotational diffusion of small
and moderate size molecules, local conformational changes and internal motions of
macromolecules. Therefore, fluorescence, which takes place in the same time scale, can
be a powerful tool to monitor these processes. It is also very sensitive to fluorophore
environm ent and can be used in structural studies. For example, a molecule that is
nonfluorescent in aqueous solution may become strongly fluorescent in a nonpolar or
rigid environment. Solute quenching studies may tell the accessibility of the binding
site to quencher and solvent molecules. Energy transfer between chromophores can be
used to determined the dynamic as well as static distance between the donor and the
acceptor up to 50 A.

Fluorescence theory and techniques have been well established (Cantor &
Schimmel, 1980; Lakowicz, 1983; O'Connor & Phillips, 1984). Briefly, fluorescence
refers to the radiative process in which a molecule in the singlet excited state (Si)
returns to the singlet ground state (S0) by em itting a photon (hv). At room temperature,
as illustrated in Figure 1.3, most molecules are in the lowest vibrational level of the
ground state. A molecule can be excited to the singlet excited state by absorbing a
photon. The excited molecule will quickly decay to the lowest vibrational level o f S \
through vibrational relaxation, which happens in a very short time scale o f 10-12 s.
Afterwards, many non-radiative processes may occur to compete with fluorescence.
Therefore, the observed fluorescence lifetime, which is a measure o f the period a
fluorophore molecule remains in the singlet excited state, is defined as
X = (&r + ^nr)~*

(1-1)

where kT is the rate constant of the radiative process and Icm the sum o f the rate
constants of all non-radiative processes including intersystem crossing (k isc), internal
conversion (kic), solute quenching (&q[QJ), proton transfer (&pt), and various other
excited state reactions. The radiative rate is typically around 108 s ' 1. The lifetime value
varies from a few picoseconds to hundreds of nanoseconds depending on kr and what
can take place rapidly enough to compete with emission. The fluorescence lifetime can
be experimentally determined from fluorescence intensity decay data, 7(t), which is
usually a sum o f exponentials:
n

/(t) = X

Oj exp(-t / Xj)

i= i

(1.2)

where n is the number of distinct lifetime species, a ; the relative amplitude, and Xj the
lifetime value. The fluorescence quantum yield is defined by
<j)f = kr / (kr + k m) = kr x
and is usually experimentally determined by comparison to a standard.

(1.3)

10

S,

cr

s0

Figure 1.3. M odified Jablonski diagram. S0, S,, and T, indicate the ground state,
the first singlet excited state, and the lowest triplet state. The first order rate constants
k{, kic, kpt, and kisc refer to radiative process, internal conversion, proton transfer,
and intersystem crossing. Solid arrow indicates radiative process, and dashed arrow
represents non-radiative process.
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M olecules in the singlet excited state can also undergo conversion to the first
triplet excited state (T i), which is called intersystem crossing. Phosphorescence refers
to the radiative transition from T \ to S0, which is quantum mechanically forbidden. It
thus has a very slow radiative rate and very long lifetime which is in the range of
milliseconds to seconds. The observed phosphorescence quantum yield depends on
both intersystem crossing yield and decay o f the triplet excited state. The intersystem
crossing yield (<f>isc) and phosphorescence yield (<j)p) are defined as

^isc — ^isc ! (kr + knT)

^p

— ^isc

I (&p + k )

(1.4a)
(1.4b)

where kp is the phosphorescence radiative rate and k' the sum of all other nonradiative
processes that occur in the triplet excited state. At room temperature, kp is usually so
slow com pared to k' that phosphorescence cannot be detected.
Fluorescence anisotropy (r) exists due to photoselection. The incident light
selectively excites those fluorophore molecules whose absorption transition dipole is
parallel to the electric vector o f the light. It is defined by
r
(1.5)
where I\\ and I± are the vertically and horizontally polarized fluorescence intensities
when molecules are excited with vertically polarized light, respectively. For molecules
whose absorption transition dipole is randomly distributed in three dimensions, the
limiting anisotropy (rc) is determined by
r,o

2 (3 cos20 - 1)
5*

2

( 1.6)
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where 0 refers to the relative orientation o f the absorption and emission transition
dipoles. The value o f r0 will be 0.4 for parallel transition dipoles and -0.2 for
perpendicular. Any factors that can displace the emission dipole during the lifetime of
the excited state will decrease the observed value o f r. For example, the observed
average value o f anisotropy for a rigid molecule in solution is determined by
=

ro
1 +(T/<t>)

(1.7)

where the rotational diffusion correlation time <j) for a sphere is given by
<|> = r)Vh/KBT

(1.8)

where r\ is the solvent viscosity, KB the Boltzmann constant, T the absolute
temperature, and ty, the hydrodynamic volume o f the molecule. Therefore,
fluorescence anisotropy is a very useful and powerful tool to study the hydrodynamic
properties and conformational changes of molecules.

1.4 Dynamics of the DNA Helix: Twisting and Bending Motions
Like fluorescent intercalating drugs, tomaymycin may also serve as an effective
fluorescence probe for monitoring the dynamics of the DNA helix. The dynamics of
the DNA helix is involved in DNA-protein recognition and attributed to the stability
and biological activity o f the resultant complex. Although the DNA helix alone is
rather rigid in principle due to basepair stacking interactions, W atson-Crick hydrogen
bonding, electrostatic repulsion of negatively charged phosphate groups on the
backbone, and solvation, it is often bent in DNA-protein complexes. A typical example
is histone in which the DNA helix is wrapped in a very tight circle o f about 140 A
diam eter (McGee & Felsenfeld, 1980), compared with the persistence length of about
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500 A (Schurr & Schmitz, 1986; Hagerman, 1988). The energetics o f deforming the
helix is governed by its elastic properties, which include torsional (or twisting) and
bending rigidity. The twisting is due to the shearing o f adjacent basepairs over each
other. The bending of duplex DNA is caused by opening up the distance between
adjacent basepairs. These internal motions o f the DNA helix occur on the time scale of
subnanosecond to microseconds (Barkley & Zimm, 1979).
The bending and twisting motions in B DNA have been studied by fluorescence
anisotropy decay (Wu et al., 1988), triplet anisotropy decay (Hogan et al., 1983),
dynamic light scattering (Sorlie & Pecora, 1988), transient electric birefringence and
dichroism (Hagerman, 1985), electron microscopy (Revet et al., 1984), *H NMR (Mirau
et al., 1985), and ligase-catalyzed cyclization rate of DNA (Shore et al., 1981). Except
for electron microscopy which can actually detect differences in various regions of
DNA molecules, statistical evaluations of motions are obtained. Analytic theories for
an elastic DNA model (Allison & Schurr, 1979; Barkley & Zimm, 1979; Schurr, 1984)
as well as Monte Carlo (Hagerman & Ramadevi, 1990) and Brownian dynamics
simulations (Lewis et al., 1988) have been used to extract dynamic parameters from
experimental data. The values o f 1.3-3 x 10 '19 erg-cm for torsional rigidity (C) and
400-850

A for persistence length (P) were generally obtained in most laboratories

depending on the measuring conditions, methods, and the theories used. The torsional
rigidity is related to the equilibrium root-mean-square fluctuation in the torsion angle
(Ay)rms between one base pair and the next as C<Ay2> = 3.4 x 10-8 lifeT where ATb is
the Boltzmann constant and T the absolute temperature. The bending rigidity, El =
P/^ b T.
Besides the B double helix, which cellular DNA mainly adopts, many other
unusual DNA structures have been identified and characterized. Some examples are A
and Z double helices, triple and quadruple helices, bent DNA, bulges, junctions, and
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loops. The biological significance of non-B structures has yet to be established.
However, a lot of circumstantial evidence has strongly suggested an important role for
these non-B structures in gene expression. Non-B DNA structures should have
different dynamics, possibly even perturbing the flexibility of contiguous B DNA
regions. However, little is known about structural consequences for flexibility, except a
few studies o f Z DNA flexibility which drew contradictory conclusions (Thomas &
Bloomfield, 1983; A shikaw aet al., 1984; Mirau et al., 1985).
The fluorescence anisotropy decay of a probe that binds tightly to the DNA
helix depends only on the rates of rotational diffusion and internal motions of the helix
and thus reports the dynamics o f the DNA helix. To observe only the internal motions,
the length of the DNA helix has to be much longer than its persistence length or 150
base pairs. Ethidium bromide is the most commonly used probe in previous studies
(Ashikawa et al., 1987; Wu et al., 1987; Millar, 1990; W inzeler & Small, 1991). Its
fluorescence lifetime is only 2 ns in water but as high as 23 ns in DNA complex
(Olmsted & Kearns, 1977). The fluorescence anisotropy decay r(t) o f a probe that binds
tightly to the DNA helix and reports only the internal motions of the DNA helix will
obey the following equation:
2
r(0 = ro X l n ( t ) F n( t ) G n(t)
n=0

(1.9)

where In(t) is the internal correlation function that depends only on the angle £ between
the emission transition dipole and the helix axis when the probe is rigidly attached.
F n(t) and G n(t) are the twisting and bending correlation functions. However, the
bending motion has been ignored or assumed to be a fixed value in previous studies.
Therefore, the torsional rigidity may have been either underestimated or ill-interpreted
due to the uncertainty o f the bending rigidity (Fujimoto & Schurr, 1990).
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1.5 Objectives of This Research Project
Tomaymycin is an important member of pyrrolo-[l,4]-benzodiazepine antitumor
antibiotics. It lacks cardiotoxicity but has weak potency. Attempts to design new drugs
based on it have been made. Its success will highly depend on the knowledge o f the
interaction between tomaymycin and DNA and the structure o f the resultant complex.
This dissertation involves the use o f steady-state and time-resolved fluorescence
spectroscopy to study the structure of tomaymycin-DNA adducts, in conjunction with
NM R and molecular modeling studies. The first part of the dissertation deals with the
relationship between the fluorescence and molecular structure of tomaymycin. Solvent
effects, solvent isotope effect, photochemical H-D exchange, and luminescence at
cryogenic temperature are studied. The second part investigates the structure of
tomaymycin-DNA adduct by time-resolved fluorescence spectroscopy. Global non
linear least squares fitting and maximum entropy methods in conjunction with
simulation are used to established the fluorescence lifetime model for the adducts. The
structures of binding species in the adduct are determined by comparison with
fluorescence results for synthetic DNAs o f defined sequence.
Tomaymycin is also a fluorescent probe to study the dynamics of the DNA helix
which is very important to DNA-protein recognition. The third part o f the dissertation,
therefore, involves studies on the flexibility of the DNA helix using time-resolved
fluorescence emission anisotropy. A global non-linear least squares data fitting
program is developed based on the existing theory o f the torsional and bending motions
of the DNA helix. The torsional rigidity and persistence length of calf thymus DNA
and poly(dA-dG)*poly(dC-dT) are measured in different time ranges.
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Chapter 2. Fluorescence Properties of Free Tomaymycin

2.1 Introduction
As a potent antitumor antibiotic, tomaymycin binds specifically to the N2 of
guanine in the minor groove o f B DNA (Figure 1.2) to inhibit DNA synthesis both in
vivo and in vitro. It can also serve as a fluorescent probe of the rapid internal bending
motions in the DNA helix using time-resolved fluorescence emission anisotropy
(Barkley & Zimm, 1979). Therefore, it is very important to understand the fluorescence
quenching mechanism of tomaymycin in order to further investigate the interaction with
DNA, the structure o f the DNA adduct, and the dynamics o f the DNA helix by means
of fluorescence spectroscopy.
The fluorescence quantum yield and lifetime o f tomaymycin in aqueous buffer
are much smaller than in organic solvent and in DNA adduct (Barkley et al., 1986,
Remers et al., 1992). Different diastereomers (i.e., 1 I R , \ la5 and 115,1 la5) and DNA
adducts o f different binding mode (i.e., 53', 55', R3', and R5') also possess different
lifetimes and quantum yields. For example, (1 1/?,1 Ia5)-TM E in methanol has a
lifetime o f 4.9 ns compared to 3.3 ns for (115,1 Ia5)-TM E (Barkley et al., 1986). The
lifetime of 53' species in tomaymycin-d(ATGCAT ) 2 adduct is 5.9 ns, while R5' is 3.3 ns
(Cheatham et al., 1988). Several possibilities, such as different substituents on C l 1,
polar or non-polar solvation effects, H-bonding, and excited-state proton transfer
(Schulman, 1976), could contribute to the fluorescence differences (Lakowicz, 1983).
In this work, excited-state proton transfer has been shown to be a major
quenching process affecting the fluorescence of tomaymycin. The solvent isotope
effect on the fluorescence of tomaymycin has been investigated using both steady-state
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and time-resolved techniques. Photochemical H-D exchange at aromatic carbons of
tomaymycin in methanol-d4 will also be reported. To the best o f our knowledge, this is
the first report of H-D exchange occurring on aromatic carbon under neutral conditions.
In addition, several important molecular parameters including the limiting anisotropy
value, the total luminescence quantum yield, and the intersystem crossing rate were
directly measured at 77 K in ethanol glass. Based on these results, a mechanism for
fluorescence quenching and excited state H-D exchange reaction is proposed.

2.2 Materials and Methods
Chemicals. (11/?, 11 aS)-tomaymycin methyl ether (TME) was a generous gift
from Dr. M. Kohsaka, Fujisawa Pharmaceutical Co. (Japan).

8 -methyl

tomaymycin

methyl ether (MTME) was synthesized at University of Texas at Austin as described in
Barkley et al., 1986. Other chemicals were obtained from commercial sources. They
were spectroscopic or HPLC grade and used without further purification. Oxygen gas
was removed from organic solvent simply by flushing with argon for 15 min. Double
distilled and microfiltered H 2 O was used at all stages. The percentages o f deuterium
atoms in deuterated solvent was 99.99 % in D 2 O, 99.8 % in CD 3 OD, 99+ % in DC1,
and 99+ % in NaOD. The aqueous buffer is 0.01 M cacodylic acid, 0.1 M NaCl, and
0.1 mM EDTA, adjusted to pH (or pD) 5.1, unless indicated otherwise. The pD value
was estimated from the reading of pH meter plus 0.4 (Lumry et al., 1951).
Fluorescence Studies. Drug solutions were prepared from a methanol stock
solution stored at -20 °C. The concentration o f the stock solution was determined from
the absorbance at 319 nm (extinction coefficient e = 3600 M 'lcm _1) for TME (Arima et
al., 1972) and 320 nm (e = 3700 M ‘ ,c n r 1) for MTME (Barkley et al., 1986) on an
AVIV 118DS UV-VIS spectrophotometer. An aliquot o f the stock solution was placed
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in a vial, and the methanol was evaporated under vacuum. Solvent was added to give
the desired concentration. Solution was equilibrated overnight at room temperature
prior to use.
The fluorescence quantum yield or relative intensity was measured in 10x10
m m 2 stoppered cuvette on an SLM 8000 fluorometer. The band-pass was 4 nm for
excitation and

8

nm for emission. The polarizer was set at 54.7° to the vertical for

excitation and at 90° for emission. The spectra were corrected for both solvent blank
and wavelength-dependent instrumental factors. Quinine sulfate (Eastman Kodak) in
1.0 N sulfuric acid (double distilled, GFS Chemicals) solution was used as the standard
with a quantum yield o f 0.546 at 25.0 °C (Melhuish, 1961). All measurements were
carried out at 25.0 °C unless indicated otherwise. The refractive index correction was
not applied because o f the similar refractive indices o f methanol, water, and acetonitrile.
Solution concentration was controlled with the absorbance at the longest maximum
absorption wavelength less than 0.1. Time-resolved fluorescence techniques will be
described in Chapter 3.
Photochemical H-D Exchange Reaction. Photochemistry was carried out in a
quartz cuvette for wavelengths shorter than 300 nm or in a thin wall Pyrex NMR tube
for longer wavelengths. TM E or guaiacol (i.e., 2-methoxyphenol) was dissolved in
99.8% C D 3 OD. Guaiacol was selected as a simple model compound of tomaymycin
only for the purpose of investigating the effect of hydroxy and methoxy groups on the
photochemical aromatic H-D exchange (Ericsson et al., 1964; Wan & Wu, 1990;
Pollard et al., 1993). Solutions were irradiated with a 200 W Hg-Xe lamp filtered by a
Corning 0-53 UV light cut-off filter for > 300 nm or without any filter for shorter
wavelengths. TM E solution was irradiated only at > 300 nm and guaiacol solution at
both wavelength ranges. The photochemical H-D exchange was monitored as a
function o f time from *H NMR spectra measured on a Bruker AC-400 M Hz FT-NM R
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spectrometer. The extent of H-D exchange (D%) of tomaymycin was determined from
the integrals o f the aromatic proton resonances (C 6 -H and C9-H) relative to the methyl
proton resonances (C I 2 -CH 3 ) o f the pyrrolo ring substituent (Figure 2.1). The apparent
pseudo-first-order rate constant (k) was obtained from the slope o f the linear portion of
a plot o f In (D%) vs time where D% < 18 %. The H-D exchange reaction o f guaiacol
was monitored by mass spectrometry as well as *H NM R spectroscopy. The relaxation
delay time in 'H NM R measurements was 5 s, and the same instrumental set-up was
used for all experiments including the unirradiated control samples.
Solute Quenching. The fluorescence intensity and H-D exchange reaction rate
were monitored as a function o f quencher concentration. Concentrations of stock
solutions o f TM E, acrylamide, and KI in methanol-d4 are 0.026, 1.04, and 0.64 M,
respectively. Aliquots o f stock solutions are added to methanol-d4 to give desired
concentrations. The concentration of TME was 0 .0 1 1M in NMR measurements.
Fluorescence intensities were measured at 320-nm excitation wavelength and 400-nm
emission wavelength for 5 5-s intervals, and the average values were used. The H-D
exchange rates were determined from 'H NMR as described above. For acrylamide,
only the (1 l/?)-C9H was clearly distinguished from the resonance signal of acrylamide
and used to calculate the H-D exchange rate. Quenching data were fit to the SternV olmer equation

X0 / X

=

(l+*sv[Q ])

(2-1)

where Xo and X are the fluorescence intensities or the H-D exchange rates in the
absence and presence o f quencher Q, and A"sy is the Stern-Volmer constant (Lakowicz,
1983). For fluorescence, Afsv = ^

0 * where

kq is the bimolecular quenching rate

constant and tq the fluorescence lifetime in the absence o f quencher.
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25

Total Luminescence Studies. Measurements of the total luminescence were also
carried out on the SLM 8000 fluorometer using a quartz ESR tube (5 mm diameter) as a
sample cell and ethanol as cryogenic solvent at 77 K. Sample solution in the tube was
degassed by several cycles o f freeze-pump-thaw to prevent cracks in the frozen ethanol
glass. The tube was sitting in a quartz Dewar flask containing liquid nitrogen, which
replaced the regular sample holder. The slit width at excitation was set to 0.5-nm
bandpass for better placement of the incident light on the sample surface and less
reflection. The position of the tube in the flask was carefully adjusted to give minimum
intensity at 325 nm (7iex = 320 nm) but maximum intensity at 376 or 444 nm in order to
minimize scattered light. A flow of nitrogen gas was used to remove moisture in the
sample chamber. The fluorescence spectra from the same ethanol solution and quinine
sulfate in 1 .0 N sulfuric acid were also taken in the same set-up but at room temperature
and used as the standards. In this case, liquid nitrogen was replaced by water. The
temperature correction factor is -0.25% (°C ) _1 for quinine sulfate (Miller, 1981). The
observed intensity (70) is approximately corrected for the refractive index (n) effect as
n2I0 (M iller, 1981). The whole spectra and the total quantum yield were obtained. The
total quantum yield of tyrosine in 6.0 N HC1 solution at 77 K is 1.0 (Bishai et al., 1967;
Kuntz et al., 1966) and was measured to check the set-up.
In another measurement, the phosphorescence spectra were recorded using the
above set-up with the Dewar flask sitting in a rotating can phosphoroscope to prevent
fluorescence from reaching the photomultiplier. The phosphoroscope is a mechanical
device that periodically modulates the excitation events out of phase of the observation
events. Only the photon whose lifetime is in the range o f milliseconds or longer is
observable, which is the time scale of phosphorescence. The detected light intensity
depends on the time that the sample is exposed to the excitation light and to the
photodetector and the time that each rotating circle takes (tc), as well as the excited
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state lifetime (x). When x »

tc, the detected light intensity becomes independent o f the

rotating speed (McCarthy & W inefordner, 1967).
After corrections for solvent blank and wavelength-dependent instrumental
factors, both the phosphorescence and total luminescence spectra were normalized at
525 nm where the fluorescence was assumed to be negligible while phosphorescence
was still much stronger than background noise. The normalized fluorescence spectra
were obtained by subtracting the normalized phosphorescence spectra from the
normalized total luminescence spectra. The ratio of the areas under the
phosphorescence and fluorescence spectra is equal to the quantum yield ratio of
phosphorescence verse fluorescence (P/F). From the P/F ratio and the total quantum
yield, the individual quantum yield o f phosphorescence and fluorescence was
determined. M ore than twelve measurements were repeated and the average value was
used. The limiting values of anisotropy through the wavelength range of the total
spectra were also recorded in the same set-up and corrected for the polarizationdependent G factor of the detection train:
7VV - G / vh
r = --------------------7VV + 2G / vh

(2.2)

where G = 7hv / 7h h >FI = horizontal, V = vertical, and the first letter in the subscript
refers to the orientation of the excitation polarizer, while the second to the emission
polarizer.
The temperature dependence of the absorption spectrum of tomaymycin ethyl
ether in ethanol was determined separately in a

10

x

10

mm 2 stoppered quartz cuvette

on an AVIV 14DS UV-VIS spectrophotometer equipped with an Oxford DN1704
nitrogen cryostat controlled by an Oxford ITC4 digital temperature controller. The
absorption spectra was found independent of temperature over the range of 300 K to
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160 K, which is close to the melting point of ethanol. No attempt below 160 K was
made due to the high risk of breaking the quartz windows of the cryostat when ethanol
glass cracks. The relative absorbance change was exactly the same as the relative
volume change o f ethanol. The absorbance at 77 K was then estimated from the
absorbance at 25 °C after correction for solvent contraction at low temperature, which
was easily determined as 20 ± 3 % from the height change o f the sample in the tube.

2.3 Results
Radiative Rate Constants. The substituent as well as the stereochemistry on
C l 1 of tomaymycin depends on solvent (Figure 2.1). For example, the substituent on
tomaymycin is -OF! and has S configuration in aqueous solution, -OR and a mixture of
S and R configurations in alcoholic solvent (ROH). C l 1 links to the guanine-NH of
DNA and is a mixture o f S and R configurations in DNA adducts (Remers et al., 1992).
However, the fluorescence radiative rate constants (kr) o f these different species
determined from quantum yield (<()) and lifetime (x) data with kr = <|) / x are very similar
(Table 2.1). The average kf is about

6 .8

x 107 s-1. The fluorescence differences among

these compounds must be due to differences in the nonradiative rates.
Solvent Effects. W hen TOM in water was diluted into methanol, the
fluorescence increased instantaneously to the same intensity as TM E in methanol.
Likewise, when TM E in methanol was diluted into water, the fluorescence decreased
instantaneously to the same intensity as TOM in water (Figure 2.2). In comparison,
methylation of TOM and hydrolysis of TM E were slow processes as monitored by
absorption spectra (Figure 2.3). The maximum absorption wavelength o f tomaymycin
is -3 2 0 nm in methanol and -3 1 3 nm in water. Epimerization of the R and S
diastereomers at C l 1 as monitored by fluorescence, absorbance, and ’H NMR was also
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Table 2.1 Radiative Rates o f Different Compounds
kr x

-7 s '

compound

solvent

<t>

^ (ns)a

TOM

H 2 O buffer

0.067

1.04

6.4

D 2 O buffer

0 .1 0 1

1.59

6.4

MeOH

0.34

4.4

7.5

MeCN^

0.13

1 .8

7.2

TOM

DNA adduct

0.31

4.65

6.7

mTOM

H 2 O buffer

0.098

1.4

7.0

D 2 O buffer

0.141

2 .0

7.1

MeOH^

0.37

5.2

7.1

MeCN^

0.18

2.3

7.8

DNA adduct^

0.40

5.88

6 .8

TME

mTME

mTOM

a x = (XajTj) / (Ea;). b Data adopted from Barkley et al., 1986.
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Figure 2.2. Solvent effects on the fluorescence of tomaymycin. The time axis for
TM E is shifted 0.1 hr for better separation at 0 hr.
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Figure 2.3. Solvent effects on the absorption spectra o f tomaymycin.
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slow (Barkley et al., 1986). Therefore, the instantaneous changes in fluorescence
intensities were exclusively due to the solvent changes rather than the different
substituent or stereochemistry on C l 1.
After the dramatic change immediately after mixing, the fluorescence intensity
o f TOM in 9:1 methanol/water mixture was slightly increased by about 10-15% in 2-3
hours and leveled off gradually afterwards. TOM in aqueous solution is predominately
(115,1 laS)-diastereomer, while TM E in methanol is the mixture o f (1 1/?,1 la5)- and
(11S, 11 a 5 )-diastereom ers. (11R, 11 aS)-TME has a longer lifetime than (11S, 11 a5)-TM E
(Barkley et al., 1986). After mixing TOM aqueous solution with methanol, both
methylation and epimerization on C l 1 occurred by the same nucleophilic substitution
mechanism through the imino intermediate (Figure 1.2). These reactions were complete
in the period of 2-3 hours as monitored by absorption spectra (Figure 2.3) and 1H and
13C NM R spectra (Barkley et al., 1986). This suggested that the 15% after-mixing
change in fluorescence intensity was due to the different diastereomers at C l 1. This
intensity change is rather small compared to the about 300% change due to solvent
change.
A similar solvent dependence of fluorescence o f TOM in the mixture solvent of
water and acetonitrile was observed (Figure 2.4) although it is com plicated probably by
the dehydration o f tomaymycin into an imino form in the excited state in acetonitrile.
The imino form o f tomaymycin is completely nonfluorescent (Barkley et al., 1986).
The quantum yield increased from 0.067 to more than 0.2 when acetonitrile
concentration was increased from 0% to 30% and leveled off. But the quantum yield
quickly dropped from 0.27 to 0.13 when the concentration o f acetonitrile increased from
90% to 100%, indicating that the effect of dehydration seemed to become significant at
high acetonitrile concentration.
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Figure 2.4. The quantum yields of tomaymycin in water/acetonitrile mixture.
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Solvent Isotope Effect. Tomaymycin and 8-methoxytomaymycin had greater
quantum yields and lifetimes in D 2 O than in H 2 O (Table 2.1). The isotope effect was
constant and the same in both compounds from pH 3-7. The quantum yield was also
constant over this pH range (Figure 2.5). The isotope effect suggested that excited-state
proton transfer was an important nonradiative process. The fluorescence quenching at
high pH represented ground-state reaction. The 8-phenolic proton of TOM dissociates
with pKa = 8 and the phenolate is non-fluorescent (Barkley et al., 1991). At pH < 2.5,
fluorescence was probably quenched through protonation. The fluorescence quantum
yield was also measured in H 2 O/D 2 O mixtures (Table 2.2). Assuming that excited-state
proton transfer and intersystem crossing (&isc) were the major nonradiative channels,
the proton transfer rates (&pt) in the mixtures were estimated using &r = 6.8 x 107 s~*
and &isc = 8.5 x 107 s_I (see the results at 77 K later in this section for details). The
proton inventory technique gave a linear plot o f k p j vs D % (Figure 2.6), indicating that
proton transfer involved a single exchangeable hydrogen (Isaacs, 1987). The proton
transfer rates in H 7 O and D 2 O were 8.6 x 108 and 5.2 x 108 s_l, respectively. On the
other hand, the estimated proton transfer rate of TM E in methanol was only 4 x 10"7 s_1,
which yielded a negligible isotope effect on the quantum yield in methanol.
Photochemical H-D Exchange. About 50 % H-D exchange at both C6 and C9
positions of the aromatic ring o f TME in methanol-d4 was observed by *H NMR after 2
hr irradiation with > 300 nm light (Figure 2.7). Both positions had similar amounts of
H-D exchange (Figure 2.8). N o H-D exchange was detected without light irradiation.
Guaiacol in methanol-d4 did not show any H-D exchange after 5 hr irradiation even
without the UV cut-off filter. Guaiacol and its hydroxy and/or methoxy substituted
derivatives can undergo the photochemical H-D exchange reaction in the presence of
strong acid, strong base or metal complex catalyst (Ericsson et al., 1964; W an & Wu,
1990; Pollard et al., 1993). This suggested that the hydroxy and methoxy substituents

Relative Fluorescence Intensity
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Figure 2.5. The solvent isotope effect on fluorescence intensity o f tomaymycin: ( • ) H20 and (A) D 2 0 .
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Table 2.2 Quantum Yield ((|>) o f Tomaymycin in D 2 O /H 2 O M ixtures

0

0.067

25

0.074

50

0.082

75

0.094

100

0.101
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Figure 2.6. Proton invenory plot. Proton transfer rate kp j was estimated from the
quantum yield in D 2 0 /H 20 mixture using k = k{ + k]sc + fcpp, where kr =
and fcisc = 8.5 x 107 s '1.
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Figure 2.7. Partial *H NM R spectra o f TM E in methanol-d4: (top) no irradiation,
(middle) 2 hr irradiation, and (bottom) 2 hr irradiation with 0.45 M KI.
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Figure 2.8. The positions and amount of photochemical H-D exchange on
tomaymycin methyl ether in methanol-d4 as monitored by 'H NMR.
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alone did not lead to the excited-state H-D exchange in neutral solution. The H-D
exchange was quenched by acrylamide and KI (Figure 2.7 & 9). The Stern-Volmer
quenching constant (Ksv) of acrylamide for H-D exchange was comparable to K $v for
fluorescence of TME, while the ATsv ° f KI for H-D exchange was about twice the value
of K $y for the fluorescence (Table 2.3).
Cryogenic M easurements and Phosphorescence. The absorption spectrum of
tomaymycin ethyl ether in ethanol did not change with temperature. The maximum
absorption wavelength remained at 319-320 nm (Figure 2.10). However, two peaks
(376 nm and 444 nm) appeared in the emission spectrum at 77 K (Figure 2.11). Only
the 444 nm peak remained when the rotating can phosphoroscope was used, indicating
that it was phosphorescence (McCarthy & Winefordner, 1967). The intensity did not
depend on the rotating speed o f the phosphoroscope, suggesting that the triplet excitedstate lifetime was in the millisecond or longer time scale.
The average value of total quantum yield was 0.99 ± 0.10 with P/F ratio of 1.2 +
0.2. The estimated quantum yield was 0.55 ± 0.10 for phosphorescence with maximum
emission at 456 ± 1 nm and 0.44 ± 0.04 for fluorescence with maximum emission at
376 ± 1 nm. The Stokes' shift is still quite large although it decreases from 100 nm at
298 K to 56 nm at 77 K. In solvent glass and at very low temperature, molecules are
presumably immobile and all temperature-dependent nonradiative processes are
negligible compared to the radiative process which is usually temperature-independent.
The remaining competitive nonradiative process is usually only intersystem crossing.
Thus the intersystem crossing rate

(&js c )

can be estimated. From (1 - <|)f)/<|>f

=

^isc^r*

the intersystem crossing rate was calculated to be (8.5 ± 1.0) x 107 s_1. In addition,
molecules will stay at exactly the same orientation during the period between
absorption and emission. Therefore, the limiting value of the fluorescence anisotropy
can be directly measured. It is a crucial parameter in the data analysis o f time-resolved
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Figure 2.9. The Stern-Volmer plot of photochemical H-D exchange ( • ) and
Fluorescence (■ ) of tomaymycin methyl ether in methanol-d4 quenched by
acrylamide (a) and KI (b). k refers to the first-order rate constant o f the H-D
exchange reaction, I the fluorescence intensity.
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Table 2.3 The Quenching Parameters
quencher
_________

fluorescence
M M -U -l)
K Sy (M -1)

H-D exchange
g Sv(M -»)

acrylamide

2.5 x 109

10.2 ± 0 .3

12 ± 1

KI

2.7 x lO 8

1.22 + 0.02

2.8 ± 1 .5

270 K
240 K
210 K
185 K
160 K
-

Absorbance

2

250

300
W avelength (nm)

350

Figure 2.10. The absorption spectra of tomaymycin ethyl ether in ethanol
at different temperatures.

-

Relative Intensity

75-

-0 .4

50-

-

0.2

Limiting Anisotropy

100

25-

■Auj/L

300

500

400

-

0.2

600

Emission W avelength (nm)

Figure 2.11. The total luminescence (thick line), fluorescence (solid line), and phosphorescence (dotted line)
spectra o f tomaymycin ethyl ether in ethanol glass at 77 K. Excitation wavelength 320 nm. The dots
represent the anisotropy values.
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and steady-state fluorescence emission anisotropy measurements. The measured
limiting anisotropy value was about 0.34 for fluorescence and about -0.1 for
phosphorescence (Figure 2.11).

2.4 Discussions
Excited state proton transfer appeared to be another major nonradiative process
besides intersystem crossing due to the following reasons: i) fluorescence intensity
depends on the nature o f solvent rather than the molecular structure change occurring in
different solvents; ii) the solvent isotope effect is present; iii) the H-D photochemical HD exchange occurs; and iv) the H-D exchange reaction can be quenched by
fluorescence quencher, implicating it occurs at the singlet excited-state. The same
isotope effect for both TOM and MTOM indicates that the 8 -phenolic group does not
contribute to it. The photochemical H-D exchange reaction happens at the singlet
excited-state because the Stern-Volmer quenching constants (ATsv) of acrylamide is the
same as the A sv f° r fluorescence. On the other hand, the A'sv of KI for the H-D
exchange is larger than that for fluorescence, suggesting the involvement o f more than
one excited-state. Heavy atoms such as iodide usually quench fluorescence through the
enhancement o f the intersystem crossing rate (Lakowicz 1983; M iller et al., 1977). The
ineffective quenching of KI to the fluorescence of tomaymycin is probably because the
intersystem crossing rate in tomaymycin is already very large. The H-D exchange
reaction may also occur at the triplet excited-state as well as the singlet excited-state. It
would be quenched by KI in both cases, which yields a larger A'sv for the H-D
exchange than that for fluorescence. Acrylamide, however, can effectively quench the
singlet excited-state. The H-D exchange reaction will occur at the singlet excited-state
as suggested by the same A sv f°r both the H-D exchange reaction and fluorescence.
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Based on these observations, an excited-state proton transfer quenching
mechanism is proposed. Shown in Figure 2.12 is the intermediate structure for both
fluorescence quenching and the H-D exchange reaction. Deuterium will be replaced by
hydrogen in a protium solvent. At the singlet excited state, N10-H donates a proton to
solvent, leaving the aromatic ring susceptible to protonation from protic solvent. The
fluorescence is quenched during proton transfer. W hen the aromatic ring is protonated
at C 6 or C9, hydrogen may leave and result in a deuterated aromatic ring.
According to this mechanism, the H-bonding pattern of N10-H will be the major
factor affecting the fluorescence. Stronger H-bonding will increase the proton transfer
rate and thus quench the fluorescence. This is the major reason that the quantum yield
and lifetime in aqueous buffer are less than those in organic solvent and adduct. In
DNA adducts, different binding modes have different H-bonding patterns (Table 2.4).
M olecular modeling calculations show that the longer lifetime species S3' has a weaker
H-bonding on N10-H than the shorter lifetime species R5' (Barkley et al., 1991;
Cheatham et al., 1988). In addition, the dipole-dipole interaction between N10-H and
C l I-O C H 3 will also increase the proton transfer rate. The more parallel orientation and
shorter distance between N10-H and C l I-O CH 3 in (I IS, 1 Ia5)-TM E lead to its shorter
lifetime compared to (1 1/?,1 la ^ -T M E (Table 2.5).
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DO-

CH

Figure 2.12. The proposed mechanism of the excited-state proton transfer process and
photochemical H-D exchange reaction o f tomaymycin. ROD can be any protic solvent
or proton acceptor and donor.
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Table 2.4 H-Bonding Parameters o f Solvated Tomaymycin-d(ATGCAT ) 2 Adductsa
acceptor to

angle

N10-H b

distance
o
A

S3'

0 2 (CIO)

2.30

S5'

N3 ( A il)

R3'
R5'

adduct

donor to

angle

C5=0

distance
o
A

147.8°

OH(water)

1 .8 8

149.5°

1.97

155.6°

OH(water)

1.91

164.7°

0 2 (C4)

1.97

165.9°

OH(water)

1.87

171.1°

N3 ( A ll)

1.93

174.5°

OH(water)

1.92

165.6°

a Data adopted from Barkley et al., 1991. ^ O and N refer to oxygen and nitrogen atoms
in DNA bases C and A, respectively.

diastereomer

distance

torsional angle

11R

2.8 A

i
00
o0

Table 2.5 Parameters for Dipole-Dipole Interaction
between N10-H and C l 1-OMe in TM Ea

1 IS

2.4

A

34°

a D ata for (115,1 la£)-TM E were obtained from the energy minimization
starting from the crystal structure o f (1 1/?,1 laS)-TM E using SYBYL.
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Chapter 3. Time-Resolved Fluorescence Studies of Tomaymycin
Bonding to DNA

3.1 Introduction
Tomaymycin reacts covalently with DNA through an aminal bond from C l 1 of
tomaymycin to N2 of guanine in the minor groove o f B-form DNA (Petrusek et al.,
1981; Barkley et al., 1986). The covalent linkage was definitively established by *H
NMR in tomaymycin-d(CICGAATTCICG )2 adduct (Boyd et al., 1990). Despite
specific reaction with guanine base, tomaymycin does not alkylate all guanine residues
in a DNA sequence with the same frequency. The relative reactivity o f a particular
guanine depends upon the antibiotic and upon the proximal bases on the modified
strand. There are 16 flanking base sequences with G in the middle. The preferred
bonding sequence was originally reported to be 5'PuGPu (Hertzberg et al., 1986; Hurley
et al., 1988). Recent results indicate that tomaymycin favors the 5'AGA sequence by a
factor o f three compared to the second preferred sequences 5G G C , 5'TGC, 5'AGC, and
5G G A (Pierce et al., 1993).
There are four possible binding modes o f tomaymycin for each bonding
sequence on DNA: R or S configuration at C l 1 with the aromatic ring o f the drug
pointing toward the 3' or 5' end o f the modified DNA strand. The binding modes of
tomaymycin at 5'TGC, 5'CGA, 5'AGC three-base sites have been determined by
fluorescence, two-dimensional 1H NMR, and molecular modeling studies of
oligodeoxynucleotide adducts containing unique binding sites (Cheatham et al., 1988;
Boyd et al., 1990; Remers et al., 1992; Wang et al., 1992; Barkley et al., 1994;
Appendix B .l). The combination of these techniques is particularly powerful for
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determining the structure o f drug-DNA complexes in the case of multiple binding
modes (Remers et al., 1992). The fluorescence lifetimes of tomaymycin adducts with
unique bonding sites appear to be more sensitive to binding mode than to flanking base
sequence (Barkley et al., 1994). The lifetimes group into two classes. The major
lifetime component usually has a longer lifetime of 5-8 ns, and the minor com ponent a
shorter lifetime o f 1.5-5 ns. The longer lifetime has been assigned to the 1 IS
diastereom er and the shorter lifetime to the 11/? diastereomer. The lifetime difference
among binding modes has been attributed to excited-state proton transfer (see Chapter
2.4 for details).
In this chapter, the bonding of tomaymycin to calf thymus DNA, which has all
16 bonding sites, will be examined. We use time-resolved fluorescence spectroscopy to
identify the number and type o f tomaymycin-DNA adducts present on natural sequence
DNA based on the results from tomaymycin-oligodeoxynucleotide adducts. Analysis of
the data by least squares and maximum entropy methods in conjunction with simulation
resolves the question of whether the fluorescence decay represents a few discrete
lifetimes or a distribution o f lifetimes in the range o f 1.5-8 ns. The effects o f solution
variables on the bonding reaction are determined. Finally, the observed lifetimes are
assigned to specific binding modes and DNA bonding sites.

3.2 Materials and Methods
Tomaymycin-DNA Adduct. To prepare adduct solution, an aliquot of
tomaymycin methyl ether stock solution in methanol (see Chapter 2.2 for detail) was
placed in a vial and the methanol was evaporated under vacuum. Certain amount of
DNA solution (1.0 x 10' 3 M nucleotide unless indicated otherwise) was added to give
desired P/D ratio. P/D ratio refers to the relative amounts o f DNA and tomaymycin
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used in the reaction. The reaction was equilibrated for 2 weeks at 4 °C. DNA adducts
appeared to be stable for up to one year when stored at 4 °C. Unbound tomaymycin
was removed by three or four extractions with equal volumes o f ethyl acetate. Traces of
ethyl acetate were removed under vacuum. The amount o f tomaymycin actually bound
to DNA was determined by a difference method, in which the amount o f unbound
tomaymycin was measured by fluorescence after iso-butanol extraction. At P/D - 1 all
sites on DNA are saturated at 17-18 nucleotides per tomaymycin (Hurley, 1977;
Barkley et al., 1994). For the sample prepared at P/D = 100, 0.50 mL o f adduct solution
was extracted four times at 5 °C with equal volumes of iso-butanol saturated with 10
mM phosphate buffer, pH 7.5. The iso-butanol layers were combined and adjusted to a
total volume o f 5.00 mL at 25 °C. The fluorescence intensity was recorded at 319 nm
excitation wavelength and 400 nm emission wavelength. Tomaymycin concentration
was determined by comparison to a standard curve obtained under the same
experimental conditions. At P/D = 100 the bonding density is 140 nucleotides per drug.
Photobleaching under laser light was completely eliminated by scrupulous
removal o f oxygen. Adduct solution was placed in a 4 x 10 mm 2 cell (Helma) sealed
with the lubricated rubber stopper from a Vacutainer sterile tube (Becton Dickinson,
#6381). The stopper was punctured by a needle above the solution. Oxygen gas was
removed from the cell by alternative cycles o f vacuum and argon for 0.5 hr. High
purity argon gas was introduced through a copper line containing an Oxisorb gas
purifier (M esser Griesheim). The stoppered cell was filled with argon after
deoxygenation. Solutions remain oxygen free for at least 3 days when properly
stoppered. Both extraction and deoxygenation were performed in an ice bath. Sample
absorbance at the lowest energy absorption maximum was <0.15 with 10-mm path
length.

Time-Resolved Fluorescence Measurements. Fluorescence lifetimes were
measured on a Photochemical Research Associates time-correlated single photon
counting instrument equipped with a Coherent 701-3 cavity-dumped DCM dye laser
synchronously pumped by a mode-locked, frequency-doubled Quantronix 416 Nd-YAG
laser. The output beam from the dye laser was frequency doubled by a BBO crystal and
vertically polarized by a half-wave retarder. Excitation wavelength was selected with a
three-plate birefringent filter. Emission was detected by a cooled Hamamatsu R955
photom ultiplier, which was wired for an instrumental response of 360 ps FW HM
(M cM ahon et al., 1992). The emission polarizer was set at 54.7° in order to eliminate
anisotropic effects. Emission wavelength was selected by an Instruments SA H-10
monochrom ator (8 -nm bandpass). Data acquisition was controlled by a M acintosh Ilex
com puter using a program based on the Lab VIEW software package (Stryjewski, 1991).
Sample temperature was controlled by a circulating bath at 5 °C unless indicated
otherwise.
Fluorescence decays from the sample and reference fluorophore were acquired
contemporaneously to 2.5-5 x 104 counts in the peak channel (5-10 x 106 total counts).
The counting rate was usually about

6

kHz; the excitation rate was 760 kHz. Decay

curves were stored in 512 or 1024 channels of 0.06 or 0.03 ns per channel, respectively.
Solutions o f quenched POPOP (Fluka) in 75% ethanol and 0.8 M KI (containing a trace
o f sodium thiosulfate to retard

13 ’

formation) or BBO in ethanol were used as reference

fluorophore. About 0.21-ns lifetime of quenched POPOP and about 1.24-ns lifetime of
BBO were determined in separate experiments using anthracene in ethanol as
monoexponential standard. Data sets at high P/D ratio as well as different pH, DNA
concentration, wavelength, chain length, and temperature were collected to about
9 x 103 counts in the peak channel (about

6

x 105 total counts) using a nitrogen flash
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lamp as described elsewhere (Barkley et al., 1994). All low count measurements were
made by Dr. Karol Maskos.
Data Analysis. Fluorescence decay curves were analyzed by reference
deconvolution (Kolber & Barkley, 1986) assuming discrete and distributed decay
models. The discrete lifetime model is described by
n

^ e m i t) —

^ c m ) e x p ( - t / X /)

(3.1)

where I(k eK, Xcm; t) is the fluorescence intensity, and the fluorescence lifetimes x; and
relative amplitudes oc<(A.ex>^em) are the fitting parameters. Single curve and multiple
curve analyses were performed using a global non-linear least squares fitting program
(Beechem, 1989). The lifetimes are usually linked in multiple curve analyses. The
reference lifetime is fixed at a known value determined separately. The success of the
fit is judged by statistical parameters: reduced chi-square X?, weighted residuals, and
autocorrelation function o f the weighted residuals.
The fluorescence decay curves measured at different temperatures were
analyzed according to eq 1 with the lifetimes X; replaced by an Arrhenius expression:
X ,- 1 =

k0i + A-, exp (-Ei / RT)

(3.2)

where the amplitudes oq, the temperature-independent rate constants k 0i, the frequency
factors Ai, and activation energies £) are the fitting parameters. The values of k0i, A ;,
and Ei at different temperatures are linked in the global analysis.
The distribution model is described by

(3.3)

o
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where a(x) is the spectrum of lifetimes x. Two types of distribution analysis were done:
(1) a(x) is assumed to have a Gaussian distribution, and (2) ot(x) is allowed to take the
form most compatible with the experimental data by maximizing the Skilling-Jaynes
entropy function (Jaynes, 1983; Livesey & Skilling, 1985).
In the Gaussian distribution model, the function a(x) is given by

a(x) = X [a/ / (a /V 2 tt )] exp[-(x-xOJ- ) 2 /( 2 a ;2)]

(3.4)

;=i

where n = 1 and n > 1 means unimodal and multimodal Gaussian distribution,
respectively. The mean lifetimes x0(- , standard deviations a,-, and peak areas a ; are the
fitting parameters. In order for a(x) to be a valid probability density function, otj must
n

be normalized so that the total area under the function a(x) is unity, £

a,- = 1. This

(=1

distribution analysis is also globalized in the same way as the discrete analysis. The
integration in eq 3.3 is carried out numerically. The user has a choice o f a few different
numerical integration methods and a flexible step size (Beechem, 1989). Although in
principle multiple components are allowed, in practice it is almost impossible to resolve
more than two. Attempts to use three or more components result in high sensitivity to
initial guess, which follows from the large number o f fitting parameters and the
presence o f local minima. This is a disadvantage o f the model-fitting approach, in
addition to the potentially more serious one o f prescribing the type o f distribution. The
Beechem global program features three types of distributions: Gaussian, Lorentzian,
and Uniform. However, expanding the repertoire o f probability density functions does
not give full flexibility to the shape of the function a(x). These weaknesses are
overcome by using an entirely different approach to data analysis, the so-called
maximum entropy method (Gull & Skilling, 1984; Skilling & Bryan, 1984).
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The important advantage of M EM is that the shape o f the function a(x) is not
predetermined. The analysis automatically results in inclusion of as many peaks (called
"modes" in Gaussian analysis jargon) as necessary for the best fit to the data. The basic
model for the decay function is still the same as in eq 3.3, but the shape o f a(x) is
determ ined from the experimental data. The best fit is approached by maximizing the
Skilling-Jaynes entropy function:
oo

J

5 (a ) =

(a(x) - m(x) - a(x) log[a(x)/m(x)]} dx

(3.5)

0

where m(x) is the initial guess, usually set to a flat distribution in the absence o f a priori
knowledge about the distribution. The FAME5 program replaces the integrations in eqs
3 and 5 by summations of up to 250 lifetime values equally spaced in logarithmic or
linear scale. The entropy S is maximized together with minimization o f X? (the
norm alized overall fitting error) for the fit to eq 3. Thus, the conventional distribution
and M EM analyses are similar in that both use the same fitting function and minimize
X r as in any non-linear least squares fitting technique. They differ in that MEM
determines the density function a(x) by maximizing the entropy function 5(a), whereas
conventional distribution analysis specifies the form of the distribution. The one
limitation of the current version o f FAME5 is that it is not globalized. However, a
global version may be available in the near future (J.-C. Brochon, personal
communication). The broadness of a peak in FAME5 is described by the dispersion D
k

k

D={[£

a (i){ x ( 0 - l } 2] / X

a « } 1/2

(3.6a)

'=J

where the average lifetime x is
k

k
(3.6b)
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and j and k define the range o f the peak. The dispersion D is the equivalent o f the
estim ated standard deviation a in the case of a Gaussian distribution. The relative
amplitude a t o f a peak is determined from its relative area.

Fluorescence decay data containing Gaussian noise were simulated by
convolution of the desired decay model with an experimental lamp profile in the
Beechem global program. One, two, and three exponential decays were generated using
eq 3.1. Unimodal and bimodal Gaussian distributions were generated using eqs 3.3 and
3.4.
Bonding Kinetics. The whole measurement and part o f the data analysis were
done by Dr. Karol Maskos. The formation of DNA adduct was monitored by
fluorescence lifetime measurements with flash lamp excitation as described elsewhere
(Barkley et al., 1994). Decay curves were acquired at different times after mixing TME
and DNA and were deconvolved by global analysis assuming three exponentials. Rate
constants were determined from changes in relative amplitudes of the lifetime
components as a function o f time. The reaction
(TOM-DNA),
TOM

+

DNA

was carried out at P/D = 100 or 25-fold excess of potential DNA bonding sites. The
hydrolysis o f tomaymycin methyl ether to form tomaymycin is fast compared to the
reaction with DNA. Therefore, at early times in the reaction where there is negligible
dissociation of adduct, pseudo-first-order kinetics can be assumed. The apparent
pseudo-first-order rate constants were k\ = k\ [DNA ] 0 for the shorter lifetime species,
k i = k2 [DNA ] 0 for the longer lifetime species, and k{ = &f[DNA]0 for free
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tomaymycin, where k f = k\ + k i and [DNA ] 0 = 1 x 10-3 M nucleotide. The pseudofirst-order rate constant kf was determined from the slope of the linear portion o f a plot
of -In (X f vs t, where o t f is the relative amplitude of the free drug decay. The pseudofirst-order rate constant ki' for species i was obtained by a least-squares fit o f the
am plitude oq to eq 3.7.
oq = (fcj'/ k f)[l - exp(-&f't)]

(3.7)

The value of kf was fixed in the analysis of aj. Arrhenius parameters were calculated
from the temperature dependence of the apparent bimolecular rate constant k\.
ki = A exp(-£a/RT)

(3.8a)

A = (KBT/h)*exp( 1 + AS*/R)

(3.8b)

where E a is the activation energy, AS+ is the activation entropy, KB is the Boltzmann
constant, and h is the Planck constant.

3.3 Results
M odel Discrimination. There are 16 DNA bonding sites on natural DNA
sequences and four binding modes at each site, for a total of 64 possible tomaymycinDNA adducts with lifetimes in the range o f 1.5-8 ns. In order to determine the number
and type of adducts present on DNA, we need to establish criteria for distinguishing
decay models. It is well known that frequently more than one model will fit the
experimental data equally well. It can be a difficult, sometimes impossible, task

to

isolate the true decay model under such circumstances. Simulation studies are a very
useful tool to validate or refute particular lifetime models. Therefore, we performed
extensive simulation studies to gain insight into the analysis of discrete and distributed
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decay models with lifetimes in the range of interest for tomaymycin-DNA adducts. A
summary of the major conclusions follows:
(1) Simulated discrete models. Increasing the model order in a discrete analysis
improves X? until redundancy of the model becomes obvious. A Gaussian distribution
analysis always gives a good fit with the same mean lifetimes T0; as the discrete
lifetimes x,- and poorly determined standard deviations a,-. For example, a simulated
3.5-ns single exponential gives an excellent fit to a unimodal Gaussian with xG = 3.5 ns
and a = 0.15-0.20. It is practically impossible to distinguish between a triple
exponential and a wide unimodal Gaussian without the help o f a model-free approach,
such as MEM. Simulated data for discrete models also fit quite well to continuous
distributions by MEM. However, in such cases typically the dispersions o f the modes
are rather small, and the number of peaks in the recovered a(x ) distribution matches the
actual number of components in the discrete model.
(2) Simulated unimodal Gaussian models. A discrete analysis gives a good X?
value if the standard deviation of the distribution is small: a = 0.01-0.15 ns. As a gets
larger, higher order discrete models give better fits. However, the recovered lifetimes
may be quite different between double and triple exponential models. A wide unimodal
Gaussian gives acceptable fits to both uni- and bimodal Gaussian models, particularly
for noisy data, because the standard deviation is so poorly determined in the analysis.
(3) Simulated bimodal Gaussian models. A double exponential analysis gives
acceptable X^ values o f about 1.3-1.5. As

<7

gets larger, a triple exponential may give an

acceptable fit and a new set o f recovered parameters.
It is preferable to recover the lifetime distribution without having to assume a
specific form in the analysis program. James and Ware (1986) proposed a commonsense method, which fixes a large number of lifetime values and determines the

59

corresponding preexponential factors in a least squares analysis. Negative amplitudes
occur frequently during this type o f fitting process. The approach o f clipping the
negative values to zero and then searching for the best fit lacks theoretical rigor. Our
trials with this method were unsatisfactory. W e therefore turned to the maximum
entropy method for fluorescence data analysis (Livesey & Brochon, 1987). Presently
we are using the M EM program in conjunction with other deconvolution programs to
help distinguish various models that fit our data equally well. In this paper Gaussian
distribution and M EM analyses are used in a cooperative, not competitive fashion; both
methods are also aided by extensive simulation studies to explore the probable behavior
o f specific models. Below we outline our strategy for model discrimination gleaned
from simulation studies.
(1) We routinely analyze all data with both discrete and distribution models. If
the data fit substantially better to one model, as judged by a lower j}x value or more
random autocorrelation function or both, then the other is discarded.
(2) If the distribution model fits equally well or better than the discrete model,
we try to confirm the distribution model by discrete analyses with increasing numbers
of components. Simulation studies have shown that the X? value for distributed lifetime
data analyzed by discrete models keeps improving with increasing numbers of
com ponents in the analysis. Therefore, if the fit to higher order discrete models fails to
show progressive improvement, then the distribution model may be discarded.
(3) If the data fit well to a bimodal Gaussian model but MEM shows only one
peak, we incline toward a unimodal distribution of non-Gaussian shape. If the data fit
equally well to the double exponential and bimodal Gaussian models, and the presence
of two peaks is verified by the MEM analysis, then we carry out simulation studies in
an attempt to reach a conclusion. Typically, we would simulate a biexponential decay

60

with the same amplitudes and lifetimes as the values recovered from discrete analysis of
the experimental data, and analyze the simulated data with various distribution models.
W e would then compare the standard deviation or dispersion obtained from these
distribution analyses to the experimental values. If they are similar, then the
distribution model is discarded altogether. Obviously, a known discrete data set
producing the same results for a distribution analysis as our experimental data renders
the distribution results meaningless.
(4)

On the other hand, if the standard deviation or dispersion for a distribution

analysis o f the experimental data were substantially larger than the value obtained from
the discrete simulated data, then we would choose the distribution model over the
discrete model. As to the actual shape o f the density function a(x), the M EM result is
more trustworthy. In our experience a data set that truly represents a Gaussian
distribution o f lifetimes yields the same values of the decay parameters for the Gaussian
and M EM analyses, whereas the fit to a discrete model gives a larger X? value.
Lifetime M odel fo r Tomaymycin-DNA Adduct. Two extreme examples of
tomaymycin-DNA adducts were studied. At P/D = 100 there is a large excess o f DNA
bonding sites and the drug will react preferentially at preferred bonding sequences. At
P/D = 1 the DNA is completely saturated with tomaymycin and less preferred bonding
sequences will also be occupied. Fluorescence decays were measured at various
excitation and emission wavelengths at 5 °C. Unreacted tomaymycin was removed
immediately prior to the experiments by extraction o f adduct solutions. Decay curves
were deconvolved in single and multiple curve analyses.
For tomaymycin-DNA adduct prepared at P/D = 100, 30 decay curves were
acquired at 318, 320, 323, and 333 nm excitation and 400, 410, 415, and 420 nm
emission wavelengths. Global analysis linking the lifetimes gave X? values of 1.3-1.5
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and randomly oscillating autocorrelation functions for fits to a double exponential and
to unimodal and bimodal Gaussian distributions (Figure 3.1; Table 3.1). Increasing the
number o f components in the discrete analysis did not improve the fit. Except for five
samples containing small amounts o f free drug, the lifetimes obtained from single curve
analyses were within 0.3 ns o f the global results. The fluorescence lifetimes were
independent o f both excitation and emission wavelengths. The relative amplitudes were
also independent o f emission wavelength, but slightly dependent on excitation
wavelength. Figure 3.1 shows the double exponential and unimodal and bimodal
Gaussian fits. The discrete analysis gave lifetimes Ti = 4.3 and

%2

= 7.1 ns, compared to

mean lifetimes o f 2.7 and 6.3 ns for the two narrow peaks o f the bimodal Gaussian
distribution. A much broader unimodal Gaussian distribution gave a slightly low er X?
value than the bimodal distribution, possible because the two discrete lifetimes are very
close. From these results alone it is difficult to choose between the double exponential
and unimodal Gaussian models.
For 25 o f the 30 decay curves, two overlapping peaks at about 4 and 7 ns were
resolved by M EM in single curve analyses (Figure 3.2). These lifetimes are very close
to the values obtained for the double exponential model. The dispersions are 0.4-0.8 ns.
However, synthetic data generated for a discrete model having these decay parameters
gave the same two peaks with comparable dispersions as the experimental data (Figure
3.3). Other simulated double exponential decays were also analyzed to see how well
M EM recovers parameters from data with 3.5 x 104 counts in the peak. Tw o distinct
peaks were observed for the 4 and 7 ns double exponential, where X2 /X1 = 1.75. The
two peaks merge into a broader peak as X2 /X1 decreases, and finally become one peak at
X2 /X1 = 1.2 (Figure 3.3). Therefore, the M EM analysis argues strongly for the double
exponential model for tomaymycin-DNA adduct. The unimodal Gaussian distribution
model was discarded because two peaks were usually obtained by MEM.
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Figure 3.1. Global analysis of fluorescence decay o f tomaymycin-DNA adduct at pH
7.5, P/D = 100, 5 °C. Xex = 333 nm, Xem = 410 nm, 0.037 ns per channel. Left curve is
reference decay; points are sample decay; smooth curve through points is best fit to the
following: (upper) double exponential model, a i = 0.41, x\ = 4.3 ns, ct2 = 0.59, %2 = 7.1
ns, local X? = 1.4; (middle) unimodal Gaussian distribution,

tq

= 5.8 ns, a = 1.4 ns, local

%r = 1-5; (lower) bimodal Gaussian distribution, oq = 0.25, Xj = 2.7 ns, ctj = 0 .1 3 ns, ct2
= 0.75, X2 = 6.3 ns, <32 = 0.23 ns, local X? = 1.5. W eighted residuals and autocorrelation
function o f the residuals (inset) are also shown.
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Table 3.1 Analysis o f Time-resolved Fluorescence Data for Tomaymycin-DNA Adductfl
t l (ns)
analysis method

P/D = 100
least squares 6
single
double
unimodal
bimodal
M EM /
P/D = 1
least squares#
single
double
triple
unimodal
bimodal
M EM /!

ai(3 3 3 nm ) 6

x (ns)c

x3 (ns)

x2 (ns)
a (ns)^

a 2(333 nm ) 6

x (ns)c

a (ns)^

X?

0.25

4.3 ± 0 .3
5.8
2.7

1.4
0.13

6.3

0.23

11.5
1.5
1.3
1.5

0.40 ± 0.05

4.2 ± 0.4

0.55

7.0 ± 0 .4

0.75

1.4

6 .0

0.41 ± 0 .0 2

7.1 ± 0 .2

5.8
0.29 ± 0.02
0.18 ± 0 . 0 2

2 .2
1 .6

0.54 ± 0.03

5.3
3.3

0.25 ± 0.03

1 .8

±
±

0 .1

0.28 ±

0 .1

0 .0 1

6.4 ± 0 .1
4.4 ± 0.6

6.7 ± 0.3

1.9
±

0 .1

2 .2

6 .6

0.43

6 .0

±

0 .1

20.9
1.7
1.5
3.4

0 .0 1

1 .6

0.97

1.5

apH 7.5, 5 °C. ^Amplitude for discrete models; area under the peak for Gaussian distributions and MEM. cLifetimes for discrete
models are obtained from global analysis. These lifetimes are identical to the average values from single curve analyses. Errors are
standard deviations from the single curve analyses. Mean lifetimes for Gaussian distributions are obtained from global analysis.
Average lifetimes and standard deviations for M EM are obtained from single curve analyses. ^Standard deviation in Gaussian
distribution analysis; dispersion in MEM analysis. ^Global analysis o f 30 decay curves. /Single curve analyses o f 25 decay curves.
^Global analysis of 10 decay curves. ^Single curve analyses of 10 decay curves.
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Figure 3.2. Lifetime distributions of tomaymycin-DNA adduct at P/D = 100 from
MEM. Analysis carried out in logarithmic space; results displayed on linear scale.
Normalized areas o f relative amplitude under peak and average lifetimes are: (-----) A,ex
= 318 nm, Xem = 410 nm, a j = 0.44, x\ = 4.3 ns, D \ = 0.54 ns, a 2 = 0.56, x2 = 6.9 ns,
D 2 = 0.73 ns, X? = 1.33; (---- ) Xex = 323 nm, Xem = 410 nm, a j = 0.11, Xi = 0.8 ns, D\
= 0.07, a 2 = 0.89, x2 = 5.8 ns, D 2 = 1.50, X2r = 1 .2 0 .
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Figure 3.3. Lifetime distributions of simulated double exponential decays analyzed by
MEM. Amplitude ratio OC2 /OC1 = 3:2, Xj = 4 ns. Lifetime ratios X2 /X1 used in simulation
and recovered dispersions are: (-----) X2 /X1 = 1.75, D\ = 0.49 ns, D 2 = 0.85 ns; (— )
X2 /X1 = 1.5, D = 1.02 ns; (.....) X2 /X1 = 1.2, D = 0.46 ns.
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For five of the 30 decay curves, only one peak around

6

ns plus a small peak

around 1 ns was obtained (Figure 3.2). The major peak had a shoulder on the short
lifetime side and a dispersion o f 1.3-1.6 ns. The presence o f a small am ount of
unreacted drug, which has a 1 -ns lifetime, appears to mask the two closely spaced
lifetimes. Treating the 1-ns component as a single discrete fixed lifetime com ponent in
the M EM analysis did not improve the resolution. Accordingly, data were simulated
using the decay parameters recovered from the double exponential analysis (4.3 and 7.1
ns) plus a 1.04-ns component for free drug. Two peaks corresponding to the longer
lifetimes could still be resolved as long as the relative amplitude of the free drug
com ponent was < 5 % (Figure 3.4). Above this value, the two longer lifetime peaks
gradually merged into a single peak with a shoulder on the short-lifetime side and the
dispersions increased from 0.7 to 1.4 ns with increasing amounts o f the free drug
component. The shoulder finally disappeared in the presence of a large amount of
unreacted drug. This indicates that the resolution o f two lifetime com ponents depends
not only on their relative separation but also on the presence of a third component. It
also explains why a few experimental data files gave a single broad peak for
tomaymycin-DNA adduct: either extraction of free drug was incomplete or some drug
dissociated after the extraction. On the other hand, the M EM results convinced us that
the extraction procedure was adequate in most circumstances.
For tomaymycin-DNA adduct prepared at P/D = 1, 10 decay curves were
acquired at 330, 333, and 337 nm excitation and 400, 405, and 410 nm emission
wavelengths and were analyzed by the strategy outlined above. Unlike the case for P/D
=

100,

increasing the number o f components in the discrete model improved the fit up

to a triple exponential (Table 3.1). Fits to four and five components depended on initial
guess with no improvement in global

values. This suggested the presence of a

distribution of lifetimes. The fit to a unimodal Gaussian distribution was unacceptable.
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Figure 3.4. Lifetime distributions of simulated triple exponential decays with two DNA
adduct components (xi = 4.3 and X2 = 7.1 ns) and one free drug component (Xf = 1.04
ns) analyzed by MEM. Amplitude ratio <X2 /(X[ = 3:2. Amount o f free drug component
used in simulation and recovered amplitude and dispersion of the major peak are:
(------- ) otf = 0 %, a i = 0 %, D j = 0.43 ns, Eh, = 0.78 ns; (— ) ctf = 5 %, a i = 6 % ,D \ =
0.08 ns, D 2 = 0.48 ns, Lh, = 0.84 ns; (-----) (Xf = 7 %, a i =

8

%, D \ = 0.15 ns,

ns; and (.....) (Xf = 22 %, a i = 22 %, D \ = 0.27 ns, D i = 1-38 ns.

£>2

= 1.36
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The bimodal Gaussian distribution gave a much better X? value, pointing to the
presence o f at least two groups o f lifetimes. The trimodal Gaussian distribution gave
physically unreasonable results and no improvement in Xp MEM recovered two peaks
at about 1.8 and 6.0 ns with dispersion values of 0.43 and 0.97 ns, respectively (Figure
3.5a). M EM analysis o f a double exponential simulated with these decay parameters
returned two narrow peaks with the same lifetimes and amplitudes but dispersion values
of only 0.11 and 0.17 ns (Figure 3.5b). In addition, a triple exponential decay was
simulated using the parameters obtained in the three component fit of the experimental
data (Table 3.1) and was analyzed using MEM. The MEM analysis gave one narrow
peak at 1.6 ns with dispersion of 0.26 ns and a broad peak at 6.7 ns with dispersion of
1.17 ns. The broad peak contained a distinct shoulder at about 4 ns, clearly indicating
the presence of the third lifetime. Such a shoulder was never seen in M EM analyses of
the experimental data. Therefore, we conclude that the two peaks from M EM analysis
of the experimental data represent two groups o f distributed lifetimes rather than two or
three discrete lifetimes. The average lifetimes were independent o f both excitation and
emission wavelengths. However, the relative amplitudes o f the two peaks varied with
excitation wavelength. For example, a i decreased from 28 % at 330 nm to 22 % at 337
nm. This is much greater than the 2 % change observed between 313 and 337 nm for
the adduct prepared at P/D = 100 (Table 3.2), presumably reflecting more
heterogeneous bonding species.
The Gaussian and M EM analyses both indicate bimodal lifetime distributions
for the experimental data at P/D = 1. The two methods gave somewhat different decay
parameters with similar X? values. The bimodal Gaussian distribution looks like one
broad peak at 3.3 ns with a standard deviation of 2.2 ns and a discrete lifetime o f 6 . 6 ns,
whereas the MEM profile has two broad peaks at 1.8 and 6.0 ns (Table 3.1). Synthetic
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Figure 3.5. (a) Lifetime distributions o f tomaymycin-DNA adduct at P/D = 1 from
MEM. Analysis carried out in logarithmic space; results displayed on linear scale. Xex
= 333 nm, Xem = 400 nm. Normalized areas o f relative amplitude under peak and
average lifetimes are: a i = 0.25, ti = 1.8 ns, D \ = 0.43 ns , ct2 = 0.75, %2 = 6.0 ns, D 2 =
1.01 ns, X? = 1.41. (b) Lifetim e distribution of simulated double exponential with decay
param eters in (a) analyzed by MEM. Recovered a i = 0.25, t i = 1.8 ns, D \ = 0.11 ns,
012

= 0.75, %2 - 6-0 ns, D 2 = 0.17 ns.
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Table 3.2 Effect o f Conditions on Tomaymycin-DNA Adduct0

P/D

pH

[DNA] (mM)

Size^

Xex (nm)

a \c

100

6.4

2.5

high MW

313

0.35
0.36
0.34

100

6.4
7.5
8.9

2.5

high MW

337

0.38^
0.31d
0.34d

100

7.5

0.25
0.63
1.3
2.5

high MW

337

0.33
0.34
0.34
0.34

100

7.5

2.5

high MW

313
337
350

0.34
0.32
0.29

100

7.5

65-110 bp
25-36 bp
< 18 bp
5-140 bp

350

0.41
0.44
0.41
0.44

500
1 ,0 0 0

"Global analysis assuming a double exponential model of data acquired at 5 °C:
X\ = 3 .7 ns, X2 = 6.7 ns. pH dependence data were acquired at 25 °C and analyzed
separately: xi = 3.1 ns, %2 = 5.6 ns. ^High M W is highly polymerized calf thymus
DNA. Short DNA fragments prepared by sonication of salmon sperm DNA and
fractionation by gel chromatography. "Estimated standard deviation < 0.02.
^Experiments at 25 °C.
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data were generated for a bimodal Gaussian distribution model with the decay
parameters obtained from the M EM analysis. Bimodal Gaussian distribution and MEM
analyses recovered the input decay parameters. Synthetic data were also generated for a
bimodal Gaussian distribution with a single broad peak at 3.3 ns and a discrete lifetime
of

6 .6

ns. The bimodal Gaussian distribution analysis recovered either the input

parameters or two broad peaks, depending on initial guess. M EM analysis returned two
broad peaks with shorter lifetimes than the input parameters, similar to the results from
the experimental data. Combining the Gaussian and M EM results, the m ajor group of
lifetimes appears centered at 6 - 6 . 6 ns and the minor at around 2-3 ns. However, the
profile of the distribution is uncertain.
Experimental Conditions. Tomaymycin appears to form only two species of
adduct on natural sequence DNA at P/D = 100, pH 7.5, and 5 °C. We surveyed a
variety o f experimental conditions and found no evidence for additional species, A
large data set containing almost

200

decay curves was measured at different excitation

and emission wavelengths, P/D ratio, pH, DNA concentration, and DNA chain length.
A X? value of 1.1 was obtained for the global fit to a triple exponential model with the
lifetimes linked: two components for tomaymycin-DNA adduct and one com ponent for
free drug. The two lifetimes for DNA adduct were T) = 3.7 ns and

%2

= 6.7 ns. Note

that these lifetimes are shorter than the values reported in Table 3.1. The reason
appears to be numerical. These decay curves were fitted to three exponentials because a
1-ns free drug component was always present, whereas the lifetime values in Table 3.1
were recovered from double exponential fits of data from extracted samples. It can be
easily verified that the mean lifetimes remain the same in all cases. Theoretical
considerations and simulation studies also suggest that if the free drug com ponent has a
very small pre-exponential factor, the double exponential analysis will yield slightly
greater lifetime values than the triple exponential analysis. The insensitivity o f the
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fluorescence lifetimes to experimental variables suggests that the same two species of
DNA adduct are present under all conditions. However, there were small changes in the
relative amplitudes o f the two components under some conditions (Table 3.2). In the
case o f ground-state heterogeneity, the amplitudes o f a fluorescence decay are
proportional to molar extinction spectrum, fluorescence emission spectrum, radiative
lifetime, and concentration o f the different species. As above, the amplitudes were
independent of emission wavelength, indicating that the emission spectra o f the two
lifetime components are the same. On the other hand, the amplitudes o f the minor
lifetime component decreased slightly relative to the major lifetime com ponent with
increasing excitation wavelength, signifying that the absorption spectrum of the minor
com ponent is blue-shifted relative to the spectrum of the major component. This is
consistent with previous results showing that different species o f tomaymycin-DNA
adduct have the same emission spectra, but slightly shifted absorption spectra (Barkley
e ta l., 1986).
The relative amplitudes o f the two components are constant at P/D ratios > 100.
Such ratios are well above the saturation level o f 17 nucleotides per drug in calf thymus
DNA (Barkley et ai., 1994).

At P/D = 100 the relative concentrations o f the two

species o f DNA adduct are not affected by DNA concentration over a 10-fold range and
by pH in the range of 6-9. The relative concentration of the minor species of DNA
adduct is 12-14 % higher in short fragments o f sonicated salmon sperm DNA (42 %
GC) than in highly polymerized calf thymus DNA (43 % GC). Apparently, short DNA
sequences favor formation of the minor species of DNA adduct.
Temperature Dependence. The fluorescence lifetimes of tomaymycin-DNA
adducts are weakly temperature dependent. Fluorescence decay curves were acquired at
5° intervals from 5-25 °C at 313, 337, and 355 nm excitation and 420 nm emission
wavelengths. The temperature data set was deconvolved globally according to eq 3.2
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with the temperature-independent rates kai, frequency factors A-h and activation energies
Ei linked in the analysis. The double exponential fit gave a global i}x o f 1.2. The
temperature-independent rates and activation energies were the same for both
components. Linking these parameters in the global analysis gave k0l = 1.1 x 108 s _1
and Ei = 21 kJ/mol. While the frequency factors were different, A \ = 1.1 x 10 12 s _1 for
the shorter lifetime component and A i = 3.5 x 1011 s _1 for the longer lifetime
component. Intersystem crossing and excited-state proton transfer are the major
nonradiative processes for tomaymycin (Barkley et al., 1994; Chen & Barkley, 1994).
The temperature-independent processes are the same for both components, while the
temperature-dependent proton transfer rates are different due to different binding modes
in the two components. The temperature-independent rate kol is usually the sum o f the
radiative kT and intersystem crossing kjsc rates. Taking kT= (5-8) x 107 s ' 1 from average
lifetime and quantum yield date (Barkley et al., 1986), the recovered k0i = 1.1 x 108 s _1
gives k\sc = (3-6) x 107 s '1. This intersystem crossing rate is a little lower than the

8

x

107 s-' value estimated from low temperature luminescence yields in ethanol (Barkley
et al., 1994). The activation energies determined from lifetime data agree well with the
23 kJ/mol value derived from quantum yield data (Barkley et al., 1991).
Bonding Kinetics. The rate o f formation o f tomaymycin-DNA adduct was
measured at 5° intervals from 5-25 °C. At each temperature fluorescence lifetime data
were acquired at 313 nm excitation and 420 nm emission wavelengths as a function of
time after mixing tomaymycin and DNA. The set of decay curves from the kinetics
experiment and a free drug decay curve were fitted to a triple exponential by global
analysis. Figure 3.6 shows the time course o f the relative amplitudes o f the free drug
com ponent and the two DNA adduct components at 10 °C. The amplitude o f each
species is proportional to its concentration. The rate constants for formation of DNA
adducts were calculated assuming pseudo-first-order kinetics. Table 3.3 gives the
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Figure 3.6. Kinetics o f formation of tom aymycin-calf thymus DNA adduct. Xcx = 313
nm, A-em = 420 nm, pH 7.5, 10 °C, [DNA] = 1 x 10' 3 M, P/D = 100. Results from
global fit to three exponentials, X? = 1.1. (■ ) free drug, (A ) 3.74-ns component, ( • )
6.57-ns component. Smooth curves are the best fit using equation 3.7.
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Table 3.3 Kinetics Data for Formation of Tomaymycin-DNA Adduct0
species

free drug
short lifetime
long lifetime

ki ( M -h -')b
0.219
0.078
0.141

Ea (kJ/mol)

A x 10- 6 ( M - V 1)

A StC JK -tm ol'1)

3.48
1.90
2.05

-127
-124
-131

39
40
39

°pH 7.5, [DNA] = 1 x 10-3 m , P/D = 100. b 10 °C.
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apparent bim olecular rate constants measured at 10 °C along with the Arrhenius
par ameters for the bonding reaction. The rate o f formation o f the longer lifetime
species is faster than the shorter lifetime species. Drug binding usually involves
positive entropy changes, presumably due to release of ordered w ater from the DNA to
bulk solvent (Breslauer et al., 1987; Barkley et al., 1991). The negative AS* values
suggest that the water molecules remain in the transition state for formation of
tomaymycin-DNA adduct.

3.4 Discussion
For tomaymycin-DNA adduct at low bonding density the preferred lifetime
model is a double exponential. The reasons are: (1) the experimental data were fitted
equally well by distribution and double exponential models; ( 2 ) the fit was not
improved when more components were considered in the discrete analysis; (3) the
standard deviations in the bimodal Gaussian distribution (0.13-0.23 ns) and the
dispersions in the M EM amplitude profile (0.55-0.75 ns) were small; (4) probably most
important, the M EM analysis o f a biexponential decay simulated with the same
parameters as the biexponential analysis of the experimental data gave the same two
peaks as the experimental data; and (5) the dispersions of the peaks obtained from these
analyses o f simulated and experimental data were similar. When the DNA is saturated
with tomaymycin, the fluorescence decay data no longer fit a double exponential model
and the lifetime model becomes a bimodal distribution. The reasons are: (1) the fit was
improved by increasing the number of discrete components up to three; (2 ) only two
peaks were recovered from Gaussian and M EM analyses; (3) simulation studies of
discrete and Gaussian distribution models supported a bimodal distribution. In practice,
it is impossible to distinguish lifetime distributions from closely-spaced multiple

discrete lifetimes (Siemiarczuk et al., 1990). Given the possibility o f 64 bonding
species, a distribution is plausible in tomaymycin-DNA adduct at high bonding density.
Because M EM analysis of time-resolved' fluorescence data is still relatively new
(Siemiarczuk & Ware, 1989; Gentin et al., 1990; Royer et al, 1990; Fetler et al., 1992),
we com m ent briefly on its performance in our hands. Apparently, M EM could separate
two discrete lifetimes as close together as 2.5 ns with the ratio %2 l%\ > 1 .5 (Figure 3.4).
Tomaymycin-DNA adduct has two lifetimes separated by 2.8 ns with X2 ^ i = 1-65
(Table 3.1). However, these lifetime differences and ratios are higher than the reported
2 ns with %2^ l = 1-4 (Livesey & Brochon, 1987). Our failure to match the published
resolution is due to lower counts in our data. The data collected by Brochon and
coworkers using a synchrotron light source has 5-8 times better counting statistics than
our data. Simulation results showed that about 1.5 x 105 counts in the peak channel are
required to achieve the reported resolution. Unfortunately, it is impractical to acquire
data o f such high precision with a picosecond dye laser excitation source. On the other
hand, dispersion values are relatively insensitive to the number o f counts. For two
discrete lifetimes o f 4.3 and 7.1 ns, the dispersions decreased from 0.55 and 0.75 ns to
0.35 and 0.48 ns, with a 20-fold increase in counts in the peak channel from 3.6 x 104 to
7.2 x 105. Thus, it appears impossible to distinguish a lifetime distribution with 0.5 ns
dispersion from a discrete model for these two peaks.
Natural sequence DNAs contain all 16 possible DNA bonding sites. At the low
bonding density (140 nucleotides per drug) used in our experiments, one drug is bonded
per 70 base pairs or one per 23 bonding sites assuming a three base pair site. Under
these conditions tomaymycin will bond preferentially at the 5'AGA sequence. Thus,
there is probably only one or at least a predominate species owing to the sequence
preference o f adduct formation. 5'AGA has two lifetimes of 4.8 and 7.2 ns with relative
amplitudes o f 0.37 and 0.63 (see Appendix B .l). Similarly, calf thymus DNA has two
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lifetimes of 4.3 and 7.1 ns with relative amplitudes of 0.41 and 0.59. The fluorescence
lifetime depends more strongly on binding mode than on flanking base sequence
(Barkley et al., 1994). M ost likely the major species with the longer lifetime is the S3'
adduct, and the minor species with the shorter lifetime is the R5' adduct (Cheatham et
al., 1988; Boyd et al., 1990; W ang et al., 1992; Barkley et al., 1994). We propose that
the two species o f DNA adduct represent mostly R5' and S3' binding modes at 5'AGA
site. Purine-pyrimidine tracts, up to 100 bp in length, are frequently found in the 5’flanking regions of eukaryotic genes, representing up to 1 % o f the genome (HoffmanLiebermann et al., 1986). The SI-nuclease hypersensitivity of these tracts suggests that
they adopt unusual conformations to regulate gene transcription (Wells, 1988). The
strong preference of pyrrolo[l,4]benzodiazepines for homopurine sites points to
regulatory regions o f the DNA as a likely biological target.
Tomaymycin saturates calf thymus DNA when there is one drug bonded per 8-9
base pairs or one per 2-3 potential bonding sites (Barkley et al., 1994). Assuming
random DNA sequences, one third to one half of the 16 bonding sites would be
occupied. The lifetimes of DNA adducts at unique bonding sites cluster in two groups:
minor component of 1.5-5 ns and major component of 5-8 ns (Barkley et al., 1994).
The amplitude profile from M EM analysis suggests that all these species may be
present on the natural DNA sequence. On the other hand, the bimodal Gaussian results
suggest that the longer discrete lifetime may represent S3' adducts at 5'PuGPu and
5'PyGPy sequences with the shorter broad lifetime distribution corresponding to the rest
of the bonding species. However, the lifetimes of adducts at specific bonding sites may
change at high bonding density due to distortion of the DNA. Finally, the bimodal
distributions at high bonding density are probably not contaminated by free drug
because all samples were extracted four times, kept at or below 5 °C, and discarded <12
hr after extraction, during which time dissociation of the adduct is negligible.

81

Tomaymycin is buried in the minor groove o f the DNA helix with the 8 hydroxyl group pointing away from the DNA core. The fluorescence intensity o f the
DNA adduct prepared at P/D = 100 is invariant from pH 6.5 to 10.5 (Barkley et al.,
1991). Thus, we expect and observe the fluorescence decay parameters to be
independent o f pH over the same range. Low molecular weight DNA fragments appear
to have a larger fraction of minor species. This may be related to the DNA
conformational change presumed to limit the bonding reaction in high m olecular weight
DNAs (Kizu et al., 1993; Barkley et al., 1994). Relaxation o f distortion through the
ends of the molecule may allow formation of a larger percentage o f the less favored
species.
Excited-state proton transfer appears to be the major environm entally sensitive
nonradiative process in tomaymycin (see Chapter 2 for details). Presumably, it
accounts for the temperature dependence of the fluorescence lifetimes o f DNA adducts.
The frequency factors o f 1.1 x 10 12 and 3.5 x 10 1 1 s' 1 and activation energy o f 21
kJ/mol are comparable to values reported for intermolecular excited-state proton
transfer reactions: 7.2 x 10 10 s _1 and 15 kJ/mol in 3-methylindole (Yu et al., 1992); 8.1
x 10 12 s ' 1 and 17 kJ/mol in naphthyl-ammonium ion-18-crown-6 com plexes (Shizuka et
al., 1985), and for the intramolecular excited-state proton transfer in tryptamine: 3.8 x
10 1 1 s -1 and 17 kJ/mol and (Shizuka et al., 1988). The proton transfer rate depends on
the proximity o f proton donors or acceptors to tomaymycin in the DNA adduct. As
suggested by molecular modeling studies of tomaymycin-d(ATGCAT ) 2 adduct,
different binding modes have different H-bonding patterns between tomaymycin and
DNA bases and water molecules in the minor groove (Barkley et al., 1991). The
hydrogen bonding pattern may be responsible for the different frequency factors in the
S3' and R5' adducts.
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Chapter 4. Flexibility of the DNA Helix Determined from TimeResolved Fluorescence Emission Anisotropy

4.1 Introduction
The internal motions o f the DNA helix are in the time scale o f subnanoseconds
to at least several hundred nanoseconds. They are characterized by torsional rigidity
and bending rigidity. Time-resolved fluorescence emission anisotropy of a fluorescent
probe tightly attached to the DNA helix has been proved to be a powerful tool to
investigate these motions, particularly for torsional motions (Barkley & Zimm, 1979,
Fujim oto & Schurr, 1990). However, the studies on bending motions have been limited
by the lack of a suitable fluorescent probe. The relative contributions of torsional and
bending motions to the fluorescence emission anisotropy decay depend on the relative
orientation between the transition dipole and the DNA helix as well as the time scale.
Bending motions are more heavily weighted at smaller angles. The commonly used
probe is ethidium bromide which intercalates into the DNA helix. It has a fluorescence
lifetime of about 23 ns and an angle of about 71°. The emission transition dipole of
tomaymycin presumably lies inside the aromatic plane (Figure 4.1). The angle is 3045° depending on binding mode as shown in Figure 4.2 (W. A. Remers, personal
communication). The smaller angle may help resolve the ambiguities in DNA
dynamics, particularly the bending rigidity. Tomaymycin can also be used for
dynamics studies of unusual DNA structures such as triplex DNA and Z DNA.
Tom aymycin remains bound when B DNA is converted into Z DNA (unpublished
results, see Appendix B.2).
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Figure 4.1. The orientation of the absorption and emission transition dipoles of
tomaymycin.
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Figure 4.2. Space-filling models o f tomaymycin-d(ATGCAT ) 2 adducts: (upper left) S3',
(upper right) S 5 \ (lower left) R 3 \ and (lower right) R 5 \
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In addition, a well-characterized DNA sample is very important to the
meaningful interpretation of the internal motions of the DNA helix (Hagerman, 1988).
The general rule is that DNA helix must be long enough in order to separate the internal
motions from the tumbling and diffusive motions of the whole molecule. Besides, the
m olecular weight distribution o f DNA, if it is not uniform, must be very narrow to rule
out potential length-dependence.
In this chapter, the bending theory of the DNA helix and the corresponding
computational analysis program will be addressed. The flexibility o f poly(dAdG)*poly(dC-dT) and calf thymus DNA, which have the same binding species 5'AGA,
will be m easured using time-resolved fluorescence emission anisotropy in different time
spans. The effect of different bonding density will also be examined.

4.2 Bending Theory and Fluorescence Anisotropy Decay Function
The torsional and bending rigidities of the DNA helix are determined by fitting
the fluorescence anisotropy decay o f TOM -DNA adduct to the theoretical decay model.
Two fluorescence decay curves /y y and /y n are acquired. The first letter in the
subscript denotes the polarization o f excitation light and the second the polarization of
em itted light. These two observed decay curves will obey the following equations:
/y y (t) = lamp (t) ® { Flu (t) * (1 + 2 * r ( t ) ) / 3 )

(4.1a)

I\H (t) = lamp (t) ® { Flu (t) * ( 1

(4.1b)

- r (t)) / 3 }

where the predicted total intensity of fluorescence from all three polarization directions
Flu(t) = X oq exp(-t !%\) is independent of polarization, lamp (t) is the instrumental

response function, and r (t) the predicted fluorescence anisotropy decay. The symbol ®
denotes convolution.
For a fluorescent probe that is tightly attached to a very long DNA helix and has
parallel absorption and emission transition dipoles, the fluorescence emission
anisotropy decay r(t) depends on the initial anisotropy rQ, the internal correlation
function In(t), the torsional correlation function F n(t), and the bending correlation
function G n(t) (Barkley & Zimm, 1979; Schurr, 1984):
r(0 =

ro X I„(t) F„(t) G n(t)
i= l

(4 .2 )

The internal correlation function is given by:
= (3cqs2e - 1 )2_
u

4

= 3sm?2e
'

4

j

= 3sm ie
z

4

(4

3a. c)

v

where e is the relative orientation between the transition dipole o f the fluorescent probe
and the axis o f the DNA helix.
The torsional correlation function Fn(t) is determined by:
F n(t) = exp [-u2K tqT (7tC p ) ' , / 2 t 1/2]

(4.4)

where A'g is the Boltzmann constant, T the absolute temperature, C the torsional
rigidity, and p the friction coefficient per unit length for rotation about the helix axis. C
governs the equilibrium root-mean-square fluctuation in twist: Yrms = (3.4 x 10~8
tfBT /C )1/2. p is equal to

47 trib2,

where b is the radius o f the DNA helix.

The bending correlation function G n(t) is determined by:

G n(0 = exP

[-(6

- n 2 )B(t) t 1/4 / 4]

(4.5)
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where B(t) is a complicated function depending on T, b, time, the bending rigidity El,
and solvent viscosity T|. E l is related to the persistence length, P, as E l = PX b T. The
explicit expression o f B(t) is given in the next section.

4.3 Computational Analysis Program: BZFIT
Based on the anisotropy decay theory described in the above section, a global
non-linear least squares fitting program, BZFIT, was written in FORTRAN 77 language
on the VAX 3100 workstation (see Appendix C .l for codes). The fitting parameters
include: i) anisotropy decay parameters: r0, b, P, e, and C; and ii) lifetime parameters:
Ti ,

and otj. The lifetime Xj can be specifically associated with an anisotropy decay

model. The fluorescence decay curves acquired at magic angle (54.7°) can also be
included in the global data analysis with Xj linked with the polarized decay curves,
which restrains the lifetime parameters and thus helps recover the anisotropy
parameters. In addition, a very important advantage of BZFIT is that all these
param eters can be set free, linked, associated, and/or fixed during the global fitting of
multiple decay curves, which has not been done in other labs (Wu et al., 1987; W u et
al., 1988; Brown et al., 1991; Guest et al., 1991).
In BZFIT, the analytical derivatives o f Xj and oq were computed directly from
the equations. However, the numerical convolution and the numerical derivative of
anisotropy decay were used due to the non-exponential expressions o f F n(t), G n(t), the
modified Bessel function, and the transcendental equations involved in the decay
model, which is the reason for the enormous computing time required for the data
analysis. The general formula for numerical convolution is:
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N

c(n) = X a(k)*b(n-k+l)
k= 0

(4.6)

where N is the maximum length of vectors a and b, and integers k < n.
B(t) is given as
3.466ATb T z(t)
B®

=

(4 ?)

where z(t) is given by the transcendental equations 4.8a & b.
z(t) = [K 0 (zmax) + ^ M .K ,(z max) ] 1/4

w (t)

z ( t) | (E I)t

(4.8a)

(4.8b)

|

and Ko and Kj are the solutions of the modified Bessel function which is solved using
the polynomial approximation (Abramowitz & Stegun, 1965; Weast, 1989):
i) when

2

<x<

jt 1/ 2 e*K 0 (x) =

1.25331414 - 0.07832358(2/x) + 0.02189568(2/x)2 0.01062446(2/x)3 + 0.00587872(2/x)4 - 0.00251540(2/x)5 +
0.00053208(2/x)6 + e;

le! < 1.9x1 O' 7
(4.10a)

x m ex Ki(x) =

1.25331414 + 0.23498619(2/x) - 0.03655620(2/x)2 +
0.01504268(2/x)3 - 0.00780353(2/x)4 + 0.00325614(2/x)5 0.00068245(2/x)6 + e;

lei < 2.2x 10' 7

(4.10b)
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ii) when

0

K 0 (jc) =

< x <2:
-ln(jc/2)I0 (jc) - 0.57721566 + 0.42278420(x/2)2 + 0.23069756(;t/2)4
+ 0.03488590(jc/2)6 + 0.00262698(v/2)8 + 0.00010750(x/2)'0 +
0.00000740(^/2) 12 +

e;

lei <

lx lO ' 8

(4.10c)
x K \(x) = xln(x/2)Ii(;c) + 1 + 0.15443144(jt/2)2 - 0.67278579(x/2)4 0.18156897(x/2)6 - 0.01919402(x/2)8 - 0.001 10404(jc/2)10 0.00004686(^/2) 12 +

e;

lei < 8 x l0 9
(4.10d)

Io(y) = 1 +

x l — + , x~ + - - ■y 6
+2 2 (1 ! ) 2 24(2 ! ) 2 2 6 (3 ! ) 2

Il&-) = f - + ^ - + - / - + ^ Z- + 2
2 3 1!2! 25 2!3! 273!4!
The reduced

%2

(4.10e)

(4 I Of)
v
;

value, weighted residuals, and the autocorrelation function of

the weighted residuals are used to judge the goodness o f fit, combined with the
knowledge from simulation and lifetime analysis at magic angle.
Some examples of auxiliary programs are BZPAR for generating various
parameter matrices as input for BZFIT, SUMWT for calculating the total fluorescence
intensities and the corresponding weighting factors, and GCORR for polarization error
corrections of total intensities using the steady-state anisotropy and of the perpendicular
data file using the measured G-factor. The G-factor is equal to / hv ^HH- BZSIMU,
which was written using the MATLAB software package, is used to simulate the
anisotropy decay curve using numerical convolution from either the experimental or
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theoretical instrumental response function. A theoretical instrumental function can be
given as:
Lamp (t) = exp(-t/A) - exp(-t/B)

(4.11)

where A and B can be any positive value with A>B. The codes for these programs can
be found in Appendix C.

4.4 Methods and Materials
Poly(dA-dG)*poly(dC-dT) was purchased from Pharm acia Co. and dissolved
into 0.01 M phosphate buffer containing 0.1 M NaCl and 0.1 mM EDTA, pH 7.5. Its
molecular weight as well as distribution was determined using 1 .0 % agarose gel
electrophoresis compared with two molecular weight markers, 1 kb DNA Ladder and
123 bp DNA Ladder purchased from GIBCO BRL. As a wide distribution was found
from the commercial samples (Figure 4.3), fractionation was performed on a
Nucleogen-DEAE 4000-7 HPLC anion-exchange preparative column purchased from
M acherey-Nagel, Diiren, F.R.G. (Colpan & Riesner, 1984; Coppella et al., 1987). This
is a silica gel-based weak anion exchange column with a hydrophilic surface. HPLC
was performed on a Rainin Rabbit-HP liquid chromatography system equipped with a
2-ml sample loop and a variable-wavelength ISCO V4 absorbance detector. The buffer
A contained 50 mM KH 2 PO 4 and 4 M urea (note:

6

M was found to give better

separation later) with pH 7.5. The buffer B was buffer A plus 1.5 M KC1. The running
gradient was 0-40 % of buffer B in 30 minutes and 40-80 % of B in 60 minutes at flow
rate of 1.0 ml/min and pressure of 500 psi. The fractions were detected at 260 nm and
collected every minute. After fractionation, salt and urea were removed by dialysis into
the desired buffer at 4 °C for at least three days. M olecular weights and distribution of
each fraction were determined using gel electrophoresis. Among them, about 4-6
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Figure 4.3. M olecular weight o f poly(dA-dG)*poly(dC-dT) determined from gel
electrophoresis: (left column) before HPLC fractionation, (middle column) after HPLC
fractionation, and (right column) molecular marker 1 kb. The arrow indicates the 1 kb
band.
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fractions that gave strongest signal at 260 nm turned out to have the same molecular
weight and were combined. The molecular weight of the combined fractions was
determined as 1,000 ± 50 bp or (6.1 ± 0.3) x 105 daltons (Figure 4.3). The final
concentration used in the fluorescence emission anisotropy decay was about 1.5 x 10-4
M nucleotide or 50 pg-DNA/m l, which gave about 0.9 absorbance at 260 nm. Other
fractions were discarded due to very low concentrations and widely spread molecular
w eight in different fractions. The adduct solution was prepared as described in Chapter
3.2 at P/D = 100 and 50. Unreacted drug was removed by extraction with ethyl acetate
prior to use. Photobleaching under intense laser light was minimized by deoxygenation.
In the fluorescence emission anisotropy decay measurement, the excitation light
from the dye laser (see Chapter 3.2 for details) is vertically polarized. The four-position
thermostatted sample holder was used in L-format detection. A dilute solution of
glycogen (Sigma) in water or water itself was used as a scatter to measure the
instrumental response profile. Two blackened quartz microcuvettes (3x3x5 m m 3 inside,
Helma) containing the adduct solution were placed in the sample holder. One position
had a vertical polarizer on the emission side (i.e., VV or parallel) and the other a
horizontal polarizer (i.e., VH or perpendicular). A DPU-2.5 optical depolarizer (Optical
For Research, Co.) was placed before the emission monochromator to eliminate
polarization dependence in the detection train. M easurements were carried out at
different time scales o f 5-41 ps/channel for 1024 channels and at 5 °C. Excitation
wavelength was 333 nm. Emission wavelength was 400-420 nm at 5-nm intervals.
About 3.5 x 104 counts in the peak channel were collected for parallel data file, and 2 x
104 for the perpendicular. The G-factor was measured from the two samples with
horizontally-polarized excitation light. It is defined as the fluorescence intensity ratio
of /h v //h h - The G-factor was measured before and after each measurement for a
period o f 15 minutes, and the average value was used. For those decays that have less
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than 0.5 % counts in the tail com pared to the counts in the peak channel, the G-factor
correction was done using the steady state anisotropy value from the same solution as
determined separately on an SLM 8000 fluorometer at the same wavelengths and
temperature.

4.5 Experimental Results and Discussions
Fluorescence Lifetime. The fluorescence decay curves for tomaymycin-DNA
and tomaymycin-poly(dA-dG)»poly(dC-dT) adducts fit well to a biexponential lifetime
model (Table 4.1). The sim ilar lifetimes suggest that both adducts have the same
binding species (see Chapter 3.4 for more details). The longer lifetime species
presumably represents the S3' species, and the shorter lifetime the R5' species. In
addition, two extra lifetime species are present due to the free drug (1.04 ns) and stray
light under intense laser light (-3 0 ps). They are fixed and dissociated from r(t) in
global anisotropy decay analysis.
Anisotropy Decay. Global anisotropy decay analysis were performed on 16
pairs of polarized decay curves acquired at different wavelengths, time scales, and P/D
ratios. The initial anisotropy (r0) is determined as -0 .3 6 for both tom aymycin-calf
thymus DNA and -poly(dA-dG)*poly(dC-dT) adducts. It is close to the limiting
anisotropy o f -0 .3 4 obtained from free drug in ethanol glass at 77 K. The radius of the
DNA helix used in the data analysis was 12.5 A. Figure 4.4 shows an exam ple o f the
polarized decay curve and the best fit to it.
The relative contributions of twisting and bending motions to the anisotropy
decay depend on the angle (e) between the transition dipole and the helix axis. The
recovered value of e from the experimental data is -35°, which agrees with the value
estim ated from the molecular modeling studies. This angle is rather small compared to

Table 4.1 Lifetime Data of Tomaymycin-Poly(dA-dG)*poly(dC-dT) and TomaymycinCalf Thymus DNA Adducts0

adduct

XI

«2

X2

X2

poly(dA-dG)*poly(dC-dT)

0.63

7.2

0.37

4.8

1 .6

calf thymus DNA

0.60

7.1

0.40

4.3

1.7

a pH 7.5, P/D = 100, 5 °C, Xcx = 333 nm, A,em = 400-420 nm at 5-nm intervals.
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Figure 4.4. Polarized fluorescence decay curve o f tom aymycin-calf thymus DNA
adduct at parallel orientation at pH 7.5, P/D = 100, 5 °C. A,ex = 333 nm, Aem = 400 nm,
33 ps per channel. Left curve is instrumental response function; points are sample
decay; smooth curve through points is best fit to the following: oci = 0.6, Ti =7. 1 ns, %2
= 4.3 ns, r0 = 0.36, b = 12.5 A, C = 2.4 x 1 0 - 19 erg.cm, e = 35°, P = 470 A, local y } =
1.7. W eighted residuals and autocorrelation function of the residuals (inset) are also
shown.
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ethidium -DNA complex whose angle is 71°. Therefore, the bending motions dominate
the anisotropy decay o f tomaymycin-DNA adduct. In contrast, twisting motions
dominate the decay in the case of ethidium-DNA complexes. This is shown in the
simulation o f r(t) using equations 1-7 (Figure 4.5). The relative contribution from
bending motions is greater at early times.
Flexibility o f the DNA Helix. The observed flexibility o f calf thymus DNA is
close to consensus values (Hagerman, 1988; Fujimoto & Schurr, 1990). However,
poly(dA-dG)*poly(dC-dT) has similar torsional rigidity but smaller bending rigidity
than calf thymus DNA. Similar flexibility is observed at P/D ratio of 100 and 50 for
poly(dA-dG)*poly(dC-dT), indicating drug binding does not significantly distort the
DNA helix at this bonding density. When the persistence length in the data analysis is
linked between the curves acquired at different time ranges, the recovered P is 130-140
o

o

o

A. W hen P is not linked, however, it varies from 120 A in the range o f 41 ns to 180 A
in the range of 5 ns (Table 4.2).
It is known that purine-pyrimidine tracts may adopt some unusual
conformations and base pair stacking (Wells, 1988). The sequence-dependence of
o

bending rigidity has been reported. A P value o f as low as 180 A was observed for
poly(dA)»poly(dT) using a triplet quenching technique (Hogan & Austin, 1987). But
the small P for poly(dA-dG)»poly(dC-dT) must be confirmed by further experiments.

0.4

0.2
10

0

20

30

40

Time (ns)
Figure 4.5. Simulated r(t) curves. 1024 channels, 41 ps/channel, 278 K, r\ = 0.01549 poise, ro = 0.4, b = 12.5
£ = 71°, C = °o ,P = 500 A; b)
10

-1 9

erg*cm, P = °°.

8

= 35°, C = 1.3 x 10~1 9 erg.cm ,P = °°; c)

8

= 35°, C = ° ° ,P = 500

A;

d)

A.

curve a)

e = 7 1 ° ,C = 1 .3 x
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Table 4.2 Torsional (C) and Bending (El) Rigidity o f the DNA Helix

Adduct

calf thymus DNA

poly(dA-dG)
•poly(dC-dT)

P/D

time
(ns)

C
(x 10*9
erg-cm)

Yrms

p a
o

(A)

El
(x 1019
erg*cm)

100

33

2.4

4.2°

470

100

41

2.2

4.4°

140 (130)

0.54

50

41

2.2

4.4°

140 (120)

0.54

10

2.2

4.4°

140 (150)

0.54

5

2.2

4.4°

140 (180)

0.54

1.8

a Shown in parenthesis are the recovered persistence length values when P was not
linked between the polarized decay curves acquired at different time ranges.
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Chapter 5. Conclusions and Future Research

There are two major nonradiative processes occurring at the singlet excited-state
o f tomaymycin. They are intersystem crossing (k\sc) and excited-state proton transfer
(kp{). The latter is responsible for the different fluorescence properties in different
solvents and DNA adducts due to its environmental sensitivity. In aqueous solution, kpt
is much faster than /qsc and the radiative rate (kr), which yields observable solvent
isotope effect as well as a short lifetime. In contrast, kpi in alcoholic solvent and DNA
adduct would be very slow compared to kr and k\sc so that the solvent isotope effect is
negligible. The excited-state proton transfer can result in photochemical H-D exchange
on the aromatic carbons C 6 and C9 of tomaymycin with similar reaction rate.

8

-

phenolic group is not responsible for the solvent isotope effect. M oreover, hydroxy and
methoxy groups on the aromatic ring alone cannot lead to the photochemical H-D
exchange. It is most likely that the excited-state proton transfer occurs between N10-H
of tomaymycin and solvent or DNA base, which quenches fluorescence and renders the
aromatic ring susceptible to protonation. Based on the proposed mechanism, the Hbonding between N 10-H and solvent or DNA base plays an important role in the
excited-state proton transfer which affects the fluorescence lifetime.
Phosphorescence becom es more efficient than fluorescence at 77 K. The
emission transition dipole o f T ]->S 0 is most likely perpendicular to the absorption
transition dipole of Si<-SG, resulting in a negative limiting anisotropy. In contrast, the
emission transition dipole o f S]-> SG is parallel to the absorption dipole o f S]<-S0.
Two binding species exist in tomaymycin-natural DNA adduct at bonding
density lower than one drug molecule per 70 nucleotides. Both occupy the preferred
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binding site 5’AGA. The major species has longer lifetime than the minor species.
They are presumably assigned to the S3' and R5' adducts, respectively. A different
fluorescence lifetime is due to a different H-bonding pattern between N10-H of
tomaymycin and the proton acceptor on the flanking DNA base. The lifetimes are not
sensitive to pH, DNA size, DNA concentration, and P/D ratio (when < 100). At high
bonding density, less preferred binding sites are also occupied, which yields distributed
lifetimes ranging from 1.5 to

8

ns due to the presence of various binding species.

Tomaymycin appears to be a promising probe to report the internal motions of
the DNA helix, particularly for bending motions. It does not seem to stiffen the DNA
helix at low bonding density. The transition dipole o f tomaymycin in the DNA adduct
is oriented at -35° to the helix axis. Therefore, bending motions dominate the
fluorescence emission anisotropy decay of tomaymycin-DNA adduct in the time range
up to 50 ns. Poly(dA-dG)«poly(dC-dT) possesses the same two binding species as calf
thymus DNA. Both DNA helices have similar torsional rigidity. But poly(dAdG)-poly(dC-dT) is more flexible in terms of bending rigidity.
Tomaymycin can remain bound in the DNA helix when B DNA is converted
into Z DNA. It may also remain bound or even be able to bind to other unusual DNA
helices such as triplex. Therefore, it provides a good opportunity to further study the
dynam ics o f unusual DNAs as well as B DNA. A lot o f circumstantial evidence
suggests that unusual DNA structures are involved in gene expression processes. The
dynamics o f the DNA helix governs its deformation and conformational change.
Besides these unusual DNA helices, the B-Z junction may be investigated because it is
possible that the tomaymycin-bound areas remain in B DNA. Tomaymycin has shown
the ability to stabilize B DNA and inhibit B-Z transition.

Appendix A.

Abbreviations and Symbols

a

pre-exponential amplitude

b

radius o f the DNA helix

BBO

2,5-bis-(4-biphenylyl)-oxazole

C

torsional rigidity

CD

circular dichroism

D/

the broadness of the ith peak from MEM analysis

DEAE

diethylamine

Ea

activation energy

F.DTA

ethylenediaminetetraacetic acid

El

bending rigidity

0

quantum yield

FW HM

full width at half maximum

h

Planck constant

r)

viscosity

HPLC

high performance liquid chromatography

Kb

Boltzmann constant

/qsc

intersystem crossing rate

km

nonradiative rate

&PX

proton transfer rate

kr

radiative rate

Xcm

emission wavelength

Aex

excitation wavelength

MEM

maximum entropy method
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MTOM

8 -methyl

tomaymycin

NMR

nuclear magnetic resonance

P

persistence length

P/D

nucleotide to drug ratio

POPOP

l,4-bis-(5-phenyl-2-oxazoyl)-benzol or l,4-bis-(5-phenyloxazol2 -yl)-benzene

Pu

purine

Py

pyrimidine

ro

limiting anisotropy or initial anisotropy

T

absolute temperature

x

lifetime

TME

tomaymycin

TOM

tomaymycin

UV-Vis

ultraviolet-visible

8

convolution

<

>

1 1 -methyl

ether

Appendix B. Some Additional Experimental Results

B .l T h e F luorescence Lifetim es o f Som e Tom aym ycin-D N A A d d u cts C on tain in g
U niqu e B inding Sites.
Tom aymycin-d(CICGATCICG)2, -d(CIAGCICTCG)2, and -d(CITCICGACG ) 2
adducts were generously provided by Dr. Hurley as lyophilized samples with two
tomaymycin molecules bonded per duplex. They were dissolved into 10 mM phosphate
buffer, pH 7.0, containing 0.1 M NaCl and 0.1 mM EDTA, to give final concentration
o f about 1 x 10' 5 M duplex. Poly(dA-dG)«poly(dC-dT) was purchased from Pharmacia,
Co. and dissolved into pH 7.5 phosphate buffer. The concentration was determined
from the absorbance at 260 nm using extinction coefficient o f 5700 M _1c n r 1. The
tomaymycin adduct was prepared as described in Chapter 3 with P/D = 1 0 0 and 50.
The fluorescence lifetimes of the above samples were measured using time-correlated
single photon counting technique at 5 °C as described in Chapter 3. All adduct
solutions were subject to the same extraction and deoxygenation procedures prior to
use. The analysis results are shown in Table B .l.
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Table B .l The Fluorescence Lifetime D ata of Some Tomaymycin-DNA Adducts
Containing Unique Binding Sites.
sequence

A-ex (nm)

ai

X\ (ns)

d(CICGATCICG)2a

318

1.00

5.6

318

0.89 + 0.01

5.4

2.6

1.35

323

0.95 + 0.01

328

0.96 + 0.01

333

0.99 ± 0.01

318

0.640 + 0.003

5.6

1.4

1.3

323

0.726 ± 0.002

328

0.796 ± 0.003

333

0.825 + 0.005

333

0.63 + 0.05

7.2

4.8

1.7

%2 (ns)

X2
1.3

323
328
333
d(CIAGCICTCG)2"

d(CITCICGACG)2"

poly(dA-dG)»poly(dC-dT)fc

"Global analysis o f the intensity decay curves at ACm = 395-415 nm (5-nm intervals).
The counts in the peak channel were 2.5 x 104. POPOP in 0.8 M KI ethanol/water (3:1)
solution was used as the reference fluorophore (see Chapter 2 for detail). ^Global
analysis of

8

intensity decay curves at Xem = 400-420 (5-nm intervals). The counts in

the peak channel were 2.5 x 104. Glycogen in aqueous solution was used as the scatter
(see Chapter 4 for detail). A short lifetime o f -3 0 ps was present due to stray light and
subtracted.
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B.2 The Effect of Tomaymycin Bonding on the B-Z Transition of Poly(dGdC)-poIy(dG-dC)
Poly(dG-dC)*poly(dG-dC) was purchased from Pharmacia, Co. and dissolved in
0.01 M phosphate buffer, pH 7.5, containing 0.1 M NaCl and 0.1 mM EDTA. The
solution concentration was determined from the absorbance at 254 nm using extinction
coefficient of 8400 M '1c n r 1. The tomaymycin adduct solution was prepared as
described in Chapter 3. The amount o f unreacted drug was determined from the
isobutanol extraction method as described in Chapter 3. The B-Z transition was
induced by 5 M NaCl (F. M. Pohl & T. M. Jovin, J. M o l Biol. 1972, 67, 375-396). The
transition was monitored from circular dichroism (CD) spectra on an AVIV 14DS CD
spectrometer. All measurements were carried out at 5 °C.
The B-Z transition o f poly(dG-dC)*poly(dG-dC) can be completed in less than 3
hr. In contrast, the formation and dissociation of adduct are very slow. Therefore, the
effect o f bound tomaymycin on the B-Z transition can be observed by adding NaCl to
solution after isobutanol extraction. The effect of unreacted tomaymycin can be
observed right after adding drag to DNA solution. The bonding densities of
tomaymycin in B and Z DNAs were very similar for up to 2 weeks within the
experimental error, indicating that tomaymycin adduct remains in Z DNA. The B-Z
transition of adducts prepared at P/D = 10 and 20 was partially inhibited, while the
inhibition at P/D = 60 was negligible (Table B.2 and Figure B .l). The percentage o f Z
DNA without isobutanol extraction is very close to that with the extraction. No
inhibition was observed when the B-Z transition was induced right after adding drug to
DNA solution. These results indicated that only the bound drug was able to inhibit the
B-Z transition.

Table B.2 The Effect o f Tomaymycin Bonding on B-Z Transition
Z% h
bonding

without

with

density0

extraction

extraction

10

26 ± 2

29 ± 5

37 + 5

20

61 + 5

72 ± 5

80 ± 5

60

386 ± 50

100 ± 5

100 + 5

P/D

°The bonding density refers to the ratio of nucleotide to reacted drug.
bZ % was calculated based on the average changes o f ellipticity at 251
and 292 nm.

Ellipticity (millidegrees)
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Figure B .l. The CD spectra of poly(dG-dC)»poly(dG-dC) and its
tomaymycin adducts in 5 M NaCl solution, 5 °C. B DNA is in 0.1 M NaCl.

Appendix C.

C .l.

Computational Program Codes

BZFIT.for

*****'*******************************************************************************
*
*
*
*
ZZZZZ
FFFFF
in TTTTT
BBBB
*
*

B B
BBBB
B B
BBBB

*

*

Z
Z
Z
ZZZZZ

F
FFFF
F
F

I
I
I

in

T
T
T
T

*

*

*
*

*
*

*

DATA ANALYSIS PROGRAM OF DNA INTERNAL MOTIONS MONITORED

*

*

B Y

*

*

TIME-RESOLVED FLUORESCENCE EMISSION ANISOTROPY

*

* * * * * *******************************************************************************

*
* BASED ON BARKLEY_ZIMM'S DNA BENDING MOTION THEORY (J. CHEM. PHYS., 1979)
* USING THE NON-LINEAR LEAST SQUARE FITTING METHOD AND
* THE SIMILAR FLOWCHAT IN 'TFIT' FOR FLUORESCENCE LIFETIME DECAY WRITTEN
* BY MARK PRITT AND JOE BEECHEM.

*

* WRITTEN IN DR. BARKLEY'S LAB ON DECEMBER 4, 1992
* MAGIC ANGLE CURVES LINKING OPTION ADDED IN JULY, 1993
* NON-1 G-FACTOR OPTION ADDED ON DECEMBER 6, 1993

*

* AVAILABLE OPTIONS:

*

*
*
*
*
*
*

1. LAMP METHOD ONLY
2. LIFETIME-ANISOTROPY ASSOCIATIVE OR NON-ASSOCIATIVE
3. Q-SHIFT
4. CHANNEL LIMITS SPECIFIED OR UNSPECIFIED
5 STANDARD OR CUSTOMER WEIGHTING
6. SAME OR DIFFERENT LAMPS FOR PARALLEL AND PERPENDICULAR CURVES
7. FILENAME CAN BE IN ANY FORMAT
6. MAGIC ANGLE CURVES LINKABLE
7. NON-1 G-FACTOR
8. ALL MOLECULAR PARAMETERS ARE FITTING PARAMETERS
INPUTS:

1. BZFIT.DAT CONTAINING DATA FILENAMES, INSTRUMENTAL AND EXPERIMENTAL
CONDITIONS, AND FITTING PARAMETERS
* 2. DECAY CURVES

*

EXAMPLE OF BZFIT.DAT
1024 (CHANNEL NUMBER)
FTAGO 1.DAT (LAMP FOR PARALLEL CURVE FOLLOWED BY )
FTAG01.DAT (LAMP FOR FOR PERPENDICULAR CURVE)
FTAG02.DAT

111

112
* FTAG02.DAT
* FTAG03.DAT (LAMP FOR MAGIC ANGLE CURVE, OPTIONAL)
* .END
* VTAG01.DAT (PARALLEL CURVE)
* YATG01 .DAT (PERPENDICULAR CURVE)
* VTAG02.DAT
* YTAG02.DAT
* ,NRT
(END OF ANISOTROPY DECAY CURVES)
* VTAG03.DAT (MAGIC ANGLE CURVE, OPTIONAL)
* .END
* ATAG01.DAT (FITTED CURVES, OPTIONAL)
*

* .END
* STANDARD (OR FILENAME CONTAINING THE WEIGHTING FACTORS)
*000
(Q-SHIFT, ONE PER LAMP)
* 0.03 0.03 (NS PER CHANNEL, ONE PER EXPERIMENT)
* 0 0 0 0 0 0 (CHANNEL LIMITS FOR SAMPLE DECAYS, ONE PAIR PER CURVE)
* 1 2 3 4 0 0 0 0 0 0 (LOGICAL NUMBER FOR LIFETIME IN EXPERIMENT 1)
* 5 6 7 8 9 0 0 0 0 0 (LOGICAL NUMBER FOR RO, C, B, EPSILON, PL IN EXPERIMENT 1)

*

* 0.5 7 0.3 3 0.4 1.2 11 33 500 (INITIAL GUESSES)
*

* 1 1 1 1 1 (ASSOCIATIVE MATRIX FOR EXPERIMENT 1)
*

* 0.9 0.9 (G-FACTOR, ONE PER ANISOTROPY EXPERIMENT)
* 278 278
(TEMPERATURE, ONE PER ANISOTROPY EXPERIMENT)
* 0.01 0.01 (VISCOSITY, ONE PER ANISOTROPY EXPERIMENT)
*L
(LAMP METHOD)

*
*

* IMPORTANT NOTES:

*

* 1. LOGICAL NUMBERS DO NOT HAVE TO BE IN ORDER, BUT MUST BE CONSECUTIVE
*
FROM 1 OVERALL.
* 2. IN PRACTICE, FIX ANISOTROPY PARAMETERS FIRST FOR THE BEST FIT OF
*
LIFETIME PARAMETERS TO AVOID FALLING INTO ARITHEMATIC TRAP, THEN
*
CONTINUE FROM THE BEST FIT WITH OR WITHOUT FIXING LIFETIMES.
PROGRAM BZFIT
* * * DECLARATION SECTION * * *
PARAMETER (NEXP=30, NCOMP=10, NCHANM=1024, NPAR=300,
$ FLINC1 = 10.0, FLINC2=10.0, PRE=l.0/3.0, LU=5, FCNGE=l.E-6,
$ DELTA_DDER=0.001)
DIMENSION ALFA(NPAR,NPAR), ALFA_LOCAL(2*NCOMP,2*NCOMP),
$ AMP(NCOMP), ARR(NPAR,NPAR), ASSOC(NCOMP/2,NEXP),
$ BETA(NPAR), BETA_LOCAL(2*NCOMP),
$ CDERIV(NCHANM), CFIT(NCHANM), CFITX(NCHANM), CHISQR(2*NEXP),
$ DELTA(NPAR), DERIV(NCHANM,2*NCOMP), DERIVX(NCHANM),
$ DKDATA(NCHANM,2*NEXP), ELAMP(NCHANM,2*NEXP), ELAMPI(NCHANM),
$ FIT(NCHANM), FITDATA(NCHANM,2*NEXP), FITX(NCHANM), FLU(NCHANM),
$ GFACM(NEXP), LIMIT(2), LIMS(2,2*NEXP), LIMS_LAMP(2,2*NEXP),
$ NCHAN_BAD(2*NEXP), NCHAN_BAD_NEW(2*NEXP), MPOINT(NCOMP,NEXP,2),
$ PAR(5), PMAIN(NPAR), PMAIN_NEW(NPAR), RT(NCHANM),
$ RTFLU(NCHANM), RTX(NCHANM), RTY(NCHANM), QS(2*NEXP),
$ S(NPAR,NPAR), SCALED_BETA(NPAR), SCRATCH(NCHANM),
$ SIGMA(NCHANM,2*NEXP), T(NPAR), TAU(NCOMP),

$ TAUP(NEXP), TCALS(NEXP), TEMPM(NEXP), VISCM(NEXP)
CHARACTER*40 NAMR, PARAM_FILE, ANSWER_FILE, CURVMAT_FILE,
$ FITNAME(2*NEXP)
CHARACTER*] EXP_TYP
LOGICAL EX, SWITCH, FLAMDEJBAD, PROBE
INTEGER ASSOC, PAR_ORDERING_DONE, BEGINNING, MARQUARDT,
$ EXIT_AND_SAVE_RESULTS, MATRIX_ERROR, EXIT_CHI_LOOP,
$ SUM_CHANNELS
DOUBLE PRECISION SUMM, SUM, Z, SCALED_BETA, ARR, S, T
DATA FLAMDE / . O i l , FLAMDE_BAD /.FALSE./, PROBE /.FALSE./
ASSIGN 100 TO PAR_ORDERING_DONE
ASSIGN 200 TO BEGINNING
ASSIGN 300 TO MARQUARDT
ASSIGN 400 TO EXIT_AND_SAVE_RESULTS
ASSIGN 500 TO EXIT_CHI_LOOP
ASSIGN 990 TO MATRIX_ER.ROR
* * * INPUT SECTION * * *
* OPEN PARAMETER FILE
PARAM_FILE = 'BZFIT.DAT'
OPEN(51, ERR=900, FILE=PARAM_FILE, STATUS='OLD', IOSTAT=IOS)
* GET THE NUMBER OF CFIANNNELS
READ (51, '(14)’) NCHAN
* GET LAMP/PROBE CURVES
NLAMPCURVES = 0
READ (51, '(A)', ERR=910) NAMR
DO WHILE (INDEX (NAMR, '.END') .EQ. 0)
NLAMPCURVES = NLAMPCURVES + 1
WRITE (LU, '(2X, "READING LAMP FILE ", A)’) NAMR
OPEN (61, ERR=900, FILE=NAMR, STATUS=’OLD', IOSTAT=IOS)
READ (61, FMT-(A)', ERR=910) FJUNK
DO I = 1, NCHAN
READ (61, *, ERR=910) FJUNK, ELAMP(I, NLAMPCURVES)
ENDDO
CLOSE (61)
READ (51, '(A)’, ERR=910) NAMR
ENDDO
WRITE (LU, '(2X, 13, " LAMP CURVES")') NLAMPCURVES
* GET ANISOTROPY DECAY DATA CURVES
NRTCURVES = 0
READ (51, '(A)', ERR=910) NAMR
DO WHILE (INDEX (NAMR, '.NRT') .EQ. 0)
NRTCURVES = NRTCURVES + 1
WRITE (LU, '(2X, "READING DATA FILE " ,A)') NAMR
OPEN (61, ERR=900, FILE=NAMR, STATUS='OLD’, IOSTAT=IOS)
READ (61, FMT='(A)', ERR=910) FJUNK
DO I = 1, NCHAN
READ (61, *, ERR=910) FJUNK, DKDATA(I, NRTCURVES)
ENDDO
CLOSE (61)
READ (51, ’(A)’, ERR=910) NAMR
ENDDO
* GET LIFETIME DECAY DATA CURVES
NLTCURVES = 0
READ (51, ’(A)1, ERR=910) NAMR
DO WHILE (INDEX (NAMR, '.END') .EQ. 0)
NLTCURVES = NLTCURVES + 1
WRITE (LU, '(2X, "READING DATA FILE ", A)’) NAMR

OPEN(6I, ERR=900, FILE=NAMR, STATUS='OLD', IOSTAT=IOS)
READ (61, FMT='(A)', ERR=910) FJUNK
DO I = 1, NCHAN
READ (61, *, ERR=910) FJUNK, DKDATA(I, NRTCURVES+NLTCURVES)
ENDDO
CLOSE (61)
READ (51, ’(A)', ERR=910) NAMR
ENDDO
NDATACURVES = NRTCURVES + NLTCURVES
IF (NDATACURVES .NE. NLAMPCURVES) THEN
WRITE (LU, '(4X, "WARNING: THE NUMBER OF LAMPS IS NOT EQUAL",
$
" TO THE NUMBER OF DATA CURVES")')
STOP
ENDIF
FIGURE OUT NUMBER OF EXPERIMENTS
NRTEXPTS = NRTCURVES/2
NLTEXPTS = NLTCURVES
NEXPERIMENTS = NRTEXPTS + NLTEXPTS
GET FIT FILENAMES
INDEX_SCRATCH = 0
READ (51, '(A)', ERR=910) NAMR
DO WHILE (INDEX (NAMR, '.END') .EQ. 0)
INDEX_SCRATCH = INDEX_SCRATCH + 1
FITNAME(INDEX_SCRATCH) = NAMR
READ (51, '(A)VERR=910) NAMR
ENDDO
GET WEIGHTING
READ (51, '(A)', ERR=910) NAMR
IF (INDEX (NAMR, ’STANDARD') .NE. 0) THEN
WRITE (LU, '(2X, "USING STANDARD WEIGHTING...")')
DO J = 1, NDATACURVES
DO I = 1,NCHAN
DATA_PT = DKDATA(I, J)
IF (DATA_PT .EQ. 0.) THEN
SIGMA(I, J) = 1.
ELSE
SIGMA(I, J) = l./DATA_PT
ENDIF
ENDDO
ENDDO
ELSE
WRITE (LU, '(2X,"FILE CONTAINING WEIGHTING IS ", A)') NAMR
OPEN (61, ERR=900, FILE=NAMR, STATUS='OLD', IOSTAT=IOS)
READ (61, *, ERR=910) ((SIGMA(I, J), 1=1, NCHAN), J=l,
$
NDATACURVES)
CLOSE (61)
ENDIF
GET QSHIFTS, TCALS, AND CHANNEL LIMITS
READ (51, *, ERR=910) (QS(I), 1=1, NLAMPCURVES),
$
(TCALS(I), 1 =1 , NEXPERIMENTS),
$
((LIMS(I,J), I = 1, 2), J = 1, NDATACURVES)
GET ALPHA/TAU LOGIC - ANISOTROPIC DATA FIRST
READ (51, *, ERR=910) (((MPOINT(I, J, K), I = 1, NCOMP),
$ K = 1, 2), J = 1, NRTEXPTS)
IF (NLTEXPTS .NE. 0) THEN
READ (51, *, ERR=910) ((MPOINT(I, J, 1), I = 1, NCOMP),
$ J = NRTEXPTS + 1, NEXPERIMENTS)
ENDIF

FIGURE OUT HOW MANY INITIAL GUESSES THERE ARE TO GET
NIN = 0
DO 1 =1 , NCOMP
DO J = 1, NEXPERIMENTS
IF (J .LE. NRTEXPTS) THIRDDIM = 2
IF (J .GT. NRTEXPTS) THIRDDIM = 1
DO K = I, THIRDDIM
L = IABS (MPOINT(I, J, K))
IF (L .GT. NIN) NIN = L
ENDDO
ENDDO
ENDDO
WRITE(*, *) NIN
NIN = 0
DO 1 =1 , NCOMP
DO J = 1, NEXPERIMENTS
IF (J .LE. NRTEXPTS) THIRDDIM = 2
IF (J .GT. NRTEXPTS) THIRDDIM = I
DO K = 1, THIRDDIM
L = IABS (MPOINT (I,J,K))
IF (L .GT. NIN) NIN = L
ENDDO
ENDDO
ENDDO
WRITE (LU,'(2X,"TOTAL NUMBER OF INDEPENDENT PARAMETERS = ”,14)')
$ NIN
GET INITIAL GUESSES
READ (51, *, ERR=910) (PMAIN(I), 1 =1 , NIN)
GET ASSOCIATION MATRIX ASSOC, ASSOC(I.K) = 1 IF TAU#I IS ASSOC’D
WITH R(T) IN EXPT#K=0 OTHERWISE ASSOC(I.K) = 0
READ (51, *, ERR=910) ((ASSOC(I, K), I = 1, NCOMP/2),
$
K = 1, NRTEXPTS)
GET G-FACTORS, TEMPERATURES, AND VISCOSITIES
READ (51, *, ERR=910) (GFACM(I), 1=1, NRTEXPTS),
$
(TEMPM(I), 1 = 1 , NRTEXPTS),
$
(VISCM(I), 1 =1 , NRTEXPTS)
GET INFORMATION ON WHAT TYPE OF EXPERIMENTS (L FOR LAMP OR
P FOR PROBE). IF PROBE, GET TAUPROBE FOR EACH 'LAMP.'
READ (51,FMT='(A1)') EXP_TYP
PROBE = .TRUE.
IF (EXP_TYP .EQ. 'L') PROBE = .FALSE.
IF (PROBE) READ (51, *) (TAUP(J), J = 1, NLAMPCURVES)
CLOSE (51)
* * DATA PREPARATION SECTION * * *
GET NAMRS FOR ANSWER OUTPUT FILES
DO WHILE (PARAM_FILE( 1:1) .EQ. ") ! LEFT-JUSTIFY FILENAMR
PARAM_FILE = PARAM_FILE(2:40)
ENDDO
ANSWERJFILE = 'ABZFIT.DAT'
CURVMAT_FILE = CBZFIT.DAT’
INQUIRE (FILE=ANSWER_FILE, ERR=930, IOSTAT=IOS, EXIST=EX)
OPEN (51, ERR=902, FILE=ANSWER_FILE, IOSTAT=IOS, STATUS='NEW')
CLOSE (51)
INQUIRE (FILE=CURVMAT_FILE, ERR=930, IOSTAT=IOS, EXIST=EX)
OPEN (51 ,ERR=904, FILE=CURVMAT_FILE, IOSTAT=IOS, STATUS='NEW')
CLOSE (51)
SHIFT LAMPS

WRITE (LU, '(2X, "SHIFTING LAMPS WHEN NEEDED")')
DO J = 1, NLAMPCURVES

Q = QS(J)
IF (Q .NE. 0.) THEN
WRITE (LU, '(2X, "SHIFTING LAMPS # ",I4)') J
IQ = ABS(Q)
RQ = ABS(Q) - FLOAT(IQ)
IF (Q .GE. 0.) THEN
! POSITIVE SHIFT
JUMP = -1
IUPLIM = NCHAN
ILOLIM = IQ + 2
IQ = -IQ
DO I = 1, ILOLIM - 2
SCRATCH® = 0.
ENDDO
SCRATCH(ILOLIM-l) = (1. - RQ)*ELAMP(1, J)
ELSE
JUMP = 1
IUPLIM = NCHAN - IQ - 1
ILOLIM = 1
DO I = IUPLIM + 2, NCHAN
SCRATCH® = 0.
ENDDO
SCRATCH(IUPLIM+1) = (1. - RQ)*ELAMP(NCHAN, J)
ENDIF
DO I = ILOLIM, IUPLIM
SCRATCH® = ELAMP(I+IQ, J) + RQ*(ELAMP(I+IQ+JUMP, J)
$
- ELAMP(I+IQ, J))
ENDDO
DO I = 1, NCHAN
ELAMP(I, J) = SCRATCH®
ENDDO
ENDIF
ENDDO
* CALCULATE ANY UNSPECIFIED CHANNEL LIMITS
DO J = 1, NDATACURVES
IF (LIMS(1,J) -EQ. 0) THEN
THRESHU = 15.
I= 1
DO WHILE (I .LT. NCHAN .AND. DKDATA® J) .LT. THRESHU)
1

=

1+1

ENDDO
LIMS(1, J) = I
ENDIF
IF (LIMS(2, J) .EQ. 0) THEN
PEAK = 0.
DO I = 1, NCHAN
IF (PEAK .LT. DKDATA® J)) THEN
PEAK = DKDATA® J)
IPEAK = I
ENDIF
ENDDO
THRESHL = ,005+PEAK
I = IPEAK
DO WHILE (I .LT. NCHAN .AND. DKDATA® J) .GT. THRESHL)
1 = 1+1
ENDDO
LIMS(2, J) = I

ENDIF
WRITE (LU, '(2X, "CHANNEL LIMITS FOR DECAY #", 13, " =",
$
15,18)')J, LIMS(1, J), LIMS(2, J)
I= 1
DO WHILE (I .LT. NCHAN .AND. ELAMP(I,J) .LT. THRESHU)
1= 1+1

ENDDO
LIMS_LAMP(1, J) = I
PEAK = 0.
DO I = 1, NCHAN
IF (PEAK .LT. ELAMP(I, J)) THEN
PEAK = DKDATA(I, J)
IPEAK = I
ENDIF
ENDDO
THRESHL = ,005*PEAK
I = IPEAK
DO WHILE (I .LT. NCHAN .AND. ELAMP(I, J) .GT. THRESHL)
1 = 1+1

ENDDO
LIMS_LAMP(2, J) = I
WRITE (LU,'(2X,"CHANNEL LIMITS FOR LAMP #",13," =",I5,I8)’)
$
J,LIMS_LAMP( 1,J),LIMS_LAMP(2, J)
ENDDO
RE-ORDER THE PARAMETERS IN MPOINT SO WE CAN IGNORE THE
FIXED PARAMETERS: FOR EXAMPLE, IF
MPOINT( , ,1) = 1 -2 -3 4 0 0 0 0 0 0
5 -2 6 4 0 0 0 0 0 0
MPOINT( , ,2) = -7 8 9 1 0 - 1 1 - 1 2 0 0 0 0
13 8 -14 10-15 -12 0 0 0 0
THEN IT WILL BE CHANGED TO
MPOINT(, , 1) = 1- 9- 13 2 0 0 0 0 0 0
3- 9 4 2 0 0 0 0 0 0
MPOINT(, ,2) = -10 5 6 7-11 - 1 2 0 0 0 0
8 5 -14 7 -15 - 1 2 0 0 0 0
NUM = 0
DO WHILE (NUM.LE.NIN)
NUM = NUM + 1
NEXPT= 1
IPOS = I
IVH = 1
DO WHILE (MPOINT(IPOS,NEXPT,IVH) .LT. NUM)
IPOS = IPOS + 1
IF (IPOS .GT. 10) THEN
IPOS = 1
NEXPT = NEXPT + 1
IF (NEXPT .GT. NEXPERIMENTS) THEN
IF (IVH.EQ.2) GO TO PAR_ORDERING_DONE
IVH = IVH + 1
IPOS= 1
NEXPT = 1
ENDIF
IF ((NEXPT .GT. NRTEXPTS) .AND. (IVH.EQ.2)) GO TO
$
PAR_ORDERING_DONE
ENDIF
ENDDO
NUM_SWITCH=MPOINT(IPOS,NEXPT,IVH)
IF (NUM .NE. NUM_SWITCH) THEN

SWITCH = .FALSE.
DO NEXPT = 1, NEXPERIMENTS
DO IPOS = 1, 10
IF (NEXPT.LE.NRTEXPTS) THIRDDIM = 2
IF (NEXPT .GT. NRTEXPTS) THIRDDIM = 1
DO IVH = 1, THIRDDIM
IF (MPOINT(IPOS,NEXPT,IVH).EQ.NUM_SWITCH) THEN
MPOINT(IPOS,NEXPT,IVH) = NUM
SWITCH = .TRUE.
ELSE
IF (MPOINT(IPOS,NEXPT,IVH).EQ.-NUM) THEN
MPOINT(IPOS, NEXPT, IVH) = -NUM_SWITCH
SWITCH = .TRUE.
ELSE
IF (MPOINT(IPOS,NEXPT,IVH).EQ.NUM) THEN
MPOINT(IPOS,NEXPT,IVH) = NUM_SWITCH
SWITCH= .TRUE.
ENDIF
ENDIF
ENDIF
ENDDO
ENDDO
ENDDO
IF (SWITCH) THEN
P = PMAIN(NUM)
PMAIN(NUM) = PMAIN(NUM_SWITCH)
PMAIN(NUM_SWITCH) = P
ENDIF
ENDIF
ENDDO
100 NIN_FREE = NUM - 1
IF (NIN .NE. NIN_FREE) THEN
WRITE (LU, '(2X, "NO. OF FIXED PARAMETERS = ", 14)')
$
NIN-NIN_FREE
WRITE (LU, '(2X, "NO. OF FITTING PARAMETERS = ", 14)')
$
NIN_FREE
ENDIF
* * * MAIN ANALYSIS SECTION * * *
* GLOBALIZED CURVE FIT
WRITE (LU, '(2X, "STARTING THE ANALYSIS ...")')
ITERATION = 0
200 ITERATION = ITERATION + 1
* ZERO OUT GLOBAL BETA, ALFA, SUM_CHANNELS, CHISQR_SUM
DO I = 1, NIN
BETA(I) = 0.
DO K = 1, NIN
ALFA(I, K) = 0.
ENDDO
ENDDO
SUM_CHANNELS = 0
CHISQR_SUM = 0.
NEXPT = 1
DO WHILE (NEXPT .LE. NEXPERIMENTS)
IF (NEXPT .LE. NRTEXPTS) THEN
DO IVH = 1, 2
! IVH = 1 FOR PARALLEL, 2 FOR PERPENDICULAR
IF (IVH .EQ. 1) NCUR = 2*NEXPT - 1
IF (IVH .EQ. 2) NCUR = 2*NEXPT

ICHAN_FIRST = LIMS(1, NCUR)
ICHAN_LAST = LIMS(2, NCUR)
GET LOCAL ALPHAS, TAUS, & BZPARS (AMP, TAU,C, PL, B, RO, AND
EPSILON) FROM THE GLOBAL ONES (IN PMAIN)
IF (IVH .EQ. 1) THEN
NTERMS_SUM = 0
DO I = 1, NCOMP
IF (MPOINT(I,NEXPT, 1) .NE. 0)
$
NTERMS_SUM = NTERMS_SUM + 1
ENDDO
NTAU = NTERMS_SUM / 2
DO I = 1, NTAU
AMP(I) = PMAIN(IABS(MPOINT(2*I - 1, NEXPT, 1)))
TAU(I) = PMAIN(IABS(MPOINT(2*I, NEXPT, 1)))
ENDDO
PAR(l) = PMAIN(IAB S(MPOINT(1, NEXPT, 2)))
PAR(2) = PMAIN(IABS(MPOINT(2, NEXPT, 2)))
PAR(3) = PMAIN(IABS(MPOINT(3, NEXPT, 2)))
PAR(4) = PMAIN(IABS(MPOINT(4, NEXPT, 2)))
PAR(5) = PMAIN(IABS(MPOINT(5, NEXPT, 2)))
ENDIF
ZERO CHISQR AND LOCAL ALFA, BETA, DERIV, FIT, RTFLU
CHISQR(NCUR) = 0.
DO I = 1, 2*NTAU + 5
BETA_LOCAL(I) = 0.
DO J = 1 ,1
ALFA_LOCAL(I, J) = 0.
ENDDO
DO ICHAN = 1, NCHAN
DERIV(ICHAN, I) = 0.
ENDDO
ENDDO
DO ICHAN = 1, NCHAN
FIT(ICHAN) = 0.
RTFLU(ICHAN) = 0.
ELAMPI(ICHAN) = ELAMP(ICHAN, NCUR)
ENDDO
CALCULATE LIFETIME DECAY, ANISOTROPY DECAY, AND CONVOLUTION
IF (IVH .EQ. 1) SCALE = 2.
IF (IVH .EQ. 2) SCALE = -1.
IF (IVH .EQ. 1) THEN
TCAL = TCALS(NEXPT)
TEMP = TEMPM(NEXPT)
VISC = VISCM(NEXPT)
GFAC = GFACM(NEXPT)
ENDIF
CALL BZFUN (PAR, TEMP, VISC, ICHAN_LAST, TCAL,
$
RT, ICHAN_BAD)
NCHAN_BAD(NCUR) = 0
IF (ICHAN_BAD .GT. 0) THEN
NCHANJBAD(NCUR) = ICHAN_BAD + LIMS_LAMP(2, NCUR) $
LIMS_LAMP(1, NCUR)
ENDIF
DO I = 1 ,NTAU
CALL FLUFUN(ICHAN_LAST, 1, AMP(I), TCAL, TAU(I), FLU)
DO ICHAN = 1, ICHAN_LAST
RTFLU(ICHAN) = ASSOC(I, NEXPT)*FLU(ICHAN) +
$
RTFLU(ICHAN)

FIT(ICHAN) = PRE*FLU(ICHAN)*( 1+ASSOC(I, NEXPT)*
SCALE*RT(ICHAN)) + FIT(ICHAN)
ENDDO
ENDDO
CALL NUMCONV (FIT, ICHAN_LAST, ELAMPI, ICHAN_LAST, CFIT)
DO I = 1, ICHAN_LAST
FITDATA(I, NCUR) = CFIT(I)
ENDDO
IF (IVH .EQ. 2) THEN
DO I = 1, ICHAN_LAST
FITDATA(I, NCUR) = FITDATA(I, NCUR) / GFAC
ENDDO
ENDIF
GET DERIVATIVE FOR TAUS AND AMPS
DO ITAU = 1, NTAU
DO ICHAN = 1, ICHAN_LAST
TAU_AMP = EXP(-TCAL*ICHAN/TAU(ITAU))
FITX(ICHAN) = PRE*(1 + ASSOC(ITAU, NEXPT)*SCALE*
$
RT(ICHAN))*TAU_AMP
FIT(ICHAN) = PRE*( 1 + ASSOC(ITAU, NEXPT)*SCALE*
$
RT(ICHAN))*TAU_AMP*AMP(ITAU)*TCAL*ICHAN/(TAU(ITAU)**2)
ENDDO
CALL NUMCONV (FITX, ICHAN_LAST, ELAMPI,
$
ICHANJLAST, CFITX)
CALL NUMCONV (FIT, ICHAN_LAST, ELAMPI, ICHAN_LAST, CFIT)
DO ICHAN = I, ICHANJLAST
DERIV(ICHAN, 2*ITAU-1) = CFITX(ICHAN)
DERIV(ICHAN, 2*ITAU) = CFIT(ICHAN)
ENDDO
ENDDO
GET DERIVATIVE FOR RTS
DO IPAR = 1, 5
DDER = DELTA_DDER*PAR(IPAR)
PARI = PAR(IPAR)
PAR(IPAR) = PARI + DDER
CALL BZFUN (PAR, TEMP, VISC, ICHAN_LAST, TCAL, RTY,
$
ICHAN_BAD)
PAR(IPAR) = PARI - DDER
CALL BZFUN (PAR, TEMP, VISC, ICHANLAST, TCAL, RTX,
$
ICHAN_BAD)
PAR(IPAR) = PARI
DO ICHAN = 1, ICHAN_LAST
FIT(ICHAN) = PRE*RTFLU(ICH AN)*( 1 + SCALE*RTY(ICHAN))
FITX(ICHAN) = PRE*RTFLU(ICHAN)*(1 + SCALE*RTX(ICHAN))
ENDDO
DO ICHAN = 1, ICHAN_LAST
DERIVX(ICHAN) = (FIT(ICHAN) - FITX(ICHAN))/(2.*DDER)
ENDDO
CALL NUMCONV (DERIVX, ICHANJLAST, ELAMPI, ICHANJLAST,
$
CDERIV)
DO ICHAN = 1, ICHAN_LAST
DERIV(ICHAN, 2*NTAU+IPAR) = CDERIV(ICHAN)
ENDDO
ENDDO
IF (IVH .EQ. 2) THEN
DO ICHAN = 1, ICHAN_LAST
DO J = 1, 2*NTAU + 5
DERIV(ICHAN,J) = DERIV(ICHAN,J) / GFAC
$

121
ENDDO
ENDDO
ENDIF
* THE CHANNEL LIMITS APPLY ONLY WHEN CALCULATING RESID, CHISQR, BETA, &
* ALFA
DO I = ICHAN_FIRST, ICHANJLAST
RESID = DKDATA(I, NCUR) - FITDATA(I, NCUR)
CHISQR(NCUR) = CHISQR(NCUR) + SIGMAII, NCUR)*RESID**2
DO J = 1, 2*NTAU + 5
BETAJLOCAL(J) = BETA_LOCAL(J)
$
+ SIGMA(I, NCUR)*RESID*DERIV(I, J)
DO K = 1, J
ALFA_LOCAL(J, K) = ALFA_LOCAL(J, K)
$
+ SIGMA(I, NCUR)*DERIV(I, J)*DERIV(I, K)
ENDDO
ENDDO
ENDDO
* GLOBAL MAPPING: LOCAL ALPHAS, BETAS ~> GLOBAL ALPHAS, BETAS
DO I = I, 2*NTAU + 5
IF (I .LE. 2*NTAU) THEN
KMPOINT = 1
IMPOINT K POINTER
IMPOINT = I
ELSE
KMPOINT = 2
IMPOINT = I - 2*NTAU
ENDIF
IP = IABS (MPOINT(IMPOINT, NEXPT, KMPOINT))
BETA(IP) = BETA(IP) + BETA_LOCAL(I)
DO J = I, 1,-1
IF (J .LE. 2*NTAU) THEN
JMPOINT = J
KMPOINT = 1
ELSE
JMPOINT = J - 2*NTAU
KMPOINT = 2
ENDIF
JP = IABS (MPOINT(JMPOINT, NEXPT, KMPOINT))
IF (JP .GT. IP) THEN
ALFA(JP, IP) = ALFA(JP, IP) + ALFA_LOCAL(I, J)
ELSE
ALFA(IP, JP) = ALFA(IP, JP) + ALFA_LOCAL(I, J)
ENDIF
ENDDO
ENDDO
SUM_CHANNELS = SUM_CHANNELS + (ICHAN_LAST $
ICHAN_FIRST + 1)
CHISQR_SUM = CHISQR_SUM + CHISQR(NCUR)
LIMIT(IVH) = ICHAN_LAST - ICHAN_FIRST + 1
ENDDO
! DO IVH = 1 , 2
WRITE (LU, *)' EXPT #',NEXPT
WRITE (LU, *) (AMP(I), TAU(I), 1=1, NTAU),
$
CHISQR(2*NEXPT-1)/LIMIT( 1), CHISQR(2*NEXPT)/LIMIT(2)
WRITE (LU, *) (PAR(I), 1 = 1 , 5 )
WRITE (LU, *) NCHANJBAD(2*NEXPT-1), NCHAN_BAD(2*NEXPT)
ELSE
IVH = 1
NCUR = 2*NRTEXPTS + (NEXPT-NRTEXPTS)
ICHAN_FIRST = LIMS(1, NCUR)

ICHAN_LAST = LIMS(2, NCUR)
GET LOCAL ALPHAS, TAUS,& BZPARS (AMP,TAU,C,PL,B,RO,AND
EPSILON) FROM THE GLOBAL ONES (PMAIN)
NTERMS_SUM = 0
DO 1=1, NCOMP
IF (MPOINT(I, NEXPT, 1) .NE. 0)
$
NTERMS_SUM = NTERMS_SUM + 1
ENDDO
NTAU = NTERMS_SUM/2
DO I = 1,NTAU
AMP(I) = PMAIN(IABS(MPOINT(2*I - 1, NEXPT, 1)))
TAU(I) = PMAIN(IABS(MPOINT(2*I, NEXPT, 1)))
ENDDO
ZERO CHISQR AND LOCAL ALFA, BETA, DERIV, FIT, RTFLU
CHISQR(NCUR) = 0.
DO I = 1, 2*NTAU
BETA_LOCAL(I) = 0.
DO J = 1 ,1
ALFA_LOCAL(I, J) = 0.
ENDDO
DO ICHAN = 1, NCHAN
DERIV(ICHAN, I) = 0.
ENDDO
ENDDO
DO ICHAN = 1, NCHAN
FIT(ICHAN) = 0.
ELAMPI(ICHAN) = ELAMP(ICHAN, NCUR)
ENDDO
CALCULATE LIFETIME DECAY,ANISOTROPY DECAY, AND CONVOLUTION
TCAL = TCALS(NEXPT)
DO I = 1,NTAU
CALL FLUFUN (ICHANJ A S T , 1, AMP(I), TCAL, TAU(I), FLU)
DO ICHAN = 1, ICHAN_LAST
FIT(ICHAN) = PRE*FLU(ICHAN) + FIT(ICHAN)
ENDDO
ENDDO
CALL NUMCONV (FIT, ICHAN_LAST, ELAMPI, ICHAN_LAST, CFIT)
DO I = 1, ICHAN_LAST
FITDATA(I, NCUR) = CFIT(I)
ENDDO
GET DERIVITIVE FOR TAUS AND AMPS
DO ITAU = 1, NTAU
DO ICHAN = 1, ICHAN_LAST
TAU_AMP = EXP(-TCAL*ICHAN/TAU(ITAU))
FITX(ICHAN) = PRE*(TAU_AMP)
FIT(ICHAN) = PRE*TAU_AMP*AMP(ITAU)*TCAL*
$
ICHAN/(TAU(ITAU)**2)
ENDDO
CALL NUMCONV (FITX, ICHAN_LAST, ELAMPI, ICHANJLAST, CFITX)
CALL NUMCONV (FIT, ICHANJLAST, ELAMPI, ICHANJAST, CFIT)
DO ICHAN = 1, ICHANJ A S T
DERIV(ICHAN, 2JTAU-1) = CFITX(ICHAN)
DERIV(ICHAN, 2*ITAU) = CFIT(ICHAN)
ENDDO
ENDDO
THE CHANNEL LIMITS APPLY ONLY WHEN CALCULATING RESID,
CHISQR, BETA, & ALPHA
DO I = ICHANJIR ST , ICHANJ A S T

RESID = DKDATA(I, NCUR) - FITDATA(I, NCUR)
CHISQR(NCUR) = CHISQR(NCUR) + SIGMA(I, NCUR)*RESID**2
DO J = 1, 2*NTAU
BETA_LOCAL(J) = BETA_LOCAL(J) +
$
SIGMA(I, NCUR)*RESID*DERIV(I, J)
DO K = 1, J
ALFA_LOCAL(J, K) = ALFA_LOCAL(J, K)
$
+ SIGMA(I, NCUR)*DERIV(I, J)*
$
DERIV(I, K)
ENDDO
ENDDO
ENDDO
GLOBAL MAPPING: LOCAL ALPHAS, BETAS ~> GLOBAL ALPHAS, BETAS
DO I = 1, 2*NTAU
KMPOINT = 1
IMPOINT K POINTER
IMPOINT = I
IP = IABS (MPOINT(IMPOINT, NEXPT, KMPOINT))
BETA(IP) = BETA(IP) + BETA_LOCAL(I)
DO J = I, 1, -1
JMPOINT = J
KMPOINT = 1
JP = IABS (MPOINT(JMPOINT, NEXPT, KMPOINT))
IF (JP .GT. IP) THEN
ALFA(JP, IP) = ALFA(JP, IP) + ALFA_LOCAL(I, J)
ELSE
ALFA(IP, JP) = ALFA(IP, JP) + ALFA_LOCAL(I, J)
ENDIF
ENDDO
ENDDO
SUM_CHANNELS = SUM_CHANNELS + (ICHAN_LAST - ICHAN_FIRST + 1)
CHISQR_SUM = CHISQR_SUM + CHISQR(NCUR)
LIMIT(IVH) = ICHAN_LAST - ICHAN_FIRST + 1
WRITE (LU, *) ’ EXPT #', NEXPT
WRITE (LU, *) (AMP(I), TAU(I), 1=1, NTAU),
$
CHISQR(NCUR)/LIMIT( 1)
ENDIF
!IF NEXPT .LE. NRTEXPT
NEXPT = NEXPT + 1
ENDDO
!DO WHILE NEXPT .LE. NEXPERIMENTS
CALCULATE REDUCED CHI-SQUARE, RCHISQR
RCHISQR = CHISQR_SUM / (SUM_CHANNELS - NIN_FREE)
WRITE (LU, *) 'ITERATION ', ITERATION,' CHISQUARE = ', RCHISQR
COMPUTE ARR (THE SCALED ALFA MATRIX) AND SCALED BETA
DO I = 1, NIN_FREE
ARR(I, I) = 1.0 + FLAMDE
DO J = 1, I
ARR(I, J) = ALFA(I, J) / SQRT(ALFA(I, I)*ALFA(J, J))
ARR(J, I) = ARR(I, J)
ENDDO
ENDDO
DO I = 1, NINJFREE
SCALED_BETA(I) = BETA(I) / SQRT(ALFA(I, I))
ENDDO
SOLVE SYSTEM TO GET DELTA (ROUTINE: SYMSV)
INPUT: ARR = SCALED ALPHA ARRAY
SCALED_BETA = SCALED BETA ARRAY
NIN_FREE = # FREE PARS. (DIMENSION OF ALPHA & BETA ARRAYS)
SCRATCH ARRAYS USED: S, T
OUTPUT: DELTA = VECTOR (TO MOVE PMAIN IN DIRECTION OF)

300 IF (ARR( 1, 1) .EQ. 0.) GO TO MATRIX_ERROR
WRITE (LU, *) ' FLAMDE = FLAMDE
IF (NIN_FREE .EQ. 1) THEN
DELTA(l) = SCALED_BETA(1) / ARR( 1, 1)
ELSE
S(l, 1) = DSQRT(DABS(ARR(1, 1)))
DO I = 2, NIN_FREE
S( I, I) = ARR( 1 ,1) / S( 1, 1)
ENDDO
DO I = 2, NIN_FREE
DO J = I, NINJFREE
SUMM = 0.
DO K = 1 ,1 - 1
SUMM = SUMM + S(K, I)*S(K, J)
ENDDO
SUM = ARR(I, J) - SUMM
IF (I .EQ. J) THEN
IF (SUM .EQ. 0.) GO TO MATRIX_ERROR
SUM = DABS (SUM)
S(I, I) = DSQRT (SUM)
ELSE
S(I, J) = SUM / S(I, I)
ENDIF
ENDDO
ENDDO
T( 1) = SCALED_BETA( 1) / S( 1, 1)
DO I = 2, NIN_FREE
Z = 0.
DOK=l,I-l
Z = Z + S(K, I)*T(K)
ENDDO
T(I) = (SCALED_BETA(I) - Z) / S(I, I)
ENDDO
L = NINJFREE
DELTA(L) = T(L) / S(L, L)
DO WHILE (L .GE. 2)
L=L- 1
SUMM = 0.
DO I = L + 1, NINJFREE
SUMM = SUMM + S(L, I)*DELTA(I)
ENDDO
SUM = SUMM
DELTA(L) = (T(L) - SUM) / S(L, L)
ENDDO
ENDIF
SCALE DELTA
DO I = 1, NIN_FREE
DELTA(I) = DELTA(I) / SQRT (ALFA(I, I))
ENDDO
DO I = NIN_FREE + 1,NIN
DELTA(I) = 0.
ENDDO
PUT NEW SET OF ANSWERS IN PMAIN_NEW
DO I = 1, NIN
PMAIN_NEW(I) = PMAIN(I) + DELTA(I)
IF (PMAINJSIEW(I) .LE. 1.E-35) PMAIN_NEW(I) = PMAIN®
ENDDO
GET REDUCED CHI-SQUARE (RCHISQR_NEW) FOR PMAIN_NEW

SUM_CHANNELS = 0
CHISQR_SUM_NEW = 0.
NEXPT = 1
DO WHILE (NEXPT .LE. NEXPERIMENTS)
IF (NEXPT .LE. NRTEXPTS) THEN
DO IVH = 1,2
! FIRST PARALLEL, THEN PERPENDICULAR
IF (IVH .EQ. 1) NCUR = 2*NEXPT - 1
IF (IVH .EQ. 2) NCUR = 2*NEXPT
ICHAN_FIRST = LIMS(1, NCUR)
ICHAN_LAST = LIMS(2, NCUR)
* GET LOCAL ALPHAS, TAUS, BZPARS (AMP, TAU, C, B, PL, EPSILON AND
C R0) FROM THE GLOBAL ONES (IN PMAIN_NEW).
IF (IVH .EQ. 1) THEN
NTERMS_SUM = 0
DO 1 = 1 , 10
IF (MPOINT(I, NEXPT, 1 ) .NE. 0)
$
NTERMS_SUM = NTERMS_SUM + 1
ENDDO
NTAU = NTERMS_SUM / 2
DO I = 1, NTAU
AMP(I) = PMAIN_NEW (IABS (MPOINT(2*I - 1, NEXPT, 1)))
TAU(I) = PMAIN_NEW (IABS (MPOINT(2*I, NEXPT, 1)))
ENDDO
PAR(l) = PMAIN_NEW (IABS (MPOINT(l, NEXPT, 2)))
PAR(2) = PMAIN_NEW (IABS (MPOINT(2, NEXPT, 2)))
PAR(3) = PMAINJ'JEW (IABS (MPOINT(3, NEXPT, 2)))
PAR(4) = PMAIN_NEW (IABS (MPOINT(4, NEXPT, 2)))
PAR(5) = PMAIN_NEW (IABS (MPOINT(5, NEXPT, 2)))
TCAL = TCALS(NEXPT)
TEMP = TEMPM(NEXPT)
VISC = VISCM(NEXPT)
GFAC = GFACM(NEXPT)
ENDIF
* CALCULATE DECAYS AND CONVOLUTION
IF (IVH .EQ. 1) SCALE = 2.
IF (IVH .EQ. 2) SCALE = -1.
CALL BZFUN (PAR, TEMP, VISC, ICHANJLAST, TCAL,
$
RT, ICHAN_BAD)
NCHAN_BAD_NEW(NCUR) = 0
IF (ICHANJBAD .GT. 0) THEN
NCHAN_BAD_NEW(NCUR) = ICHAN_BAD + LIMS_LAMP(2, NCUR) $
LIMS_LAMP(1, NCUR)
ENDIF
DO ICHAN = 1, NCHAN
FIT(ICHAN) = 0.
ELAMPI(ICHAN) = ELAMP(ICHAN, NCUR)
ENDDO
DO I = 1,NTAU
CALL FLUFUN (ICHAN_LAST, 1, AMP(I), TCAL, TAU(I), FLU)
DO ICHAN = 1, ICHANJLAST
FIT(ICHAN) = PRE*FLU(ICHAN)*(1 + ASSOC(I, NEXPT)*SCALE
$
*RT(ICHAN)) + FIT(ICHAN)
ENDDO
ENDDO
CALL NUMCONV (FIT, ICHANJ A S T , ELAMPI, ICHAN_LAST, CFIT)
IF (IVH .EQ. 2) THEN
DO ICHAN = 1, ICHAN_LAST
CFIT(ICHAN) = CFIT(ICHAN) / GFAC

ENDDO
ENDIF
DO I = ICHANJFIRST, ICHAN_LAST
RESID = DKDATA(I, NCUR) - CFIT(I)
CHISQR_SUM_NEW = CHISQR_SUM_NEW+SIGMA(I, NCUR)*RESID**2
ENDDO
SUM_CHANNELS = SUM_CHANNELS + (ICHAN_LAST $
ICHAN_FIRST + 1)
IF ((CHISQR_SUM_NEW-CHISQR_SUM)/CHISQR_SUM .GT. FCNGE)
$
GO TO EXIT_CHI_LOOP
ENDDO
!D0 IVH= 1,2 ABOVE
ELSE
IVH = 1
NCUR = 2*NRTEXPTS + (NEXPT-NRTEXPTS)
ICHAN_FIRST = LIMS(1, NCUR)
ICHAN_LAST = LIMS(2, NCUR)
GET LOCAL ALPHAS, TAUS FROM THE GLOBAL ONES( IN PMAIN_NEW).
NTERMS_SUM = 0
DO 1 = 1 , 10
IF (MPOINT(I, NEXPT, 1) .NE. 0) NTERMS_SUM = NTERMS_SUM + 1
ENDDO
NTAU = NTERMS_SUM/2
DO I = 1, NTAU
AMP(I) = PMAIN_NEW (IABS (MPOINT(2*I-l, NEXPT, 1)))
TAU(I) = PMAIN_NEW (IABS (MPOINT(2*I, NEXPT, 1)))
ENDDO
TCAL = TCALS(NEXPT)
DO ICHAN = 1, NCHAN
FIT(ICHAN) = 0.
ELAMPI(ICHAN) = ELAMP(ICHAN, NCUR)
ENDDO
DO I = 1 ,NTAU
CALL FLUFUN (ICHANjLAST, 1, AMP(I), TCAL, TAU(I), FLU)
DO ICHAN = 1, IOHAN_LAST
FIT(ICHAN) = PRE*FLU(ICHAN) + FIT(ICHAN)
ENDDO
ENDDO
CALL NUMCONV (FIT, ICHAN_LAST, ELAMPI, ICHAN_LAST, CFIT)
DO I = ICHAN_FIRST, ICHAN_LAST
RESID = DKDATA(I, NCUR) - CFIT(I)
CHISQR_SUM_NEW = CHISQR_SUM_NEW + SIGMA(I, NCUR)*RESID**2
ENDDO
SUM_CHANNELS = SUM_CHANNELS + (ICHAN_LAST - ICHAN_FIRST + 1)
IF ((CHISQR_SUM_NEW-CHISQR_SUM)/CHISQR_SUM .GT. FCNGE)
$
GO TO EXIT_CHI_LOOP
ENDIF
!IF (NEXPT .LE. NRTEXPT) FROM ABOVE
NEXPT = NEXPT + 1
ENDDO
!DO WHILE NEXPT .LE. NEXPERIMENTS
500 RCHISQR_NEW = CHISQR_SUM_NEW/(SUM_CHANNELS - NIN_FREE)
SEE IF CHI-SQUARE INCREASED OR DECREASED, AND ACT ACCORDINGLY
IF (RCHISQR_NEW .GT. RCHISQR) THEN ! CHI-SQUARE INCREASED
FLAMDE = FLAMDE*FLINC 1
IF (FLAMDE .GE. 1.E35) THEN
! ABORT IF STUCK
FLAMDE_BAD = .TRUE.
GO TO EXIT_AND_SAVE_RESULTS
ENDIF
DO I = 1, NIN
ARR(I, I) = 1.0 + FLAMDE

ENDDO
DELTA_RCHISQR = ABS(RCHISQR_NEW - RCHISQR) / RCHISQR
IF (DELTA_RCHISQR .GE. FCNGE) GO TO MARQUARDT
ELSE
! CHI-SQUARE DECREASED
FLAMDE = FLAMDE / FLINC2
IF (FLAMDE .LE. 1.E-35) THEN
! ABORT IF STUCK
FLAMDE_BAD = .TRUE.
GO TO e x it _ a n d _ s a v e _r e s u l t s
ENDIF
DO 1=1, NIN
PMAIN(I) = PMAIN_NEW(I)
! UPDATE ANSWERS
ENDDO
DELTAJRCHISQR = ABS(RCHISQR_NEW - RCHISQR) / RCHISQR
IF (DELTA_RCHISQR .GE. FCNGE) GO TO BEGINNING
ENDIF
* * ANSWER SAVING SECTION * * *
SAVE ANSWERS AND CURVATURE MATRIX (ALFA)
400 WRITE (LU, ’(/2X, "ANALYSIS COMPLETED")')
WRITE (LU, '(2X, "ANSWERS STORED IN FILE ",A)') ANSWER_FILE
IF ('P’ // CURVMAT_FILE(2:40) .NE. PARAM_FILE) THEN
WRITE (LU, '(2X, "CURVATURE MATRIX IN FILE ",A)')
$
CURVMATJTLE
ENDIF
WRITE (LU, ’(/2X, "TO GET CONFIDENCE INTERVALS, RUN PROGRAM")')
WRITE (LU, '(2X, "ACON, WITH PARAMETER FILE ",A)')PARAM_FILE
SAVE ANSWERS
OPEN (51 ,ERR=900,FILE=ANSWER_FILE,IOSTAT=IOS,STATUS='UNKNOWN')
L = 40
! L = CHAR. LENGTH OF PARAMETER FILENAMR
DO WHILE (PARAM_FILE(L:L) .EQ.'')
L=L- 1
ENDDO
WRITE (51 ,’("* ANSWERS FOR PARAMETER FILE ",A)',ERR=920)
$
PARAM_FILE (1:L)
IF (FLAMDE_BAD) THEN
WRITE (51 ,’("* ABORTED: FLAMDE OUT OF RANGE")',ERR=920)
ENDIF
WRITE (51 ,’("* GLOBAL REDUCED CHI-SQUARE = ",G14.7)’,ERR=920)
$
RCHISQR
WRITE (51 ,’("* ALPHAS & TAUS, & PAR. & PERP. REDUCED CHISQR",
$
"PER LINE,")’,ERR=920)
WRITE (51,'("* FOLLOWED BY R0, C, B, EPSILON, & PL (EACH ",
$
"LINE = ONE EXPERIMENT):")’,ERR=920)
DO N = 1, NRTEXPTS
K= 1
DO WHILE (K .LE. NCOMP .AND. MPOINT(2*K-l,N,l) .NE. 0)
K= K+ 1
ENDDO
NUM_COMP_SUM = K - 1
CHISQR_LOC_PAR = CHISQR(2*N - 1) / (LIMS(2,2*N - 1) $
LIMS( 1,2*N - 1) - 2*NUM_COMP_SUM - 4)
CHISQR_LOC_PERP = CHISQR(2*N) / (LIMS(2,2*N) $
LIMS( 1,2*N) - 2*NUM_COMP_SUM - 4)
WRITE (51,*,ERR=920) ((PMAIN(IABS(MPOINT(2*I - 1,N,1))),
$
PMAIN(IABS(MPOINT(2*I,N, 1)))),
$
1 =1 , NUM_COMP_SUM),
$
CHISQR_LOC_PAR, CHISQR_LOC_PERP,
$
NCHAN_BAD(2*N-1),NCHAN_BAD(2*N)
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ENDDO
DO N = 1, NLTEXPTS
NEXPT = NRTEXPTS + N
NCUR = 2*NRTEXPTS + N
K= 1
DO WHILE (K .LE. NCOMP .AND. MPOINT(2*K-l,NEXPT, 1) .NE. 0)
K= K+ 1
ENDDO
NUM_COMP_SUM = K - 1
CHISQR_LOC = CHISQR(NCUR) / (LIMS(2, NCUR) $
LIMS( 1, NCUR) - 2*NUM_COMP_SUM + 1)
WRITE (51 ,*,ERR=920) ((PMAIN(IABS(MPOINT(2*I - 1,NEXPT, 1))),
$
PMAIN(IABS(MPOINT(2*I,NEXPT, 1)))),
$
1 =1 , NUM_COMP_SUM),
$
CHISQR_LOC
ENDDO
DO N = 1, NRTEXPTS
WRITE (51,*,ERR=920) (PMAIN(IABS(MPOINT(I,N,2))),I = 1,5)
ENDDO
CLOSE (51)
* SAVE CURVATURE MATRIX
OPEN (51 ,ERR=900,FILE=CURVMAT_FILE,IOSTAT=IOS ,STATUS='UNKNOWN')
WRITE (51,*,ERR=920) NIN_FREE, ((ALFA(I, J),J=1,I),I=1,NIN_FREE)
CLOSE (51)
* SAVE FITS TO DATA
DO I = 1 ,NDATACURVES
OPEN (61 ,ERR=900,FILE=FITNAME(I),STATUS-NEW',IOSTAT=IOS)
WRITE (61JFMT—(" FIT DATA")’)
DO J = 1 ,NCHAN
WRITE (61, *, ERR=920) J, FITDATA(J, I)
ENDDO
CLOSE (61)
ENDDO
STOP
* * * ERR MESSAGE AND STOP CONTROL SECTION * * *
900 WRITE (LU, '(2X, "OPEN ERROR",16)') IOS
STOP
902 WRITE (LU, ’(2X, "OPEN ERROR",16,5X,5HFILE ,A)') IOS, ANSWER_FILE
STOP
904 WRITE (LU, ’(2X, "OPEN ERROR", 16,5X.5HFILE ,A)') IOS, CURVMAT_FILE
STOP
910 WRITE (LU, '(2X, "READ ERROR",16)') IOS
STOP
920 WRITE (LU, '(2X, "WRITE ERROR",16)’) IOS
STOP
930 WRITE (LU, '(2X, "INQUIRE ERROR",16)') IOS
STOP
990 WRITE (LU, '(2X, "ERROR: CANNOT INVERT MATRIX")')
STOP
END
* * * END OF MAIN PROGRAM * * *

************************************************************************************

* * * SUBROUTINES AND FUNCTIONS SECTION * * *
* NUMERICAL CONVOLUTION ROUTINE TESTED NOV 23,1992
* AM BM - TWO ARRAYS TO BE CONVOLUTED

NA >= NB
SUBROUTINE NUMCONV (AM, NA, BM, NB, CM)
DIMENSION AM(NA), BM(NB), CM(NA)
DO N = 0, NA-1
CM(N+1) = 0.
DO K = 0, NA-1
IF (K .GT. N) GO TO 11
IF ((N-K+l) .GT. NB) GO TO 11
CM(N+1) = CM(N+1) + AM(K+1)*BM(N-K+1)
11 ENDDO
ENDDO
RETURN
END
FLUORESCENCE DECAY FUNCTION SUBROUTINE
SUBROUTINE FLUFUN (ICHAN_LAST, NTAU, AMP, TCAL, TAU, FLU)
DIMENSION AMP(NTAU), TAU(NTAU), FLU(ICHAN_LAST)
DO ICHAN = 1, ICHAN_LAST
FLU(ICHAN) = 0.
DO ITAU = 1, NTAU
FLU(ICHAN) = AMP(ITAU)*EXP(-ICH AN*TC AL/TAU (ITAU))
$
+ FLU(ICHAN)
ENDDO
ENDDO
RETURN
END
SUBROUTINE PROGRAM FOR R(T) BASED ON BARKLEY_ZIMM BENDING THEORY
WRITTEN BY QI CHEN ON DECEMBER 4, 1992 IN BARKLEY'S LAB
SUBROUTINE BZFUN (PAR, TEMP, VISC, ICHAN_LAST, TCAL,
$
RT,ICHAN_BAD)
DIMENSION PAR(5), GI(3), RT(ICHAN_LAST)
REAL GI, K_B, PAR
PI = 3.141592654
K_B = 1.380662E-16
R0 = PAR( 1)
C = PAR(2)*1.E-19
B = PAR(3)*l.E-8
EPSILON = PAR(4)
PL = PAR(5)*l.E-8
El = PL*K_B*TEMP
GI(1) = (3.*COSD(EPSILON)**2 - l.)**2/4.
GI(2) = 3.*(SIND(2*EPSILON))**2/4.
GI(3) = 3.*(SIND(EPSILON))**4/4.
A = K_B*TEMP/SQRT(PI*C*4.*PI*VISC*B**2)
ZMAX_G =4.153382
ICHAN_BAD = 0
DO ICHAN = 1, ICHANLAST
DELTA_Z = 1.
DID_ZERO = B*SQRT(SQRT(5.024*PI*VISC/(EI*TCAL*ICHAN*LE-9)))
IF (DID_ZERO .GT. 1.745274) THEN
ICHANJ3AD = ICHAN
Z = 0.4202057
GO TO 12
ENDIF
ZMAX FITTING AND BESSEL FUNCTION
DO WHILE (DELTA_Z .GT. 0.0001)
ZMAX_1 = 2./ZMAX_G

ZMAX_2 = ZMAX_G/2.
IF (ZMAX_G .GT. 2) THEN
BK0_1 = 1.25331414 - 0.07832358*ZMAX_1 + 0.02189568*ZMAX_1**2
$
- 0.01062446*ZMAX_ 1**3 + 0.00587872*ZMAX_1**4
$
- 0.00251540*ZMAX_ 1**5 + 0.00053208*ZMAX_1**6
BK1_1 = 1.25331414 + 0.23498619*ZMAX_1 - 0.03655620*ZMAX_1**2
$
+ 0.01504268*ZMAX_1**3 - 0.00780353*ZMAX_1**4
$
+ 0.00325614*ZMAX_1 **5 - 0.00068245*ZMAX_1 **6
BKO = EXP(LOG(BK0_ 1) - 0.5*LOG(ZMAX_G) - ZMAX_G)
BK1 = EXP(LOG(BK1_ 1) - 0.5*LOG(ZMAX_G) - ZMAX_G)
ELSE
BIO = 1.
BI1 = ZMAX_2
* PRECISELY TO 4E-8 FROM 7 ITERATION OF FACTORAL
DO IBI = 1,7
BIO = BIO + ZMAX_2**(2*IBI)/(FACTO (IBI))**2
BI1 = BI1 + (ZMAX_2)**(2*IBI + 1) /
$
(FACTO(IBI)*FACTO (IBI + 1))
ENDDO
BKO = -LOG(ZMAX_2)*BI0 - 0.57721566 +
$
0.42278420*ZMAX_2**2 + 0.23069756*ZMAX_2**4 +
$
0.03488590*ZMAX_2**6 + 0.00262698*ZMAX_2**8 +
$
0.00010750*ZM AX_2** 10 + 0.00000740*ZMAX_2** 12
BK1 = (ZMAX_G*LOG(ZMAX_2)*BIl + 1. + 0.15443144*ZMAX_2**2
$
- 0.67278579*ZMAX_2**4 - 0.18156897*ZMAX_2**6
$
- 0.01919402*ZMAX_2**8 - 0.00110404*ZMAX_2**10
$
- 0.00004686*ZMAX_2** 12)/ZMAX_G
ENDIF
Z = SQRT(SQRT(BK0 + (ZMAX_G/2.)*BK1))
Z_MAX = DID_ZERO/Z
DELTA_Z = ABS((Z_MAX - ZMAX_G)/Z_MAX)
ZMAX_G = Z_MAX
ENDDO
12 BT = 3.466*K_B*TEMP*Z/SQRT(EI*SQRT(PI**5.*EI*VISC))
RT(ICHAN) = 0.
DO INDEX = 1,3
N = INDEX - 1
RT(ICHAN) = RT(ICHAN)
$
+ GI(INDEX)*EXP(-N**2*A*SQRT(TCAL*ICHAN* 1.E-9)
$
- (6-N**2)*BT*SQRT(SQRT(ICHAN*TCAL* 1,E-9))/4.)
ENDDO
RT(ICHAN) = RT(ICHAN)*R0
ENDDO
RETURN
END
* FACTORAL FUNCTION
REAL FUNCTION FACTO(N)
FACTO = 1.
DO I = 1, N
FACTO = FACTO* I
ENDDO
RETURN
END
* * * END OF COMPLETE PROGRAM * * *

C.2.

BZPAR.for

* BZPAR.FOR PROGRAM FOR BZFIT.FOR
* FROM Modified APAR.FOR on November, 1992
* WRITTEN IN BARKLEY_LAB, LSU
DIMENSION LAMPJFILE(200),QSHIFT(200),SAMPLE_AFILE( 100),
$ SAMPLE_FILE( 100), SAMPLE_MHLE( 100), EXPNO(IOO),
$CHAN_LIM(200),STOREJFILE(200),STORE_AFILE(200),
$ STORE_MFILE(200),TCALM( 100),LINK_MAT( 100,10),
$ ALFATAU_MAT(1000),BZ_MAT( 1000),VISC_GFAC_MAT(200),
$ TAUP_MAT( 100),ASSOC(5,200),LINK_MAT_BZTEM( 10),
$ IND_PAR_MAT(2000),TEMPM( 100),VISCM( 100)
CHARACTER WEIGHT*20,QSHIFT_INTEREST,EXP_METHOD,TAUP_NUMBER,
$ TAUP_TYPE,TCAL_NUMBER,LAMP_FILEN*20,LAMP_FILE*20,
$ SAMPLE_AFILE*20,SAMPLE_FILE*20,SAMPLE_MFILE*20,
$ STORE,STORING_STRING*20,STORE_AFILE*20,STORE_MFILE*20,
$ STORE_FILE*20,FIX,TEMP_NUMBER,VISC_NUMBER,GFAC,
$ LINK_TERM_STRING*25,LIM_SET_STRING*25
CHARACTER*20 WEIGHT_FILE_STRING
REAL TCAL_SINGLE,ALFATAU_MAT,BZ_MAT,TCALM,QSHIFT,IND_PAR_MAT,
$ TEMP_SINGLE,VISC_SINGLE
INTEGER ANUM,FNUM,AFIT,MFIT,FILENOL,POSITIION,LINK_MAT,
$ LINKEY,EXPNO,ASSOC, LINK_MAT_BZTEM,CHAN_LIM, MNUM
* INSTRUMENTAL SETUP
WRITE(6,fmt='(3x,"The channel number is [512/1024]: "$)')
READ(5,*)nchan
WRITE(6,fmt='(/,3x,"(S)ingle or (M)ultiple Teals? "$)')
READ(5,fmt='(al)')tcal_number
IF(tcal_number.eq.'s' .or.tcal_number.eq.'S')THEN
WRITE(6,fmt='(/,3x,"Give the value of Teal: "$)')
READ(5,*)tcal_single
END IF
* MEASURING CONDITION
WRITE(6,fmt='(/,3x,"(S)ingle or (M)ultiple (Temp)eratures? "$)')
READ(5,fmt='(al)')temp_number
IF(temp_number.eq.'s' .or.temp_number.eq.'S')THEN
WRITE(6,fmt='(/,3x,"Give the Value of Temp in K: "$)')
READ(5,*)temp_single
END IF
WRITE(6,fmt='(/,3x,"(S)ingle or (M)ultiple (Visc)osilies? "$)')
READ(5,fmt='(al )')visc_number
IF(visc_number.eq.'s' .or.visc_number.eq.'S')THEN
WRITE(6,fmt='(/,3x,"Give the value of viscosity: "$)')
READ(5,*)visc_single
END IF
* TYPE OF EXPERIMENT
WRITE(6,fmt='(/»3x,"(L)amp or (P)robe Method Experiment: "$)')
READ(5,fmt='(al)')exp_method
IF(exp_method.eq.'p'.or.exp_method.eq.'P')THEN
WRITE(6,fmt='(/,3x,"(S)ingIe or (M)ultiple Tauprobes: "$)')
READ(5,fmt—(al )')taup_number
IF(taup_number.eq.'S'.or.taup_number.eq.'s')THEN
WRITE(6,fmt='(/,3x,"Give the Value of Tauprobe: "$)')
READ(5,*)tauprobe
END IF
ELSE
exp_method = 'L'
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WRITE(6,fmt='(/,3x,"Input qshift: "$)')
READ(5,FMT-(Al)')qshift_interest
END IF
* WEIGHTING OPTION GET THE WEIGHTING FILE
WRITE(6,FMT='(/,3X,"Enter Weighting Filename or S for Standard
$ Weighting: "$)')
READ(5,fmt='(a20)')weight
IF(weight.eq.'S'.or.weight.eq.'s')THEN
weight_file_string='STANDARD WEIGHTING'
ELSE
weight_file_string=weight
END IF
WRITE(6,fmt='(/,3x,"Do you wish to store the fitted
$ data(y/n) ?"$)')
READ(5,fmt=’(a 1)')store
* READ LAMP FILE NAMES
fnum=l
WRITE(6,fmt='(/,3x,"Lamp filenames: enter lamp files
$ corresponding to",/,3x," anisotropic files first in
$ the order of each parallel file",/,3x,"followed by the
$ corresponding perpendicular file",/,3x,"Then enter lamp
$ files corresponding",/,3x,"to magic angle files. Type
$ "end" at the prompt",/,3x,"to terminate requests for
$ files")')
WRITE(6,fmt='(/,3x,"Lamp/Probe File #",i3,":",$)')fnum
READ(5,fmt='(a25)')lamp_file(fnum)
DO WHILE(lamp_file(fnum).ne.'end'.and.lamp_file(fnum).ne.'END')
IF(qshift_interest.eq.'y'.or.qshift_interest.eq.'Y')THEN
WRITE(6,fmt='(/,3x,"Q_shift",i3," = ",$)')fnum
READ(5,*)qshift(fnum)
ELSE
qshift(fnum) = 0.
END IF
IF(taup_..number.eq.'m'.or.taup_number.eq.'M')THEN
WRITE(6,fmt='(/,3x,"Give the Value of Tauprobe for
$ File #",i3,":",$)')fnum
READ(5,*)taup_mat(fnum)
ELSE
taup_mat(fnum) = tauprobe
END IF
fnum = fnum + 1
WRITE(6,fmt='(/,3x,"Lamp/Probe File #",I4,":",$)')fnum
READ(5,fmt='(a25)')lamp_file(fnum)
ENDDO
lamp_lile(fnum) = '.END'
WRITE(6,fmt='(3x,a)')(lamp_file(i),i=l,fnum)
filenol = fnum - 1
* READ SAMPLE DATA FILE NAMES
100 anum = 1
anum = 1
WRITE(6,fmt='(/,3x,"Sample data files: Enter anisotropic
$ data",/,3x," files first in the order of each parallel
$ file",/,3x,"followed by the corresponding perpindicular
$ file.",/,3x," Type "end" at the prompt to terminate
$ requests for files.")')
WRITE(6,fmt-(/,3x,"Anisotropic Sample Data
$
File #",i3,":",$)')anum
READ(5,fmt=’(a25)')sample_afile(anum)

DO WHILE(sarnple_afile(anum).ne.'end'
$ .and.sample_afile(anum).ne.'end')
anum = anum + 1
WRITE(6,fmt='(/,3x,"Anisotropic Sample Data
$ File #",I3,":",$)')anum
READ(5,fmt='(a25)')sampIe_afile(anum)
END DO
sample_afile(anum) = '.nrt'
anum = anum - 1
read magic angle data files
WRITE(6,fmt- (/,3x,"Now enter magic angle data files.",
$ /,3x"If there are no magic angle files type "end" at
$ the",/,3x"prompt. Terminate requests for files by
$ typing",/,3x,'""end" at the prompt.")')
mnum = 1
WRITE(6,fmt='(/,3x,"Magic Angle Data File #"
$ ,i3,":",$)')mnum
READ(5,fmt='(a25)')sample_mfile(mnum)
DO WHILE(sample_mfile(mnum).ne.'end'
$.and.sample_mfile(mnum).ne.'END')
mnum = mnum + 1
WRITE(6,fmt='(/,3x,"Magic Angle Data File
$ i3,":",$)')mnum
READ(5,fmt='(a25)')sample_mfile(mnum)
END DO
sample_mfile(mnum) = '.end'
mnum = mnum - 1
NUMBER OF ANISOTROPIC EXPERIMENTS HAS TO BE EVEN
IF(mod(anum,2).eq.0)then
num_aexp = anum/2
ELSE
WRITE(6,fmt='(/,3x,"# OF DATA FILES LESS THAN EXPECTED.
$ CHECK AND RE-ENTER")')
GO TO 100
END IF
num_exp = anum/2 + mnum
CHANNEL LIMITS BEING ESTABLISHED(IN THIS CASE ASSUMED TO BE 0)
DO LCHN = 1, 2*filenol
CHANJJM(LCHN) = 0
END DO
WRITE STORE FILE NAMES
IF(store.eq .’y'.or. store.eq.'Y')THEN
WRITE(6,fmt='(/,3x,"Data will be stored in files with
$ the same file name",/,3x,"as the sample data file
$ but with a .fit extension")')
afit = 0
lnum = 1
do i = 1,anum
position = index(sample_afile(i),'.')
storing_string = sample_afile(i)
storing_string((position+l):(position+3)) = 'fit'
store_afile(i) = storing_string
afit = afit + 1
lnum = lnum + 1
end do
mfit = 0
do k = 1, mnum
position = index(sample_mfile(k),'.')

storing_string = sample_mfile(k)
storing_string((position+l):(position+3)) = 'fit'
store_mfile(k) = storing_string
mfit = mfit + 1
lnum = lnum + 1
end do
END IF
store_file(lnum) = '.END'
* Initialization of linking paramater matrix
DO j = 1, filenol
DO k = 1,10
link_mat(j,k) = 0
END DO
END DO
* GET THE MAXIMUM NUMBER OF LIFETIME COMPONENTS
WRITE(6,fmt='(/,3x,"Give the Number of Lifetimes: ",$)')
READ(5,fmt='(i2)')num_at_par
* LINKING OF PARAMETERS
IF(num_exp.eq. 1)GO TO 5000
WRITE(6,fmt=’(//,3x,"To link parameters, type in the
$ names one by one after prompts ",/,3x,"using the
$ format NAME#")')
WRITE(6,fmt=’(/,3x,"Example: ALFA1, TAU1, C, rO, b, PL,
$ epsilon, and END")')
1000 WRITE(6,fmt='(/,3x,"Link_Term: ",$)')
READ(5,fmt='(a)')link_term_string
DO WHILE(link_term_string.ne.'end'.and.link_term_string
$ .ne.'END')
IF(link_term_string(l:3).eq.'tau'.or.link_term_string(l:3)
$ ,eq.'TAU')THEN
linkey = ichar(link_term_string(4:4))-ichar('0')
IF(abs(linkey).gt.5)GO TO 1000
WRITE(6,fmt='(/,3x,"Linking of TAU #",il,$)')linkey
DO li = 1 , anum, 2
lj = 2*linkey
link_mat(li,lj) = lj
END DO
DO li = (anum+1), filenol
lj = 2*linkey
link_mat(li,lj) = lj
END DO
ELSEIF(link_term_string(l:4).eq.'alfa'.or.
$ link_term_string( 1:4).eq.'ALFA')THEN
linkey = ichar(link_term_string(5:5))-ichar('0')
IF(abs(linkey).gt.5)GO TO 1000
WRITE(6,fmt-(/,3x,"Linking of ALFA #",il)')linkey
DO li = 1, anum, 2
lj = 2*linkcy - 1
link_mat(li,Ij) = lj
END DO
DO li = anum+1, filenol
lj = 2*linkey - 1
Iink_mat(ii,lj) = lj
END DO
ELSEIF(link_term_string( 1:2).eq.'r0'.or.link_term_string(l :2)
$ .eq.'R0')THEN
WRITE(6,fmt='(/,3x,"Linking of r0")')
DO li = 2, anum, 2
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lj = 2*num_at_par + 1
link_mat(li,l) = lj
END DO
ELSEIF(link_term_string( 1:1 ).eq.'C'.or.link_term_string( 1:1)
$ .eq.'c')THEN
WRITE(6,fmt='(/,3x,"Linking of C")’)
DO li = 2, anum, 2
lj = 2*num_at_par + 2
link_mat(li,2) = lj
END DO
ELSEIF(link_term_string( 1:1 ).eq.'B'.or.link_term_string( 1:1)
$ .eq.'b')THEN
WRITE(6,fmt='(/,3x,"Linking of b")’)
DO li = 2, anum, 2
lj = 2*num_at_par + 3
Iink_mat(li,3) = lj
END DO
ELSEIF(link_term_string(l:7).eq.'epsilon'.or.
$ Iink_term_string( 1:7).eq.'EPSILON')THEN
WRITE(6,fmt='(/,3x,"Linking of epsilon")')
DO li = 2, anum, 2
lj = 2*num_at_par + 4
link_mat(li,4) = lj
END DO
ELSEIF(link_term_string(l:2).eq.'PL'.or.link_term_string(l:2)
$ .eq.'pl')THEN
WRITE(6,fmt='(/,3x,"Linking of PL")')
DO li = 2, anum, 2
lj = 2*num_at_par + 5
link_mat(li,5) = lj
END DO
END IF
WRITE(6,fmt='(/,3x,"Link_Term: ",$)')
READ(5,fmt='(a)')link_term_string
END DO
WRITE(6,fmt='( 10i4)')((link_mat(i,j),j= 1,10),i= 1,filenol)
* Initialisation of the visc_gfac_mat
5000 DO i = 1, anum
visc_gfac_mat(i) = 1
END DO
WRITE(6,fmt='(/,3x,"Want to input G-factor(y/n)?",$)')
READ(5,fmt='(a)')gfac
* GET INITIAL GUESSES
WRITE(6,fmt='(///,3x,"Give the Initial Guesses:")')
mat_indexat = 0
mat_indexbz = 0
DO j = 0, (num_exp - 1)
* for lifetimes
WRITE(6,fmt='(/,3x,"For Experiment #",i3)')(j + 1)
mat_indexat = 2*j*num_at_par
IF((j+1).eq. 1)THEN
DO i = I, num_at_par
WRITE(6,fmt='(//,3x," ALFA #",Il,"=",$)')i
READ(5,*)alfatau_mat(2*i-1)
WRITE(6,fmt='(//,3x," TAU #",Il,"=",$)')i
READ(5,*)alfatau_mat(2*i)
END DO
ELSE

DO i = 1, num_at_par
IF(link_mat((2*j+1),2*i-1).eq.O)THEN
WRITE(6,fmt='(//,3x," ALFA #",Il,"=",$)')i
READ(5,*)alfatau_mat(mat_indexat+(2*i-1))
ELSE
WRITE(6,fmt=,(//,3x," ALFA #",11,"=",O')
$ i,alfatau_mat(2*i-l)
alfatau_mat(mat_indexat+(2*i-l)) = 0
END IF
IF(Iink_mat((2*j+l),2*i).eq.0)THEN
WRITE(6,fmt='(//,3x," TAU #",Il,"=",$)')i
READ(5,*)alfatau_mat(mat_indexat+2*i)
ELSE
WRITE(6,fmt='(//,3x," TAU #",11,"=",O')
$
i,alfatau_mat(2*i)
alfatau_mat(mat_indexat+2*i) = 0
END IF
END DO
END IF
mat_index_atf = mat_indexat + 2*(i-l)
* for anisotropy decay
IF((J+1 ).LE.NUM_AEXP) THEN
mat_indexbz = j*5
IF((j+1).eq. 1)THEN
WRITE(6,fmt-(/,3x,"rO = "$)')
READ(5,*)bz_mat(l)
WRITE(6,fmt='(/,3x,"C = "$)')
READ(5,*)bz_mat(2)
WRITE(6,fmt='(/,3x,"b = "$)’)
READ(5,*)bz_mat(3)
WRITE(6,fmt='(/,3x,"epsilon = "$)')
READ(5,*)bz_mat(4)
WRITE(6,fmt=,(/,3x,"PL = "$)')
READ(5,*)bz_mat(5)
ELSE
IF(link_mat(2*(j+l), 1).eq .0)THEN
WRITE(6,fmt='(/,3x," rO = "$)’)
READ(5,*)bz_mat(mat_indexbz+l)
ELSE
WRITE(6,fmt='(/,3x," rO = ",0')bz_mat(l)
bz_mat(mat_indexbz+l) = 0
ENDIF
IF(link_mat(2*(j+l),2).eq.0)THEN
WRITE(6,fmt=’(/,3x," C = "$)')
READ(5,*)bz_mat(mat_indexbz+2)
ELSE
WRITE(6,fmt='(/,3x," C = ”,0')bz_mat(2)
bz_mat(mat_indexbz+2) = 0
END IF
IF(link_mat(2*(j+1),3).eq.0)THEN
WRITE(6,fmt='(/,3x," b = "$)')
READ(5,*)bz_mat(mat_indexbz+3)
ELSE
WRITE(6,I’mt='(/,3x," b = ",0')bz_mat(3)
bz_mat(mat_indexbz+3) = 0
END IF
IF(link_mat(2*(j+l),4).eq.0)THEN
WRITE(6,fmt='(/,3x," epsilon = "$)')
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READ(5,*)bz_mat(mat_indexbz+4)
ELSE
WRITE(6,fmt='(/,3x," epsilon = ",f)')bz_mat(4)
bz_mat(mat_indexbz+4) = 0
END IF
IF(link_mat(2*(j+l),5).eq.0)THEN
WRITE(6,fmt='(/,3x," PL = "$)')
READ(5,*)bz_mat(mat_indexbz+5)
ELSE
WRITE(6,fmt='(/,3x,” PL = ”,f),)bz_mat(5)
bz_mat(mat_indexbz+5) = 0
END IF
END IF
ENDIF
mat_index_bzf = mat_indexbz + 3
IFCgfac.eq.y.or.gfac.eq.'Y'yTHEN
WRITE(6,fmt='(/,3x,"Gfactor for Exp #",i3,"= "$)')(j+l)
READ(5,*)gfact
visc_gfac_mat(2*(j+l)) = gfact
ENDIF
IF(tcal_number.eq.'M'.or. tcal_number.eq.'m')THEN
WRITE(6,fmt='(/,3x,"TCAL for Exp #",i3,"=",$)')(j+l)
READ(5,*)tcalm(j+I)
ELSE
tcalm(j+l) = tcal_single
END IF
IF(temp_number.eq.'M'.or. temp_number.eq.'m')THEN
WRITE(6,fmt=’(/,3x,"TEMP for Exp #",i3,"=",$)')(j+l)
READ(5,*)tempm(j+1)
ELSE
tempm(j+l) = temp_single
END IF
IF(visc_number.eq.’M’.or. visc_number.eq.'m’)THEN
WRITE(6,fmt='(/,3x,"VISC for Exp #",i3,"=",$)')(j+l)
READ(5,*)viscm(j+l)
ELSE
viscmG+1) = visc_single
END IF
END DO
ind_par_num = 1
DO i = I, num_exp
DO j = 1, 2*num_at_par
IF(alfatau_mat(2*(i-1)*num_at_par+j).ne.O)THEN
ind_par_mat(ind_par_num) = alfatau_mat(2*(i-l)*num_at_par+j)
ind_par_num = ind_par_num + 1
END IF
END DO
DO ij = 1, 5
IF(bz_mat((i-1)*5+ij).ne.0)THEN
ind_par_mat(ind_par_num) = bz_mat((i-l)*5+ij)
ind_par_num = ind_par_num + 1
END IF
END DO
END DO
* Completing the linking matrix
link_index = 1
DO i = 1, filenol
IF(i.eq.2)THEN

IF(num_exp.eq. 1)THEN
DOj = 1,5
link_mat(i,j) = linkjndex
link_index = linkjndex + 1
END DO
ELSE
DOj = I, 5
IF(link_matJ>ztem(j).eq.O)THEN
link_mat(i,j) = linkjndex
linkjndex = linkjndex + 1
ELSE
DO ij = 2, filenol, 2
link_mat(ij,j) = linkjndex
END DO
linkjndex = linkjndex + 1
ENDIF
END DO
END IF
ELSE
IF(mod(i,2).ne.0)THEN
DOj = 1, 2*num_at_par
IF(link_mat(i,j).eq.O)THEN
link_mat(i,j) = linkjndex
linkjndex = linkjndex + 1
ELSE
IF(linkJndex.le.link_mat(i,j))linkJndex = linkjndex + 1
END IF
END DO
ELSE
DOj = 1, 5
IF(link_mat(i,j).eq.O)THEN
link_mat(i,j) = linkjndex
linkjndex = linkjndex + 1
ELSE
IF(linkJndex.le.link_mat(i,j))linkJndex = linkjndex + 1
ENDIF
END DO
END IF
END IF
END DO
FIXING OF PARAMETERS
WRITE(6,fmt='(/,3x,"Do you wish to fix any parameter
$ (y/n)?",$)')
READ(5,fmt='(a)')fix
IF(fix.eq.y.or.fix.eq.'Y')THEN
WRITE(6,fmt-(/,3x,"Fix TAUS(y/n):",$)’)
READjS.fmt^jaj'jansfix
IFCansfix.eq.'y'.or.ansfix.eq.'Y’jTHEN
1
WRITE(6,fmt='(/,3x,"TAU #",$)')
READ(5,*)taui
WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi-l),2*taui) = (-l)*link_mat((2*expi-l),2*taui)
WRITE(6,lmt=’(/,3x,"Fix Another TAU(y/n):",$)')
READ(5,fmt='(a)')ansfix
IFjansfix.eq.'y'.or.ansfix.eq.'Y'jGO TO 11
END IF
WRITE(6,l'mt-(/,3x,"Fix ALPHAS(y/n):",$)')

READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')THEN
12
WRITE(6,fmt='(/,3x,"ALFA #",$)’)
READ(5,*)alfai
WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi-l),(2*alfai-l)) = (-l)*link_mat(
$ (2*expi-1),(2*alfai-1))
WRITE(6,fmt='(/,3x,"Fix Another ALFA(y/n):",$)')
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')GO TO 12
END IF
WRITE(6,fmt='(/,3x,"Fix rO (y/n):",$)')
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.’Y')THEN
13
WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi),l) = (-l)*link_mat((2*expi),l)
WRITE(6,fmt='(/,3x,"Fix Another rO(y/n):",$)')
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')GO TO 13
END IF
WRITE(6,fmt='(/,3x,"Fix C (y/n):",$)')
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.y.or.ansfix.eq.'Y')THEN
14
WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi),2) = (-l)*link_mat((2*expi),2)
WRITE(6,fmt='(/,3x,"Fix Another C(y/n):",$)')
READ(5,fmt-(a)’)ansfix
IF(ansfix.eq.'y’.or.ansfix.eq.'Y')GO TO 14
END IF
WRITE(6,fmt='(/,3x,"Fix b (y/n):",$)’)
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')THEN
15
WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi),3) = (-l)*link_mat((2*expi),3)
WRITE(6,fmt='(/,3x,"Fix Another b(y/n):”,$)')
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')GO TO 15
END IF
WRITE(6,fmt=,(/,3x,"Fix epsilon (y/n):",$)')
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')TFIEN
16
WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi),4) = (-l)*link_mat((2*expi),4)
WRITE(6,fmt='(/,3x,"Fix Another epsilon(y/n):",$)')
READ(5,fmt='(a)')ansfix
IF(ansfix.eq.'y'.or.anslix.eq.'Y')GO TO 16
END IF
WRITE(6,fmt='(/,3x,"Fix PL (y/n):",$)')
READ(5,fmt='(a)')ansFix
17 IF(anslix.eq.'y'.or.ansfix.eq.'Y')THEN
WRITE(6,fmt='(/,3x,"EXP #",$)')
READ(5,*)expi
link_mat((2*expi),5) = (-1 )*link_mat((2*expi),5)

WRITE(6,fmt='(/,3x,"Fix Another PL(y/n):",$)’)
READ(5,fmt='(a)’)ansfix
IF(ansfix.eq.'y'.or.ansfix.eq.'Y')GO TO 17
END IF
END IF
* READING THE ASSOCIATION MATRIX
DO 1 =1 , num_exp
DO J = 1, 5
ASSOC(J,I) = I
END DO
END DO
WRITE(6,fmt='(/,3x,"Do you not want to associate any
$ TAUS & r(t) (y/n)?",$)')
READ(5,fmt='(a)')associate
IF(associate.eq.'y'.or. associate.eq.'Y')THEN
51
WRITE(6,fmt='(/,3x,"ASSOCIATE TAU # ",$)')
READ(5,*)NASSO_TAU
WRITE(6,fmt='(/,3x,"In EXP # ",$)’)
READ(5,*)NASSO_EXP
ASSOC(NASSO_TAU,NASSOJEXP) = 0
WRITE(6,fmt=’(/,3x,"Associate Another TAU & r(t) ?",$)')
READ(5,fmt='(a)')asso_ans
IF(asso_ans.eq.'y'.or.asso_ans.eq.'Y')GO TO 51
END IF
* WRITE SECTION
OPEN(unit=50,file='bzfit.dat',status='new')
WRITE(50,fmt='(i4)')nchan
DO i = 1, (filenol+l)
WRITE(50,fmt='(a20)')lamp_file(i)
END DO
DO i = 1, (anum+1)
WRITE(50,fmt='(a20)')sample_afile(i)
END DO
DO i = l,(mnum+l)
WRITE(50,fmt='(a20)')sample_mfile(i)
END DO
DO i = l,afit
WRITE(50,fmt='(a20)')store_afile(i)
END DO
DO i = 1,mfit
WRITE(50,fmt='(a20)')store_mfile(i)
END DO
WRITE(50,fmt='(a20)')store_file(lnum)
WRITE(50,fmt='(al8)')weight_file_string
WRITE(50,*)(qshift(i),i=l,filenol)
WRITE(50,*)(tcalm(i),i=l ,num_exp)
WRITE(50,frnt='(<2*fnum>i4)')(chan_Iim(i),i= 1,2*fiIenoI)
WRITE(50,fmt='( 10i4)')((l ink_mat(i,j),j= 1,10),i= 1,filenol)
WRITE(50,*)(ind_par_mat(i),i= 1,(ind_par_nuni-1))
DO J = 1, num_exp
WRITE(50,*)(ASSOC(I,J),I=1,5)
END DO
WRITE(50,*)(visc_gfac_mat(i),i=l,num_exp)
WRITE(50,*)(tempm(i),i=l,num_exp)
WRITE(50,*)(viscm(i),i= 1,num_exp)
WRITE(50,fmt='(a)')exp_method
IF(exp_method.eq.'P'.or.exp_method.eq.'p')THEN
WRITE(50,*)(taup_mat(i),i=l,filenol)
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END IF
CLOSE(50)
END

C.3.

GCORR.for

PROGRAM GCORR
* TO PERFORM G-FACTOR CORRECTION FOR PERPENDICULAR CURVE FROM STEAD Y* STATE ANISOTROPY
* MODIFIED BASED ON GFAC.FOR (FAHMIDA CHOWDHARY)
* BY ON 3-17-93
CHARACTER DV*20,DH*20,FV*20,FH*20
WRITE(6,40)
40
FORMAT(//,3X,'NUMBER OF CHANNELS’,27X,' :
$)
READ(5,*)N
WRITE(6,45)
45
FORMAT(//,3X,'STEADY STATE ANISOTROPY VALUE', 16X,1:
$)
READ(5,*)R
WRITE(6,10)
10
FORMAT(//,3X,'FILENAMES: DECAYS V & H, AND REFERENCES V & H : 7 )
READ(5,FMT='(A)')DV,DH,FV,FH
OPEN (UNIT= 1,HLE=DV,STATUS='OLD’)
OPEN (UNIT=2,FILE=DH,STATUS-OLD1)
OPEN (UNIT=3,FILE=FV,STATUS='OLD')
OPEN (UNIT=4,FILE=FH,STATUS='OLD’)
WRITE(6,*)' OPENING DATA AND REFERENCE FILES'
READ( 1,’(A)’)JUNKLINE
READ(2,'(A)')JUNKLINE
READ(3,'(A)’)JUNKLINE
READ(4,'(A)')JUNKLINE
SUMDV = 0
SUMDH = 0
SUMFV = 0
SUMFH = 0
DO 1=1,N
READ( I,*)X, YDV
READ(2,*)X,YDH
READ(3,*)X,YFV
READ(4,*)X,YFH
SUMDV = SUMDV + YDV
SUMDH = SUMDH + YDH
SUMFV = SUMFV + YFV
SUMFH = SUMFH + YFH
END DO
CLOSE(l)
CLOSE(2)
CLOSE(3)
CLOSE(4)
DVN = SUMDV/SUMFV
DHN = SUMDH/SUMFH
GFAC = DVN*( 1-R)/(DHN*( 1+2*R))
WRITE(6,*)' G-FACTOR =',GFAC
WRITE(6,*)’ CORRECTING THE VH DECAY FILE BY G-FACTOR'
OPEN(UNIT=2,FILE=DH,STATUS='OLD')
OPEN(UNIT=7,FILE=DH,STATUS='NEW')
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READ(2,'(A)')JUNKLINE
WRITE(7,*)’ THIS VH FILE HAS BEEN CORRECTED FOR G = ',GFAC
DO 1=1,N
READ(2,*)X,YDH
YDH = YDH * GFAC
WRITE(7,*)I, YDH
END DO
CLOSE(2)
CLOSE(7)
WRITE(6,*)' ALL DONE...GOOD LUCK WITH ANISOTROPY ANALYSIS!'
STOP
END

C.4.

SUMWT.for

* PROGRAM SUMWT
* TO CALCULATE THE TOTAL INTENSITIES AND CORRESPONDING WEIGHTING FACTORS
* FROM PARALLEL AND PERPENDICULAR ANISOTROPY DECAY CURVES USING
* I_TOTAL = I_VV + 2*I_VH
* WEIGHTING_FACTOR = I_VV + 4*I_VH
PROGRAM SUMWT
DIMENSION VVDATA( 1024), VHDATA( 1024),SUMDATA( 1024)
DIMENSION SUMA( 1024),SIGMA( 1024)
CHARACTER*20 VVFILE,VHFILE,TOTAL,WEIGHTINGS
WRITE(6,FMT=’(2x,"The channel number is "$)’)
READ(5,*) NCHAN
WRITE(6,FMT='(2x,"Parallel file name is "$)')
READ(5,FMT='(A)') VVFILE
WRITE(6,FMT='(2x,"Perpendicular file name is "$)')
READ(5 ,FMT='(A)') VHFILE
OPEN(61,FILE=VVFILE,STATU S='OLD')
READ(61,FMT='(A)')FJUNK
DO I = 1, NCHAN
READ(61,*)FJUNK,VVDATA(I)
END DO
CLOSE(61)
OPEN(61,FILE=VHFILE,STATUS='OLD')
READ(61,FMT- (A)')FJUNK
DO I = 1, NCHAN
READ(61,*)FJUNK,VHDATA(I)
END DO
CLOSE(61)
DO 1 =1 , NCHAN
SUMDATA(I) = VVDATA(I) + 2.*VHDATA(I)
END DO
OPEN(61,FILE='TOTAL.DAT',STATUS='NEW')
WRITE(61,*)' THE TOTAL INTENSITY'
DO I = 1, NCHAN
WRITE(61,*)I, SUMDATA(I)
END DO
CLOSE(61)
DO I = 1 ,NCHAN
SUMA(I) = VVDATA(I) + 4 *VHDATA(I)
IF (SUMA(I).EQ.O) THEN
SIGMA(I) = 1.

ELSE
SIGMA® = l./(SUMA®)
END IF
END DO
OPEN(61,FILE='WEIGH.DAT',STATUS='NEW')
DO I = 1, NCHAN
WRITE(61,*)SIGMA(I)
END DO
CLOSE(61)
END

C.5

BZSIMU.m

clc; clear; echo off; clg;
% Fluorescence Anisotropy Decay Simulation Program
% supporting function: noiseg.m
% supporting data file (optional): zmax.dat
% created October 29,1991
% modified December, 1992
disp('NOTE: 1. If you will use an experimental lamp file,
');
disp('
please rename the lamp file as "lamp.mat" before you go on.');
disp('
2. C.G.S unit wil be used in this program.');
disp('
3. Do not type anything unless you see the p ro m p t» !');
disp(");
disp(' Hit space_bar to continue » ' ) ;
pause;
K_B= 1.380662e-16;
% erg/K
global noi_length;
% Find any files listed under global
a9='y'; alO =’y'; al5 = 'y '; al6 = 'y '; al9 = 'y ';
y= 1;Y= 1;n=0;N=0;
while eval(a9) == 1
% to start over
if eval(alO) == 1
% to re-calculate Bessel function
% Molecular Parameters / E l to be calculated from PL
b=le-8*input(' Helix Hydrodynamic Radius (b) in Angstrom is » '); % cm;
PL=le-8*input(' Persistence Length (PL) in Angstrom is » ');
% cm;
% Experimental Conditions
eta=input(' Viscosity in P is » ');
% P = dyn*s*(cm)-2;
Temp=input(' Temperature in Kelvin is » ');
% K;
nchan=input(' Channel number is (512/1024) » ');
t_c=le-9*input(' Time Calibreation in ns is » ');
% second;
% Calculation of Parameters & Matrix Assignment (those related to r)
EI=PL*K_B*Temp;
% Bending Ridigity, cm*erg ;
z=zeros(nchan,l);
z_0=zeros(nchan,l);
time=zeros(nchan,l);
channel=( 1:nchan); chan(:,l)=channel(:); time=t_c:!:chan;
B=zeros(nchan,l);
F=zeros(nchan,3);
10 = zeros(nchan,l);
Il= zeros(nchan,l);
K O_l=zeros(nchan,l); K l_ l= zero s(n ch an ,l);
K 0=zeros(nchan,l);
K l=zeros(nchan,l); GF=zeros(nchan,l);
FF=zeros(nchan,l);
delta=zeros(nchan,l); G=zeros(nchan,3);
zm ax=zeros(nchan,l); zm ax_l=zeros(nchan,l); zm ax_2=zeros(nchan,l);
disp (");d isp (");d isp (");d isp (");
dispC
****** TO GENERATE r(t) FROM B-Z THEORY ******'); disp("
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% Modified Bessel Function
a30 = input(' Load built-in zmax as initial guess (y/n) » ','s');
y= l;Y =l;n=0;N = 0;
if eval(a30) == 1
load zmax.dat;
zmax = zmax(l:nchan);
else
zmax=exp(z)*input(' Initial zmax is (suggested 1) » ');
end
% if a30 load zmax
disp(' Calculating r(t), please wait...');
i = sqrt(-l);
delta=exp(z_0);
zif 1 = 0; zif2 = 0; zif3 = 0; % used to monitor the loops used
while max(delta) > le-6
zm ax_l = 2*zmax.A(-l); zmax_2 = zmax/2;
zindex = length(find(zmax > 2)) + 1;
% vary from 0+1 to nchan+1
if zindex == (nchan + 1 )
% for zmax > 2 only
zif 1 = zif 1 + 1;
K0_1=1.25331414 - 0.07832358*zm ax_l + 0.02189568*zm ax_l.A2;
K 0_l=K 0_l-0.01062446*zm ax_l.A3 + 0.00587872*zm ax_l A4;
K0_ 1=K 0_ 1-0.00251540*zm ax_ 1. A5 + 0.00053208 *zm ax_l.A6;
K l _ l = l .25331414 + 0.23498619*zm ax_l - 0.03655620*zm ax_l A2;
K1_1=K1_1+0.01504268*zmax_ 1.A3 - 0.00780353*zm ax_l.A4;
K l_ l= K l_ l+ 0 .0 0 3 2 5 6 1 4 * zm ax _ l.A5 - 0.00068245*zm ax_l A6;
K 0=exp(log(K0_l) - 0.5*log(zmax) - zmax);
K l= e x p (lo g (K l_ l) - 0.5*log(zmax) - zmax);
elseif zindex == 1
% for zmax < 2 only
zif2 = zif2 + 1;
10 = iA(-0)*BESSELN(0,i*zmax);
11 = iA(-l)*B ESSELN (l,i*zm ax);
% different from HELP ?
K0 = -log(zm ax_2).*real(I0) - 0.57721566 + 0.42278420*zmax_2 A2;
K0 = K0 + 0.23069756*zmax_2.A4 + 0.03488590*zmax_2 A6;
K0 = K0 + 0.00262698*zmax_2.A8 + 0.00010750*zmax_2.A10;
K0 = KO + 0.00000740*zmax_2.A12;
K1 = zm ax.*log(zm ax_2).*real(Il) + 1 + 0.15443144*zmax_2.A2;
K1 = K 1-0.67278579*zmax_2. A4 -0 .18156897*zmax_2. A60.01919402*zm ax_2.A8;
K1 = (K 1-0.00110404*zmax_2.A10-0.00004686*zmax_2.A12).*(zmax.A(-l));
else % for both zmax
% for zmax <=2
zif3 = zif3 + 1;
IO(zindexrnchan) = iA(-0)*BESSELN(0,i*zmax(zindex:nchan));
Il(zindex:nchan) = iA( - l) :|;BESSELN(l,i*zniax(zindex:nchan));
K0(zindex:nchan) = -log(zmax_2(zindex:nchan)).*real(I0(zindex:nchan));
K0(zindex:nchan) = K0(zindex:nchan) - 0.57721566;
K0(zindex: nchan) = K0(zindex:nchan) + 0.42278420*zmax_2(zindex:nchan).A2;
K0(zindex:nchan) = K0(zindex:nchan) + 0.23069756*zmax_2(zindex:nchan).A4;
K0(zindex:nchan) = K0(zindex:nchan) + 0.03488590*zmax_2(zindex:nchan).A6;
K0(zindex:nchan) = K0(zindex:nchan) + 0.00262698:|:zmax_2(zindex:nchan).A8;
K0(zindex:nchan) = K0(zindex: nchan) + 0.0 0 0 10750*zmax_2(zindex:nchan).A10;
K0(zindex:nchan) = K0(zindex:nchan) + 0.00000740*zmax_2(zindex:nchan).A12;
Kl(zindex:nchan) = zmax(zindex:nchan).*log(zmax_2(zindex:nchan));
K1 (zindex: nchan) = Kl(zindex:nchan).*real(Il(zindex:nchan));
K l(zindex:nchan) = K1 (zindex:nehan)+l+0.15443144*zmax_2(zindex:nchan).A2;
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K l(zindex:nchan) = K1 (zindex:nchan) - 0.67278579*zmax_2(zindex:nchan).A4;
K l(zindex:nchan) = K l(zindex:nchan) - 0.18156897*zmax_2(zindex:nchan).A6;
K l(zindex:nchan) = K1 (zindex:nchan) - 0.01919402*zmax_2(zindex:nchan).A8;
K l(zindex:nchan) = K l(zindex:nchan) - 0.00110404*zmax_2(zindex:nchan).A10;
K l(zindex:nchan) = K l(zindex:nchan) - 0.00004686*zmax_2(zindex:nchan).A12;
K1 (zindex: nchan) = Kl(zindex:nchan).*(zmax(zindex:nchan).A(-l));
% for zmax > 2
K 0_l(l:zindex-1) = 1.25331414 - 0.07832358*zm ax_l(l:zindex-l);
K 0_l(l:zindex-1) = K 0_l(l:zindex-1) + 0.02189568*zm ax_l(l:zindex-l).A2;
K 0_l(l:zindex-1) = K 0_l(l:zindex-1) - 0.01062446*zm ax_l(l:zindex-l).A3;
K 0_l(l:zindex-1) = K 0_l(l:zindex-1) + 0.00587872*zm ax_l(l:zindex-l).A4;
K 0_l(l:zindex-1) = K 0_l(l:zindex-1) - 0.00251540*zm ax_l(l:zindex-l).A5;
K 0_l(l:zindex-1) = K 0_l(l:zindex-1) + 0.00053208*zm ax_l(l:zindex-l).A6;
K l_ l(l:zin d ex -1 ) = 1.25331414 + 0.23498619*zm ax_l(l:zindex-l);
K 1_ 1(1:zindex-1) = K l_ l(l:zin d ex -1 ) - 0.03655620*zm ax_l(l:zindex-l).A2;
K l_ l(l:zin d ex -1 ) = K l_ l(l:zin d ex -1 ) + 0.01504268*zm ax_l(l:zindex-l).A3;
K l_ l(l:zin d ex -1 ) = K l_ l(l:zin d ex -1 ) - 0.00780353*zm ax_l(l:zindex-l).A4;
K l_ l(l:zin d ex -1 ) = K l_ l(l:zin d ex -1 ) + 0.00325614*zm ax_l(l:zindex-l).A5;
K l_ l(l:zin d ex -1 ) = K l_ l(l:zin d ex -1 ) - 0.00068245*zm ax_l(l:zindex-l).A6;
K 0(l:zindex-1) = exp(log(K O _l(l:zindex-l)) - 0.5*log(zm ax(l:zindex-l))...
- zm ax(l:zindex-l));
K l(l:zin d ex -1 ) = ex p (lo g (K l_ l(l:zin d ex -l)) - 0.5*log(zm ax(l:zindex-l))...
- zm ax(l :zindex-1));
end
% o f if zindex
z = (K 0+(zm ax/2).*K l).A(l/4 );
z_0 = b*(5.024*pi*eta*(EI*tim e).A(-l)).A(l/4 ).* z.A(-l);
delta = abs(z_0-zmax).*abs(z_0).A(-l);
zmax = z_0;
end
% of while max(delta)
B=3.466*KJB*Tem p/(piA5*EIA3*eta)A(l/4)*z;
G F=B.*time.A(l/4)/4;
% used in loop for k = l:3
end
% a 10 if re-calculate Bessel function
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y= 1; Y= 1;n=0;N=0;
if eval(al5) == 1
% new C
C=input(' Torsional Ridigity in erg*cm is » ');
end
% a l5 if new C
rho=4*pi*eta*bA2;
A=K_B*Temp/(pi*C*rho)A(l/2);
FF=A*tim e.A(l/2 );
% used in the loop for k =1:3
y=l ;Y=1 ;n=0;N=0;
if eval(al6) == 1
% if new angle
epsilon=input(' The Angle between the Transition Dipole & the Helix Axis »
epsilon=(epsilon/180)*pi;
I=zeros(3,l);
I( 1)=(3 *(cos(epsilon))A2 -1) A2/4;
I(2)=3*(sin(2*epsilon))A2/4;
I(3)=3*(sin(epsilon))A4/4;
end
% a l 6 if new angle
y= 1;Y= 1;n=0;N=0;
a 17 = eval(a 16) + eval(a 15) + eval(a 10);
if a l7 >= 1
% new r(t)
r=zeros(nchan,l); G=zeros(nchan,3); F=zeros(nchan,3);
for k= 1:3

');
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n = k -1;
G (:,k)=exp(-(6-nA2)*GF);
F(:,k)=exp(-nA2*FF);
r=0.4*I(k).*G(:,k).*F(:,k) + r;
end
% o f for
end
% a 17 if new r(t)
*************************
a7='y';
y= l;Y =l;n=0;N = 0;
while eval(a7) == 1
% new lamp and lifetime decay
d isp(");d isp (");d isp (");
dispC ****** TO GENERATE AN IDEAL LIFETIME DECAY CURVE ******');
disp(");
y= l;Y =l;n=0;N = 0;
if eval(al9) == 1
% new parameters
Flu_the=zeros(nchan,l); Lm ax=zeros(nchan,l); L=zeros(nchan,l);
Flu_obs_max=zeros(nchan, 1);
n=input(' How M any Components of Lifetime ? » ');
for k = l:n
x=[' A lp h aJ n u m 2 str(k )' is » ']; disp(x); alpha(k)=input(");
x=[' Tau_' n u m 2 str(k )' in ns is » ']; disp(x); tau(k)=le-9*input(");
F lu jh e = alpha(k)*exp(-time/tau(k)) + Flu_the;
end
p=input(' The desired peak counts is » '); % only filename_max having max p
^

^
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^ ^
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a2=input(' Experimental or theoretical lamp (E or T) » ','s');
E=l;e=l;T=0;t=0;
if eval(a2)== 1
% a2 for theo / expt lamp
load lamp; Lmax=lamp;
else
disp(' To generate a lamp file from exp(-t/A) - exp(-t/B )');
D =le-9*input(' A in ns is » '); E =le-9*input(' B in ns is » ’);
L=zeros(nchan,l);
L=exp(-time/D)-exp(-time/E);
plmax = p/max(L);
Lmax = plmax*L;
disp(");
disp(T. Theoretical lamp with no noise added.1);
disp('2. Theoretical lamp with Gaussian noise added after convolution.');
disp('3. Theoretical lamp with Gaussian noise added before convolution.');
a3=input(' Select number 1, 2, or 3 » ');
% a3 for lamp options
if a3==3
noi_length = length(Lmax);
Lmax = Lmax + noiseg.*sqrt(Lmax);
for k = 1:nchan
if Lmax(k) < 0
Lmax(k) = 0;
end
end
end
% o f if a3
end
% of if a2
I

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * :* * * * * * * * :(;* * * * * * * * * * * * * * * * * * * * * * * *

% generate observed decay curves
Flu_obs = conv(Lmax,Flu_the);
Flu_obs = Flu_obs( 1:nchan);

% take only nchan rows o f data
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pmax = p/max(Flu_obs);
Flu_obs_max = pmax*Flu_obs;
end

% a l9 if new parameters

% To generate I_pa & I_pe from r(t), lamp, & Flu_the
I_pa_the=zeros(nchan,l);
I_pe_the=zeros(nchan,l);
I_pa_max=zeros(nchan, 1);
I_pe_max=zeros(nchan, 1);
I_pa_the = (1/3)*(1 + 2*r).*Flu_the;
I_pe_the = (1/3)*(1 - r).*Flu_the;
I_pa_obs = conv(Lmax,I_pa_the);
I_pa_obs = I_pa_obs(l: nchan);
p_I_pa_max = p/max(I_pa_obs);
I_pa_max = p_I_pa_max*I_pa_obs;
I_pe_obs = conv(Lmax,I_pe_the);
I_pe_max = p_I__pa_max*l__pe_obs( 1: nchan);
if a3==2
% noisey lamp after convolution
noi_length = length(Lmax);
Lmax = Lmax + noiseg.*sqrt(Lmax);
for k = 1: nchan
if Lmax(k) < 0
Lmax(k) = 0;
end
end
end
noi_length = length(I_pa_max);
I_pa_max = I_pa_max + noiseg.*sqrt(I_pa_max);
noi_length = length(I_pe_max);
I_pe_max = I_pe_max + noiseg.*sqrt(I_pe_max);
for k = 1:nchan
if I_pa_max(k) < 0
I_pa_max(k) = 0;
end
if I_pe_max(k) < 0
I_pe_max(k) = 0;
end
end
a4=input(' Plot Lam p & Flu_obs (Y/N) ? » ','s ') ;
y= l;Y = l;n= 0;N = 0;
axis([l 2 3 4]);axis;
if eval(a4)==l
plot( le9*tim e,Lm ax,'-', 1e9*time,Flu_obs_max( 1:length(tim e)),7);
title('Lam p (-) & Flu_obs (.)');
xlabel('TIM E (ns) '); disp(' Hit space_bar to continue » '); pause;
end
% a4 if plot lamp
a5 = input(' Plot I_pa & I_pe (Y/N) ? » ','s');
y= l;Y = l;n= 0;N = 0;
axis([l 2 3 4]);axis;
if e v a l( a 5 ) = l
plot(le9*tim e,I_pa_m ax(l:length(tim e)),':',...
Ie9*tim e,l_pe_m ax(l:length(tim e)),'—');
title('I_pa (:) & I_pe (—)'); xlabel('TIM E (ns)');
disp(' Hit space_bar to continue » '); pause;
end
% a5 if plot I_pae
disp(");
disp('****** To generate r_obs(t) from I_pa & I_pe ******');disp(");
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I_pa_z = find(I_pa_max > 0);
if max(I_pa_z) == nchan
x=[' I_pa > 0 at all ',num2str(nchan),' channels'];disp(x);
else x=[' I_pa = 0 after channel # ',num2str(max(I_pa_z))];disp(x);
end
I_pe_z = find(I_pe_max > 0);
if max(I_pe_z) == nchan
x=[' I_pe > 0 at all ',num2str(nchan),' channels'];disp(x);
else x=[' I_pe = 0 after channel # ',num2str(max(I_pe_z))];disp(x);
end
j=input(' Start calculation at channel # = » ');
k=input(' End calculation at channel # = » ');
r_obs(j:k)=(I_pa_max(j:k) - I_pe_max(j:k))./(I_pa_max(j:k) + 2*I_pe_max(j:k));
a6 = input(' Plot r_obs(t) (Y/N) ? » ',’s');
y= l;Y = l;n= 0;N = 0;
axis([l 2 3 4]);axis;
while eval(a6)==l
plot(le9*time(j:k),r_obs(j:k));
title('r_obs(t)');
xlabel('TIM E (ns)'); disp(' Hit space_bar to continue » '); pause;
a6 = input(' Print r_obs(t) (Y/N) ? » ','s');
y= l;Y = l;n= 0;N = 0;
if eval(a6)==l
p rin tjaser;
end
% a6 if print r
a6 = input(' W ant to reset the r axis (y/n) » ','s'); y= l;Y = l;n= 0;N = 0;
if eval(a6) == 1
r_min = input(' Lower value o f r axis is » ’);
r_max = input(' Upper value of r axis is » ');
v=[ le9*tim e(j), le9*time(k),r_rnin,r_max];
axis(v);
end
% a6 if
end
% a6 while plot r
a6 = input(' Plot r(t) directly from theory (Y/N) ? » ','s');
y= l;Y = l;n= 0;N = 0;
axis([l 2 3 4]);axis;
while eval(a6) == 1
plot( le9*time(j :k),r(j :k));
title('r_the(t)');
xlabel('TIM E (ns)'); disp(' Hit space_bar to continue » '); pause;
a6 = input('Print r_the(t) (Y/N) ? » ','s');
y= l;Y = l;n= 0;N = 0;
if eval(a6)==l
p rin tjaser;
end
% a6 if print r
a6 = input('W ant to reset the r axis (y/n) » ','s'); y= l;Y = l;n= 0;N = 0;
if eval(a6) == 1
r_min = input(' Low er value o f r axis is » ');
r_max = input(' Upper value of r axis is » ');
v=[le9*tim e(j),le9:i:time(k),r_min,r_max];
axis(v);
end
% a6 if reset axis
end
% a6 while plot r
disp(");
x = ['r(l) = ',num 2str(r(l)),' r(end) = ’,num2str(r(nchan))];disp(x);
x= ['r_obs(l) = ’,num 2str(r_obs(l)),’ r_obs(end) = ’,num2str(r_obs(nchan))];
disp(x);
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a7=input(' Change Lamp and lifetime parameters now (y/n) » ','s');
a l9 = ’y ’;
end
% a7 while new lamp and lifetime decay
a8=input(' Save I_pa_obs & I_pe_obs as VsimOO.VV & VsimOO.VH (y/n) »
y=l;Y =l;n=0;N = 0;
if eval(a8) == 1
vsimOOvv = [chan,I_pa_max];
vsimOOvh = [chan,I_pe_max];
vsimOOdat = [chan,Flu_obs_max];
lampdat = [chan,Lmax];
save vsimOO.vv vsimOOvv -ascii;
save vsimOO.vh vsimOOvh -ascii;
save vsimOO.dat vsimOOdat -ascii;
save lamp.dat lampdat -ascii;
disp(' I_the and lamp saved as vsimOO.dat and lamp.dat');
al8=input(' Generate a probe data file (y/n) » ','s');
y= 1; Y= 1;n=0;N=0;
if eval(al8) == 1
t_p=le-9*input(' t_p will be ');
probe=exp(-time/t_p);
probe=conv(Lmax,probe);
probe=probe( 1:nchan);
probe_max=(p/max(probe))*probe;
if a l2 == 1
% 3rd a l 2 if add noise
noi_length = length(probe_max);
probe_max = probe_max + noiseg.*sqrt(probe_max);
for k = 1:nchan
if probe_max(k) < 0
probe_max(k) = 0;
end
end
end
% 3rd a l 2 if add noise
fsimOOdat = [chan,probe_max];
save fsimOO.dat fsimOOdat -ascii;
end
% a l8 if generate probe
end
% a8 if save
a9=input(' W ant to start over (y/n) » ','s');
y= 1; Y= 1;n=0;N=0;
if eval(a9) == 1
% 2nd a9
alO=input(' W ill temperature, viscosity, b, or PL change (y/n) »
al5=input(' W ill torsional rigidity C change (y/n) » ','s');
al6=input(' W ill the angle change (y/n) » ','s');
disp(");
disp(' W ill Lamp and Lifetime decay param eters');
a l9 =input(' (including timing parameters) change (y/n) » ','s');
end
% 2nd a9 if
end
% 1st a9 while to start over
c^q -}■-f-'(■•}■-j-'j*'}■'!•-I*'}•']• 't' '}•
end of the pro^fflni

','s');

% Function noiseg.m to generate a Gaussian noise array for BZSIMU.M
% The length is noi_length given by global

','s');

function noise=noiseg;
rand('uniform ');
noise=sqrt(-2*log(rand(noi_length,l))).*cos(2*pi*rand(noi_length,l));
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